Title - 2-SUBSTITUTED HETEROARYLOXYPYRIDINES AND THEIR SALTS AND THEIR USE AS HERBICIDAL AGENTS

Abstract

Substituted 2-heteroaryloxypyridine compounds of general formula (1) and their use as herbicides, in particular for controlling weeds and / or wild grasses in useful crop plants and / or as plant growth regulators to affect the growth of useful crop plants. This also refers to herbicide and / or plant growth regulator compositions comprising one or more compounds of general formula (1).

Description

2-SUBSTITUTED HETEROARYLOXYPYRIDINES AND THEIR SALTS AND THEIR USE AS HERBICIDAL AGENTS Description The invention relates to the technical field of crop protection agents, in particular herbicides for selective control of weeds and wild plants in crops. Specifically, this invention relates to substituted 2-heteroaryloxypyridines and their salts, to processes for their preparation and their use as herbicides. Currently known pesticides for selective weed control in crops, or active compounds for controlling unwanted vegetation, present some disadvantages in their application. These disadvantages include (a) providing little or insufficient herbicidal activity against certain weeds, (b) a very narrow spectrum of weeds that can be controlled with an active compound, (c) having too low selectivity in crops, and / or (d) having an unfavorable toxicological profile. Furthermore, some active compounds can be used as plant growth regulators in some crops, while in others they may undesirably reduce yields or are compatible with the crop or only effective within a narrow application rate range. Some known active compounds cannot be produced economically on an industrial scale because the precursors and reagents are difficult to obtain or have insufficient chemical stability.In the case of other active ingredients, the effect depends too much on environmental conditions, such as climate and soil conditions. CLARKE MODET & CO. (ARGENTINA) - 30540437455 Digitally signed by PORTALTRAMITES - INPI Date: 2019.06.25 13:43:01 -03:00 Reason: Digitally Signed by the INPI Location: Buenos Aires, Argentina The herbicidal action of these known compounds should be improved, particularly at low application doses, or their compatibility with crop plants should be enhanced. WO2011 / 22313 mentions and describes 2-heteroaryloxypyridines as components that affect the glutamate receptor, offering pharmaceutical benefits. Furthermore, WO2015 / 89003 and WO2015 / 108779... WO2016 / 10731, WO2016 / 196606 and WO2017 / 11288 describe heteroaryloxybenzoles, and they were assigned herbicidal action. On the other hand, substituted 2-heteroaryloxypyridines or their salts have not been described as herbicidal compounds. Surprisingly, substituted 2-heteroaryloxypyridines or their salts have now been found to be particularly suitable as herbicidal active ingredients. The object of the present invention then comprises providing the substituted 2heteroaryloxypyridine of the general formula (I) or its salts (I) where X is nitrogen, -CF- or -CH-, A is oxygen, -S(O)n-, -C(R4)(R(I) * * * 5) -, -C(=O) - or -NR6 where n is 0, 1 or 2, R1 is an optionally substituted aryl, heteroaryl, heterocyclyl, (C3-C10)-cycloalkyl or (C3-C10)cycloalkenyl, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7; R2 are, independently of each other, halogen, cyano, nitro, formyl, formamide, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C2-C8)-alkenyl, (C2C8)-alkynyl, (C2-C8)-haloalkenyl, (C2-C8)-haloalkynyl, (C1-C4)-alkoxy(C1-C4)-alkyl, (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1C4)-alkyl, (C1-C4)-alkylsulfinyl-(C1-C4)-alkyl, (C1-C4)-alkylsulfonyl-(C1C4)-alkyl, (C1-C8)-alkylcarbonyl, (C1-C8)-haloalkylcarbonyl, (C3-C8)cycloalkylcarbonyl, carboxyl, (C1-C8)-alkoxycarbonyl, (C1-C8)haloalkoxycarbonyl, (C3-C8)-cycloalkoxycarbonyl, carbamoyl, (C2-C8)alkylaminocarbonyl, (C2-C10)-dialkylaminocarbonyl, (C3-C10)cycloalkylaminocarbonyl, (C1-C4)-alkoxycarbonyl-(C1-C4)-alkyl, (C1-C4)haloalkoxycarbonyl-(C1-C4)-alkyl, carboxy-(C1-C4)-alkyl, hydroxy, amino, (C1-C8)-alkoxy, (C1-C8)-haloalkoxy, (C1-C8)-alkylthio, (C1-C8)-haloalkylthio, (C3-C8)-cycloalkylthio, (C1-C8)-alkylsulfinyl, (C1-C8)-haloalkylsulfinyl, (C3-C8)-cycloalkylsulfinyl,(C1-C8)-alkylsulfonyl, (C1-C8)haloalkylsulfonyl, (C3-C8)-cycloalkylsulfonyl, (C1-C8)alkylaminosulfonyl, (C2-C8)-dialkylaminosulfonyl or (C3-C8)-trialkylsilyl, m is 0, 1, 2 or 3, R3 is hydrogen, halogen, cyano, nitro, formyl, (C1-C8)-alkyl, (C1-C8)haloalkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C2-C8)-haloalkenyl, (C2-C8)-haloalkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy3 (Ci-C4)-alkyl, (Ci-C4)-alkylthio-(Ci-C4)-alkyl, (Ci-C4)-alkylsulfinyl-(Ci-C4)-alkyl, (Ci-C4)-alkylsulfonyl-(Ci-C4)-alkyl, (Ci-C8)-alkylcarbonyl, (Ci-C8)-haloalkylcarbonyl, (C3-C8)-cycloalkylcarbonyl, carboxyl, (C1C8)-alkoxycarbonyl, (C1-C8)-haloalkoxycarbonyl, (C3-C8)cycloalkoxycarbonyl, (C1-C8)-alkylaminocarbonyl, (C2-C8)dialkylaminocarbonyl, (C3-C8)-cycloalkylaminocarbonyl, hydroxy, (Ci-C8)-alkoxy, (Ci-C8)-haloalkoxy, (Ci-C8)-alkylthio, (Ci-C8)-haloalkylthio, (C3C8)-cycloalkylthio, (Ci-C8)-alkylsulfinyl, (Ci-C8)-haloalkylsulfinyl, (C3C8)-cycloalkylsulfinyl, (Ci-C8)-alkylsulfonyl, (Ci-C8)-haloalkylsulfonyl, (C3-C8)-cycloalkylaminosulfonyl, (Ci-C8)-alkylaminosulfonyl, (C2-C8)dialkylaminosulfonyl or (C3-C8)-trialkylsilyl, R4 and R5 are, independently of each other, hydrogen, hydroxy, halogen, (Ci-C8)-alkyl, (Ci-C8)-haloalkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (Ci-C4)-alkoxy-(Ci-C4)-alkyl, (Ci-C4)-haloalkoxy-(Ci-C4)-alkyl, (Ci-C4)alkylthio-(Ci-C4)-alkyl, (Ci-C4)-alkylsulfinyl-(Ci-C4)-alkyl, (Ci-C4)alkylsulfonyl-(Ci-C4)-alkyl, (Ci-C8)-alkylcarbonyl, (Ci-C8)haloalkylcarbonyl, (C3-C8)-cycloalkylcarbonyl, (Ci-C8)-alkoxycarbonyl, (Ci-C8)-haloalkoxycarbonyl, (C3-C8)-cycloalkoxycarbonyl, (Ci-C8)alkylaminocarbonyl, (C2-C8)-dialkylaminocarbonyl, (C3-C8)cycloalkylaminocarbonyl, (Ci-C8)-alkoxy, (Ci-C8)-alkylthio, (Ci-C8)haloalkylthio, (C3-C8)-cycloalkylthio, or R4 and R5 together form a 3- to 6-membered carbocyclic ring or a 3- to 6-membered saturated heterocyclic ring having up to 2 oxygen atoms, R4 and R5 together form a (C1-C3)-alkylidene radical or a (C1-C3)haloalkylidene radical, R6 is hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, aryl-(C1-C6)-alkyl, heteroaryl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)alkyl, (C3-C6)-halocycloalkyl, (C3-C6)-halocycloalkyl-(C1-C4)-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1-C4)-alkyl, (C1-C4)alkylsulfinyl-(C1-C4)-alkyl (C1-C4)-alkylsulfonyl-(C1-C4)-alkyl, (C1-C8)alkylcarbonyl, (C1-C8)-haloalkylcarbonyl, (C3-C8)-cycloalkylcarbonyl, formyl, (C1-C8)-alkoxycarbonyl, (C1-C8)-haloalkoxycarbonyl, (C3-C8)cycloalkoxycarbonyl, (C1-C8)-alkylaminocarbonyl, (C2-C8)dialkylaminocarbonyl, (C3-C8)-cycloalkylaminocarbonyl, and R7 is hydrogen, halogen, cyano, nitro, formyl, (C1-C8)-alkyl, (C1-C8)haloalkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C2-C8)-haloalkenyl, (C2-C8)-haloalkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1-C4)-alkyl, (C1-C4)-alkylsulfinyl-(C1-C4)-alkyl, (C1-C4)-alkylsulfonyl-(C1-C4)-alkyl, (C1-C8)-alkylcarbonyl, (C1-C8)-haloalkylcarbonyl, (C3-C8)-cycloalkylcarbonyl, carboxyl, (C1C8)-alkoxycarbonyl, (C1-C8)-haloalkoxycarbonyl, (C3-C8)cycloalkoxycarbonyl, (C1-C8)-alkylaminocarbonyl, (C2-C8)dialkylaminocarbonyl, (C3-C8)-cycloalkylaminocarbonyl, hydroxy, (C1C8)-alkoxy, (C1-C8)-haloalkoxy, (C1-C8)-alkylthio, (C1-C8)-haloalkylthio, (C3C8)-cycloalkylthio, (C1-C8)-alkylsulfinyl, (C1-C8)-haloalkylsulfinyl, (C35 Cs)-cycloalkylsulfinyl, (C1-C8)-alkylsulfonyl, (C1-C8)-haloalkylsulfonyl, (C3-C8)-cycloalkylsulfonyl, (C1-C8)-alkylaminosulfonyl, (C2-C8)dialkylaminosulfonyl or (C3-C8)-trialkylsilyl.Compounds of General Formula (I) can be prepared by adding an inorganic or organic acid, such as mineral acids (e.g., HCl, HBr, H₂SO₄, H₃PO₄, or HNO₃) or organic acids (e.g., carboxylic acids (e.g., formic, acetic, propionic, oxalic, lactic, or salicylic acids) or sulfonic acids (e.g., p-toluenesulfonic acid), to a basic group (e.g., amino, alkylamino, dialkylamino, piperidine, morpholine, or pyridine) to form salts. These salts then contain the base conjugate to the acid as an anion. Suitable substituents, present in a deprotonated form (e.g., sulfonic acids, some amides of sulfonic acids, or carboxylic acids), can in turn form internal salts with protonable groups, such as amino groups.Salt formation can also be effected by the action of a base on compounds of General Formula (I). Suitable bases include, for example, organic amines such as trialkylamines, morpholine, piperidine, and pyridine, and hydroxides, carbonates, and bicarbonates of ammonium, alkali metals, or alkaline earth metals, and in particular, sodium and potassium hydroxide, sodium and potassium carbonate, and sodium and potassium bicarbonate. These salts are compounds in which the hydrogen of the azide is replaced by a cation suitable for agriculture, for example, metallic salts, in particular salts of alkali metals or salts of alkaline earth metals, particularly sodium and potassium salts, or ammonium salts, salts with organic amines, or quaternary ammonium salts, for example, with cations. From the formula [NRaRbRcRd] +, where Ra to Rd each independently represent an organic radical, in particular alkyl, aryl, arylalkyl or alkylaryl.Alkylsulfonium and alkylsulfoxonium salts are also suitable, such as (C1-C4) trialkylsulfonium and (C1-C4) trialkylsulfoxonium salts. The substituted 2-heteroaryloxypyridines of general formula (I) according to the present invention of Formula (I) may be present as different tautomeric structures, depending on eventual external conditions such as pH, solvent and temperature, all of which are included in General Formula (I). From now on, the compounds of Formula (I) and their salts will be referred to as compounds of the general Formula (I). A preferred object of the invention comprises compounds of the general formula (I), wherein X is nitrogen, -CF- or -CH-, A is oxygen, -S(O)n-, -C(R4)(R5) -, -C(=O) - or -NR6 where n is 0, 1 or 2, R1 is an optionally substituted aryl, heteroaryl or heterocyclyl group, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7, R2 is, independently of each other, halogen, cyano, nitro, formyl, formamide, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2C6)-alkynyl, (C2-C6)-haloalkenyl, (C2-C6)-haloalkynyl, (C1-C4)-alkoxy(C1-C4)-alkyl, (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)-alkylthio-(C17 C4)-alkyl, (Ci-C4)-alkylsulfinyl-(Ci-C4)-alkyl, (Ci-C4)-alkylsulfonyl-(CiC4)-alkyl, (C1-C6)-alkylcarbonyl, (C1-C6)-haloalkylcarbonyl, (C3-C6)cycloalkylcarbonyl, carboxyl, (C1-C6)-alkoxycarbonyl, (Ci-C6)haloalkoxycarbonyl, (C3-C6)-cycloalkoxycarbonyl, carbamoyl, (C2-C6)alkylaminocarbonyl, (C2-C8)-dialkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (Ci-C4)-alkoxycarbonyl-(Ci-C4)-alkyl, (Ci-C4)haloalkoxycarbonyl-(C1-C4)-alkyl, carboxy-(C1-C6)-alkyl, hydroxy, amino, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C6)-alkylthio, (C1-C6)-haloalkylthio, (C3-C6)-cycloalkylthio, (C1-C6)-alkylsulfinyl, (C1-C6)-haloalkylsulfinyl, (C3-C6)-cycloalkylsulfinyl, (C1-C6)-alkylsulfonyl, (C1-C6)haloalkylsulfonyl, (C3-C6)-cycloalkylsulfonyl, (C1-C6)alkylaminosulfonyl, (C2-C8)-dialkylaminosulfonyl or (C3-C8)-trialkylsilyl, m is 0, 1.2 or 3, R3 is hydrogen, halogen, cyano, nitro, formyl, (C1-C6)-alkyl, (C1-C6)haloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkenyl, (C2-C6)-haloalkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1-C4)-alkyl, (G1-G4)-alkylsulfinyl-(C1-C4)-alkyl, (C1-C4)-alkylsulfonyl-(C1-C4)-alkyl, (C1-C6)-alkylcarbonyl, (C1-C6)-haloalkylcarbonyl, (C3-C6)-cycloalkylcarbonyl, carboxyl, (C1C6)-alkoxycarbonyl, (C1-C6)-haloalkoxycarbonyl, (C3-C6)cycloalkoxycarbonyl, (C1-C6)-alkylaminocarbonyl, (C2-C8)dialkylaminocarbonyl, (C3-C6)-cycloalkylaminocarbonyl, hydroxy, (C1C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C6)-alkylthio, (C1-C6)-haloalkylthio, (C3-C6)-cycloalkylthio, (C1-C6)-alkylsulfinyl, (C1-C6)-haloalkylsulfinyl, (C3-C6)-cycloalkylsulfinyl, (C1-C6)-alkylsulfonyl, (C1-C6)8 haloalkylsulfonyl, (C3-C6)-cycloalkylaminosulfonyl, (C1-C6)alkylaminosulfonyl, (C2-Cs)-dialkylaminosulfonyl or (C3-Cs)-trialkylsilyl, R4 and R5 are,independently of each other, hydrogen, hydroxy, halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)alkylthio-(C1-C4)-alkyl, (C1-C4)-alkylsulfinyl-(C1-C4)-alkyl, (C1-C4)alkylsulfonyl-(C1-C4)-alkyl, (C1-C6)-alkylcarbonyl, (C1-C6)haloalkylcarbonyl, (C3-C6)-cycloalkylcarbonyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-haloalkoxycarbonyl, (C3-C6)-cycloalkoxycarbonyl, (C1-C6)alkylaminocarbonyl, (C2-Cs)-dialkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1-C6)-alkoxy, (C1-C6)-alkylthio, (C1-C6)haloalkylthio, (C3-C6)-cycloalkylthio, or, R4 and R5 together form a 3- to 6-membered carbocyclic ring or a 3- to 6-membered saturated heterocyclic ring having up to 2 oxygen atoms, or R4 and R5 together form a (C1-C3)-alkylidene radical or a (C1-C3)haloalkylidene radical, R6 is hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, aryl-(C1-C4)-alkyl, heteroaryl-(C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C4)alkyl, (C3-C6)-halocycloalkyl, (C3-C6)-halocycloalkyl-(C1-C4)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1-C4)-alkyl, (C1-C4)alkylsulfinyl-(C1-C4)-alkyl (C1-C4)-alkylsulfonyl-(C1-C4)-alkyl, (C1-C6)9 alkylcarbonyl, (C1-C6)9 haloalkylcarbonyl, (C3-C6)-cycloalkylcarbonyl, formyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-haloalkoxycarbonyl, (C3-C6)cycloalkoxycarbonyl, (C1-C6)-alkylaminocarbonyl, (C2-C6) dialkylaminocarbonyl, (C3-C6)-cycloalkylaminocarbonyl, and R7 is hydrogen, halogen, cyano, nitro, formyl, (C1-C6)-alkyl, (C1-C6)haloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkenyl, (C2-C6)-haloalkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy(C1-C4)-alkyl, (C1-C4)-alkylthio-(C1-C4)-alkyl, (C1-C4)-alkylsulfinyl-(C1-C4)-alkyl, (C1-C4)-alkylsulfonyl-(C1-C4)-alkyl, (C1-C6)-alkylcarbonyl, (C1-C6)-haloalkylcarbonyl, (C3-C6)-cycloalkylcarbonyl, carboxyl, (C1C6)-alkoxycarbonyl, (C1-C6)-haloalkoxycarbonyl, (C3-C6)cycloalkoxycarbonyl, (C1-C6)-alkylaminocarbonyl, (C2-Cs)dialkylaminocarbonyl, (C3-C6)-cycloalkylaminocarbonyl, hydroxy, (C1C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C6)-alkylthio, (C1-C6)-haloalkylthio, (C3C6)-cycloalkylthio, (C1-C6)-alkylsulfinyl, (C1-C6)-haloalkylsulfinyl, (C3Ce)-cycloalkylsulfinyl, (C1-C3)-alkylsulfonyl, (C1-C3)-haloalkylsulfonyl, (C3-Ce)-cycloalkylaminosulfonyl, (C1-Ce)-alkylaminosulfonyl, (C2-Cs)dialkylaminosulfonyl or (C3-Cs)-trialkylsilyl. A particularly preferred object of the invention comprises compounds of the general formula (I), wherein X is nitrogen, -CF- or -CH-, A is oxygen, -S(O)n-, -C(R4)(R5) -, -C(=O) - or -NR6 where n is 0, 1 or 2, R1 is an optionally substituted aryl, heteroaryl or heterocyclyl group, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7, R2 is, independently of each other, halogen, cyano, nitro, formyl, formamide, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C2-C4)-alkenyl, (C2C4)-alkynyl, (C2-C4)-haloalkenyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1C4)-haloalkoxy-(C1-C4)-alkyl, (C1-C4)-alkylcarbonyl, (C1-C4)haloalkylcarbonyl, carboxyl, (C1-C4)-alkoxycarbonyl, (C1-C4)haloalkoxycarbonyl, (C3-C6)-cycloalkoxycarbonyl, carbamoyl, (C2-C4)alkylaminocarbonyl, (C2-C6)-dialkylaminocarbonyl, (C1-C4)alkoxycarbonyl-(C1-C4)-alkyl, (C1-C4)-haloalkoxycarbonyl-(C1-C4)-alkyl, carboxy-(C1-C4)-alkyl, hydroxy, amino, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1-C4)-alkylaminosulfonyl, (C2-C6)-dialkylaminosulfonyl or (C3-C6)-trialkylsilyl, m is 0, 1, 2 or 3, R3 is hydrogen, halogen, cyano, nitro, formyl, (C1-C4)-alkyl, (C1-C4)haloalkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C2-C4)-haloalkenyl, (C2-C4)-haloalkynyl, (C1-C4)-alkylcarbonyl, (C1-C4)-haloalkylcarbonyl, carboxyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-haloalkoxycarbonyl, (C3-C6)cycloalkoxycarbonyl, (C1-C4)-alkylaminocarbonyl, (C2-C6)dialkylaminocarbonyl, hydroxy, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-haloalkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1-C4)-haloalkylsulfonyl, (C111 C4)-alkylaminosulfonyl, (C2-C6)-dialkylaminosulfonyl or (C3-C6)trialkylsilyl, R4 and R5 are, independently of each other, hydrogen, hydroxy, halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-haloalkoxycarbonyl or (C3-C6)cycloalkoxycarbonyl, or R4 and R5 together form a (C1-C3)-alkylidene radical or a (C1-C3)haloalkylidene radical, R6 is hydrogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, aryl-(C1-C4)-alkyl, heteroaryl-(C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C4)alkylcarbonyl, formyl or (C1-C4)-alkoxycarbonyl, and R7 is hydrogen, halogen, cyano, nitro, formyl, (C1-C4)-alkyl, (C1-C4)haloalkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C2-C4)-haloalkenyl, (C2-C4)-haloalkynyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C4)-haloalkoxy(C1-C4)-alkyl, (C1-C4)-alkylcarbonyl, (C1-C4)-haloalkylcarbonyl, carboxyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-haloalkoxycarbonyl, (C3-C6)cycloalkoxycarbonyl, (C1-C4)-alkylaminocarbonyl, (C2-C6)dialkylaminocarbonyl, (C3-C6)-cycloalkylaminocarbonyl, hydroxy, (C1C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-haloalkylthio, (C1C4)-alkylsulfinyl, (C1-C4)-haloalkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1C4)-haloalkylaminosulfonyl, (C1-C4)-alkylaminosulfonyl, (C2-C6)dialkylaminosulfonyl or (C3-C6)-trialkylsilyl. A particularly preferred object of the invention comprises compounds of the general formula (I), wherein X is nitrogen, -CF- or -CH-, A is oxygen, -S(O)n-, -C(R4)(R5) -, -C(=O) - or -NR6 where n is 0, 1 or 2, R1 is an optionally substituted phenyl, pyridyl or pyrimidiyl, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7, R2 is, independently of each other, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, carboxyl, (C1-C4)-alkoxycarbonyl, (C1-C4)alkoxycarbonyl-(C1-C3)-alkyl, (C1-C4)-haloalkoxycarbonyl-(C1-C3)-alkyl, carboxy-(C1-C3)-alkyl or (C1-C4)-alkoxy, m is 0, 1, 2 or 3, R3 is hydrogen, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C2C4)-alkenyl, (C2-C4)-alkynyl, (C2-C4)-haloalkenyl, (C2-C4)haloalkynyl, (C1-C4)-alkoxy or (C1-C4)-haloalkoxy, R4 and R5 are, independently of each other, hydrogen, halogen, (C1-C4)alkyl or (C1-C4)-alkoxycarbonyl, R6 is hydrogen, (C1-C4)-alkyl, (C1-C4)-alkylcarbonyl or (C1-C4)alkoxycarbonyl, and R7 is hydrogen, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, carboxyl, (C1-C4)-alkoxycarbonyl, hydroxy, (C1-C4)-alkoxy or (C1-C4)haloalkoxy. Another additional preferred object of the invention comprises the compounds of General Formula (I), wherein X is nitrogen, -CF- or -CH-, A is oxygen, sulfur, -CH2 - or -NR6-, R1 is an optionally substituted phenyl, pyridyl or pyrimidiyl, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7, R2 is, independently of each other, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, carboxyl, (C1-C4)-alkoxycarbonyl, (C1-C4)alkoxycarbonyl-(C1-C3)-alkyl, (C1-C4)-haloalkoxycarbonyl-(C1-C3)-alkyl, carboxy-(C1-C3)-alkyl or (C1-C4)-alkoxy, m is 0, 1, 2 or 3, R3 is hydrogen, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1C4)-alkoxy or (C1-C4)-haloalkoxy, R6 is hydrogen or methyl, and R7 is hydrogen, halogen, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1C4)-alkoxy or (C1-C4)-haloalkoxy. Another additional preferred object of the invention comprises the compounds of General Formula (I), wherein X is -CH-, -CF- or nitrogen, A is oxygen, sulfur, -CH2 - or -NR6-, R1 is an optionally substituted phenyl, pyrid-2-yl or pyrimid-2-yl, wherein each ring is optionally substituted with a maximum of 5 substituents selected independently from each other from group R7, R2 is, independently of each other, fluorine, chlorine, bromine, cyano, methyl, ethyl, trifluoromethyl, methoxy, methoxycarbonylmethyl, carboxylmethyl, m is 0, 1, 2 or 3, R3 is hydrogen, fluorine, chlorine, cyano, methyl, trifluoromethyl, methoxy, trifluoromethoxy, R6 is hydrogen or methyl, and R7 is hydrogen, fluorine, chlorine, bromine, cyano, methyl, trifluoromethyl, methoxy, trifluoromethoxy. A particularly preferred object of the invention comprises the compounds of General Formula (I), wherein X is -CH-, -CF- or nitrogen, A is oxygen, sulfur, -CH2- or -NHR1is phenyl, 4-fluorophenyl, 2,4-difluorophenyl, 3,4-difluorophenyl, 3(trifluoromethyl)phenyl, 3-methoxyphenyl, 3-chlorophenyl, 4-chlorophenyl 4cyanophenyl, 4-methylphenyl, 3-fluoro-4-methylphenyl, 4-fluoro-3-methylphenyl, 2,4difluoro-3-methoxyphenyl, 5-chloro-3-fluoropyrid-2-yl, 5-chloropyrid-2-yl, 5fluoropyrid-2-yl, 3,5-difluoropyrid-2-yl, 5-fluoropyrid-2-yl, 5-chloropyrimid2-yl; R2 is methyl, m is 0, 1 or 2, and R3 is hydrogen, fluorine, chlorine, trifluoromethyl. The general or preferred definitions of the radicals indicated above apply both to the final products of General Formula (I) and to the starting materials or intermediates required in each case for their preparation. These definitions of the radicals may be combined as needed, i.e., also within the specified preferred ranges. The compounds of General Formula (I) mentioned, or salts thereof, or their use in accordance with this invention, are of particular interest primarily for achieving greater herbicidal activity, better selectivity and / or improved manufacturability, wherein the individual radicals comprise one of the meanings already mentioned or to be mentioned below or, in particular, those in which one or more of the preferred meanings mentioned above or below are combined. With regard to the compounds according to the invention, the terms used above and those used below will be explained. These terms are known to a person skilled in the art and, in particular, have the meanings explained below: Unless otherwise defined, it is generally true that for the description of chemical groups, the bond to the skeleton or the rest of the molecule is applied by the structural unit mentioned last of the chemical group in question, that is, for example, in the case of (C2-C8)-alkenyloxy it is by the oxygen atom, and in the case of heterocyclyl-(C1-C8)-alkyl or R12O(O)C-(C1-C8)-alkyl, respectively it takes place by the carbon atom of the alkyl group. According to the invention, an “alkylsulfonyl”—representing either alone or as part of a chemical group—is a linear or branched chain alkylsulfonyl, preferably of 1 to 8, or of 1 to 6 carbon atoms, for example (but not limited to) (C1-C6)-alkylsulfonyl such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1 ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,33,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2 ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl. According to the invention, an alkylthio is - isolated or as part of a chemical group - a linear or branched S-alkyl chain, preferably of 1 to 8, or of 1 to 6 carbon atoms, such as (C1-C10)-, (C1-C6)- or (C1-C4)alkylthio, for example (but not limited to) (C1-C6)-alkylthio such as methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio, 1,1-dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2trimethylpropylthio, 1-ethyl-1-methylpropylthio and 1-ethyl-2-methylpropylthio. An “alkylsulfinyl (alkyl-S(=O)-)” is, unless otherwise defined according to the invention, an alkyl radical, which is attached by means of -S(=O)- to the skeleton, such as (C1-C10)-, (C1-C1)- or (C1-C10)-alkylsulfinyl, for example (but not limited to) (C1-C6)-alkylsulfinyl such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl., An “alkoxy” is an alkyl radical bonded to an oxygen atom, for example (but not exhaustively) (C1-C6)-alkoxy, such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy. An alkenyloxy is linked by means of an oxygen atom to an alkenyl radical, while an alkynyloxy is linked by means of an oxygen atom to an alkynyl radical such as (C2-C10)-, (C2-C3)-, or (C2-C4)-alkenoxy, or, respectively, a (C3-C10)-, (C3-C3)-, or (C3-C4)-alkynoxy. An “alkylcarbonyl” (alkyl-C(=O)-), unless otherwise defined, according to the invention, is an alkyl radical, attached by means of -C(=O)- to the skeleton, such as (C1-C10)-, (C1-C6)- or (C1-C4)-alkylcarbonyl. The number of carbon atoms refers to the alkyl radical in the alkylcarbonyl group. An alkoxycarbonyl (alkyl-OC(=O)-) comprises, unless otherwise defined: an alkyl radical, linked by means of -OC(=O)- to the backbone, such as (C1-C10)-, (C1-C6)-, or (C1-C4)-alkoxycarbonyl. The number of carbon atoms refers to the alkyl radical in the alkoxycarbonyl group. Similarly, an “alkenyloxycarbonyl” and an “alkynyloxycarbonyl”, unless otherwise defined according to the invention, are an alkenyl or alkynyl radical, respectively, linked by means of -C(=O)- to the backbone, such as (C2-C10)-, (C2-C6)-, or (C2-C4)-alkenyloxycarbonyl or (C3-C10)-, (C3-C6)-, or (C3-C4)-alkynyloxycarbonyl. The number of carbon atoms refers to the alkenyl radical or the alkynyl radical in the alken- or alkynyloxycarbonyl group. The term “aryl” means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring carbon atoms, e.g., phenyl, naphthyl, anthril, phenanthrenyl and the like, preferably phenyl. A heterocyclic radical (heterocyclyl) includes at least one saturated or partially saturated heterocyclic ring (=carbocyclic ring, in which at least one carbon atom has been replaced by a heteroatom, preferably a heteroatom from group N, O, S, or P) and may or may not be substituted, with the bonding site located on a ring atom. When the heterocyclic or heterocyclic ring is optionally substituted, it can fuse with other carbocyclic or heterocyclic rings. In the case of an optionally substituted heterocyclyl, it also includes other cyclic systems, such as, for example, 8-aza-bicyclo[3.2.1]octanyl, 8-aza-bicyclo[2.2.2]octanyl, or 1-azabicyclo[2.2.1]heptyl. In the case of an optionally substituted heterocycle, it also includes spirocyclic systems, such as, for example, 1-oxa-5-azaspiro[2,3]hexyl. Unless otherwise defined, the heterocyclic ring preferably comprises 3 to 9 ring atoms.in particular 3 to 6 atoms of the ring and most preferably 1 to 4, in particular 1,2 or 3 heteroatoms in the heterocyclic ring, preferably selected from the group N, O and S, however, it cannot have two oxygen atoms directly adjacent, such as, for example, with one heteroatom of the group N, O and S, 1- or 2- or 3pyrrolidinyl, 3,4-dihidro-2H-pyrrol-2- o 3-ilo, 2,3-dihidro-1H-pyrrol-1- o 2- o 3- o 4o 5-ilo; 2,5-dihidro-1H-pyrrol-1- o 2- o 3-ilo, 1- o 2- o 3- o 4-piperidinilo; 2,3,4,5tetrahydropyridin-2- o 3- o 4- o 5-ilo o 6-ilo; 1,2,3,6-tetrahydropyridin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,2,3,4-tetrahydropyridin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,4dihydropyridin-1- o 2- o 3- o 4-ilo; 2,3-dihydropyridin-2- o 3- o 4- o 5- o 6-ilo; 2,5dihydropyridin-2- o 3- o 4- o 5- o 6-ilo, 1- o 2- o 3- o 4-azepanilo; 2,3,4,5tetrahydro-1H-azepin-1- o 2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,4,7-Tehydro-1Hazepin-1- o 2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,6,7-tetrahydro-1H-azepin-1- o 2- o 3- o 4-ilo; 3,4,5,6-tetrahydro-2H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 4,5-dihidro1H-azepin-1- o 2- o 3- o 4-ilo; 2,5-dihidro-1H-azepin-1- o -2- o 3- o 4- o 5- o 6- o 7-ilo; 2,7-dihidro-1H-azepin-1- o -2- o 3- o 4-ilo; 2,3-dihidro-1H-azepin-1- o -2- o 3- o 4- o 5- o 6- o 7-ilo; 3,4-dihidro-2H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 3,6dihidro-2H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 5,6-dihidro-2H-azepin-2- o 3- o, 4- o 5- o 6- o 7-ilo? 4,5-dihydro-3H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 1Hazepin-1- o -2- o 3- o 4- o 5- o 6- o 7-ilo; 2H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 3H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 4H-azepin-2- o 3- o 4- o 5- o 6- o 7-ilo, 2- o 3-oxolanilo (= 2- o 3-tetrahydrofuranil); 2,3-dihydrofuran-2- o 3- o 4- o 5-yl; 2,5-dihydrofuran-2- o 3-ilo, 2- o 3- o 4-oxanilo (= 2- o 3- o 4-tetrahydropyranil); 3,4-dihydro-2H-pyran-2- o 3- o 4- o 5- o 6-ilo; 3,6-dihydro-2H-pyran-2-o3-o4-o5-o6-yl; 2H-pyran-2- o 3- o 4- o 5- o 6-ilo; 4H-pyran-2- o 3- o 4-ilo, 2- o 3- o 4oxepanyl; 2,3,4,5-tetrahydrooxepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,3,4,7tetrahydrooxepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,3,6,7-tetrahydrooxepin-2- o 3- o 4-yl; 2,3-dihydrooxepin-2- o 3- o 4- o 5- o 6- o 7-yl; 4,5-dihydrooxepin-2- o 3- o 4-yl; 2,5-dihydrooxepin-2- o 3- o 4- o 5- o 6- o 7-yl; oxepin-2- o 3- o 4- o 5- o 6o 7-yl; 2- o 3-tetrahydrothiophenyl; 2,3-dihydrothiophen-2- o 3- o 4- o 5-yl;2,5dihydrothiophene-2- o 3-heme; tetrahydro-2H-thiopyran-2- o 3- o 4-hero; 3,4-dihydro-2Hthiopyran-2- o 3- o 4- o 5- o 6-heart; 3,6-dihydro-2H-thiopyran-2- o 3- o 4- o 5- o 6-il; 2H-thiopyran-2- o 3- o 4- o 5- o 6-heart; 4H-thiopyran-2- or 3- or 4-heart. Preferred 3-ring and 4-ring heterocycles comprise, for example, 1- or 2-aziridinyl, oxyranyl, thiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thiatanyl, 1,3dioxetan-2-yl. Other examples of “heterocyclyl” comprise a partially or fully hydrogenated heterocyclic radical having two heteroatoms of the N, O and S group, such as, for example, 1- or 2- or 3- or 4-pyrazolidinyl; 4,5dihydro-3H-pyrazole- 3- o 4- o 5-yl; 4,5-dihydro-1H-pyrazole-1- o 3- o 4- o 5-yl; 2,3dihydro-1H-pyrazole-1- o 2- o 3- o 4- o 5-yl; 1- o 2- o 3- o 4-imidazolidinyl; 2,3dihydro-1H-imidazole-1- o 2- o 3- o 4-il; 2,5-dihydro-1H-imidazole-1- o 2- o 4- o 5il; 4,5-dihydro-1H-imidazole-1- o 2- o 4- o 5-il; hexahydropyridazine-1- o 2- o 3- o 4-heart;1,2,3,4-tetrahidropiridazin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,2,3,6 tetrahidropiridazin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,4,5,6-tetrahidropiridazin-1- o 3o 4- o 5- o 6-ilo; 3,4,5,6-tetrahidropiridazin-3- o 4- o 5-ilo; 4,5-dihidropiridazin-3o 4-ilo; 3,4-dihidropiridazin-3- o 4- o 5- o 6-ilo; 3,6-dihidropiridazin-3- o 4-ilo; 1,6-dihydropiriazin-1- o 3- o 4- o 5- o 6-ilo; hexahidropirimidin-1- o 2- o 3- o 4-ilo; 1,4,5,6-tetrahydropyrimidin-1- o 2- o 4- o 5- o 6-ilo; 1,2,5,6-tetrahydropyrimidin-1o 2- o 4- o 5- o 6-ilo; 1,2,3,4-tetrahydropyrimidin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,6dihidropirimidin-1- o 2- o 4- o 5- o 6-ilo; 1,2-dihydropyrimidin-1- o 2- o 4- o 5- o 6ilo; 2,5-dihidropirimidin-2- o 4- o 5-ilo; 4,5-dihidropirimidin- 4- o 5- o 6-ilo; 1,4dihidropirimidin-1- o 2- o 4- o 5- o 6-ilo; 1- o 2- o 3-piperazinilo; 1,2,3,6tetrahidropirazin-1- o 2- o 3- o 5- o 6-ilo; 1,2,3,4-tetrahidropirazin-1- o 2- o 3- o 4- o 5- o 6-ilo; 1,2-dihidropirazin-1- o 2- o 3- o 5- o 6-ilo;1,4-dihydropyrazin-1- o 2- o 3-yl; 2,3-dihydropyrazin-2- o 3- o 5- o 6-ilo; 2,5-dihydropyrazin-2-o 3-yl; 1,3dioxolan-2- o 4- o 5-ilo; 1,3-dioxol-2-o 4-yl; 1,3-dioxan-2- o 4- o 5-yl; 4H-1,3dioxin-2- o 4- o 5- o 6-ilo; 1,4-dioxan-2- o 3- o 5- o 6-ilo; 2,3-dihydro-1,4-dioxin2- o 3- o 5- o 6-ilo; 1,4-dioxin-2- o 3-ilo; 1,2-dithiolan-3- o 4-ilo; 3H-1,2-dithiol-3- o 4- o 5-yl; 1,3-dithiolane-2- o 4-ilo; 1,3-dithiol-2- o 4-yl; 1,2-dithiane-3- or 4-ilo; 3,4dihydro-1,2-dithiin-3- o 4- o 5- o 6-yl; 3,6-dihydro-1,2-dithiin-3-o 4-yl; 1,2-dithiin-3-o 4-ilo; 1,3-dithian-2- o 4- o 5-ilo; 4H-1,3-dithiin-2- o 4- o 5- o 6-ilo; isoxazolidin-2- o 3- o 4- o 5-ilo; 2,3-dihydroisoxazol-2- o 3- o 4- o 5-ilo; 2,5-dihydroisoxazol-2- o 3o 4- o 5-yl; 4,5-dihydroisoxazol-3- o 4- o 5-yl; 1,3-oxazolidin-2- o 3- o 4- o 5-yl; 2,3-dihydro-1,3-oxazol-2- o 3- o 4- o 5-yl; 2,5-dihydro-1,3-oxazol-2- o 4- o 5-yl; 4,5-dihydro-1,3-oxazol-2- o 4- o 5-yl; 1,2-oxazinan-2- o 3- o 4- o 5- o 6-yl;3,4dihydro-2H-1,2-oxazin-2- o 3- o 4- o 5- o 6-ilo; 3,6-dihidro-2H-1,2-oxazin-2- o 3o 4- o 5- o 6-ilo; 5,6-dihidro-2H-1,2-oxazin-2- o 3- o 4- o 5- o 6-ilo; 5,6-dihidro4H-1,2-oxazin-3- o 4- o 5- o 6-ilo; 2H-1,2-oxazin-2- o 3- o 4- o 5- o 6-ilo; 6H-1,2 oxazin-3- o 4- o 5- o 6-ilo; 4H-1,2-oxazin-3- o 4- o 5- o 6-ilo; 1,3-oxazinan-2- o 3- o 4- o 5- o 6-ilo; 3,4-dihidro-2H-1,3-oxazin-2- o 3- o 4- o 5- o 6-ilo; 3,6dihidro-2H-1,3-oxazin-2- o 3- o 4- o 5- o 6-ilo; 5,6-dihidro-2H-1,3-oxazin-2- o 4o 5- o 6-ilo; 5,6-dihidro-4H-1,3-oxazin-2- o 4- o 5- o 6-ilo; 2H-1,3-oxazin-2- o 4o 5- o 6-ilo; 6H-1,3-oxazin-2- o 4- o 5- o 6-ilo; 4H-1,3-oxazin-2- o 4- o 5- o 6-ilo; morpholin-2- o 3- o 4-ilo; 3,4-dihidro-2H-1,4-oxazin-2- o 3- o 4- o 5- o 6-ilo; 3,6dihidro-2H-1,4-oxazin-2- o 3- o 5- o 6-ilo; 2H-1,4-oxazin-2- o 3- o 5- o 6-ilo; 4H1,4-oxazin-2- o 3-ilo; 1,2-oxazepan-2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,4,5tetrahydro-1,2-oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo;2,3,4,7-tetrahydro-1,2oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,5,6,7-tetrahydro-1,2-oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 4,5,6,7-tetrahydro-1,2-oxazepin-3- o 4- o 5- o 6- o 7-yl; 2,3-dihydro-1,2oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,5-dihydro-1,2-oxazepin-2- o 3- o 4- o 5o 6- o 7-yl; 2,7-dihydro-1,2-oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 4,5-dihydro1,2-oxazepin-3- o 4- o 5- o 6- o 7-ilo; 4,7-dihydro-1,2-oxazepin-3- o 4- o 5- o 6- o 7-ilo; 6,7-dihydro-1,2-oxazepin-3- o 4- o 5- o 6- o 7-ilo; 1,2-oxazepin-3- o 4- o 5o 6- o 7-ilo; 1,3-oxazepan-2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,4,5-tetrahydro-1,3oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,3,4,7-tetrahydro-1,3-oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,3,6,7-tetrahydro-1,3-oxazepin-2- o 3- o 4- o 5- o 6- o 7-yl; 2,5,6,7-tetrahydro-1,3-oxazepin-2- o 4- o 5- o 6- o 7-yl; 4,5,6,7-tetrahydro-1,3oxazepin-2- o 4- o 5- o 6- o 7-yl;2,3-dihydro-1,3-oxazepin-2- o 3- o 4- o 5- o 6o 7-ilo; 2,5-dihydro-1,3-oxazepin-2- o 4- o 5- o 6- o 7-ilo; 2,7-dihydro-1,3oxazepin-2- o 4- o 5- o 6- o 7-ilo; 4,5-dihydro-1,3-oxazepin-2- o 4- o 5- o 6- o 7ilo; 4,7-dihydro-1,3-oxazepin-2- o 4- o 5- o 6- o 7-ilo; 6,7-dihydro-1,3-oxazepin-2o 4- o 5- o 6- o 7-ilo; 1,3-oxazepin-2- o 4- o 5- o 6- o 7-ilo; 1,4-oxazepan-2- o 3 o 5- o 6- o 7-ilo; 2,3,4,5-tetrahydro-1,4-oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,4,7-tetrahydro-1,4-oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3,6,7-tetrahydro1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; 2,5,6,7-tetrahydro-1,4-oxazepin-2- o 3- o 5 o 6- o 7-ilo; 4,5,6,7-tetrahydro-1,4-oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 2,3dihydro-1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; 2,5-dihydro-1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; 2,7-dihydro-1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; 4,5-dihydro-1,4oxazepin-2- o 3- o 4- o 5- o 6- o 7-ilo; 4,7-dihydro-1,4-oxazepin-2- o 3- o 4- o 5o 6- o 7-ilo;6,7-dihidro-1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; 1,4-oxazepin-2- o 3- o 5- o 6- o 7-ilo; isotiazolidin-2- o 3- o 4- o 5-ilo; 2,3-dihidroisotiazol-2- o 3- o 4- o 5-ilo; 2,5-dihidroisotiazol-2- o 3- o 4- o 5-ilo; 4,5-dihidroisotiazol-3- o 4- o 5ilo; 1,3-tiazolidin-2- o 3- o 4- o 5-ilo; 2,3-dihidro-1,3-tiazol-2- o 3- o 4- o 5-ilo; 2,5-dihidro-1,3-tiazol-2- o 4- o 5-ilo; 4,5-dihidro-1,3-tiazol-2- o 4- o 5-ilo; 1,3tiazinan-2- o 3- o 4- o 5- o 6-ilo; 3,4-dihidro-2H-1,3-tiazin-2- o 3- o 4- o 5- o 6ilo; 3,6-dihidro-2H-1,3-tiazin-2- o 3- o 4- o 5- o 6-ilo; 5,6-dihidro-2H-1,3-tiazin-2o 4- o 5- o 6-ilo; 5,6-dihidro-4H-1,3-tiazin-2- o 4- o 5- o 6-ilo; 2H-1,3-tiazin-2- o 4- o 5- o 6-ilo; 6H-1,3-tiazin-2- o 4- o 5- o 6-ilo; 4H-1,3-tiazin-2- o 4- o 5- o 6-ilo. Additional examples of “heterocyclic” include partially or completely hydrogenated heterocyclic radicals with 3 heteroatoms selected from the group N, O and S, such as, for example, 1,4,2-dioxazolidin-2- o 3- or 5-ilo;1,4,2-dioxazole-3- or 5-yl; 1,4,2-dioxazine-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,4,2dioxazine-3- or 5- or 6-yl; 1,4,2-dioxazine-3- or 5- or 6-yl; 1,4,2-dioxazepane-2- or 3- or 5- or 6- or 7-yl; 6,7-dihydro-5H-1,4,2-dioxazepine-3- or 5- or 6- or 7-yl; 2,3-dihydro7H-1,4,2-dioxazepine-2- or 3- or 5- or 6- or 7-yl; 2,3-dihydro-5H-1,4,2-dioxazepine-2o 3- or 5- or 6- or 7-yl; 5H-1,4,2-dioxazepine-3- or 5- or 6- or 7-yl; 7H-1,4,2dioxazepine-3- or 5- or 6- or 7-yl. Structural examples of other optionally substituted heterocycles are listed below:; JN N . ¿X'-'X ΧΧ / NN«XX^N^ X\ / N ^xC / N * / CÑx> X) o^X ^A^-N S'^X >X\ / -'NI^^N NXX^ X\ZN *-''CZ-^N 1 z^N 1 ^N— ^XX^N'^~ , N XX^X X'XXX X'''^ N^~^ χΧ·^^ X^N^ N X'^'N'^^ ^^^2^ X'^N'' x: b *X'''N''^ X'^N^''^ x'X'N^''''^ N^NX^N^ X^'N'^'^ ^' ^' .. . ^^''''•N''^ N^''^ ^^-N^ X^Ñ^ x^xN X'~'N^X χΧχ ^z^-N'^ ^^^ΝζΖ XJ] ^x'-CZ'N—' '•^^Z'^N ^j^^N^ N ^j^^N^ ^j^^N^ A Φ '''^ZZ'Zx i5 Z\^NX> Ν^'''-^'^ X-^^N φ Φ >zZNZ N^^ φΖ^Ν ^0 When a basal group is substituted by one or more radicals from a list of radicals (= group) or a generically defined group of radicals, this includes in each case the simultaneous substitution with a plurality of radicals that may be structurally the same and / or different. If this were the case, the nitrogen of a partially or completely saturated heterocycle could be associated with the rest of the molecule by means of a carbon or a nitrogen. Suitable substituents of substituted heterocyclic radicals are those mentioned later, as well as oxo and thioxo groups. An oxo group as a substituent on a carbon atom of the ring represents, for example, a carbonyl group on the heterocyclic ring. Therefore, they preferably also include lactones and lactams. An oxo group can also be present on hetero atoms of the ring, for example, on N and S, and can exist in different oxidation states. Thus, for example, it can form divalent groups N(O), S(O) (also called SO), and S(O)₂ (also called SO₂) on the heterocyclic ring. In the case of the N(O)⁻ and -S(O)⁻ groups, both enantiomers are included. According to the invention, the term “heteroaryl” refers to heterocyclic compounds, i.e., fully unsaturated aromatic heterocyclic compounds, preferably with 5- to 7-membered rings with 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O, S or N. De acuerdo con la invención, un heteroarilo comprende, por ejemplo, 1H-pyrrol-1-ilo; 1H-pyrrol-2-yl; 1H-pyrrol-3-yl; furan-2-yl; furan-3-yl; thien-2-ilo; thien-3-yl, 1H-imidazol-1-yl; 1H-imidazol-2-yl; 1H-imidazol-4-yl; 1H-imidazol-5yl; 1H-pyrazol-1-yl; 1H-pyrazol-3-yl; 1H-pyrazol-4-yl; 1H-pyrazol-5-ilo, 1H-1,2,3triazol-1-ilo, 1H-1,2,3-triazol-4-ilo, 1H-1,2,3-triazol-5-ilo, 2H-1,2,3-triazol-2-ilo, 2H-1,2,3-triazol-4-ilo, 1H-1,2,4-triazol-1-ilo, 1H-1,2,4-triazol-3-ilo, 4H-1,2,4triazol-4-ilo, 1,2,4-oxadiazol-3-ilo, 1,2,4-oxadiazol-5-ilo, 1,3,4-oxadiazol-2-ilo, 1,2,3-oxadiazol-4-ilo, 1,2,3-oxadiazol-5-ilo, 1,2,5-oxadiazol-3-yl, azepinyl, pyridin-2-ilo, pyridin-3-ilo, pyridin-4-ilo, pyrazin-2-ilo, pyrazin-3-ilo, pyrimidin-2-ilo, pyrimidin-4-ilo, pyrimidin-5-ilo, pyridazin-3-ilo, pyridazin-4-ilo, 1,3,5-triazin-2-ilo, 1,2,4-triazin-5-ilo, 1,2,4-triazin-6-ilo, 1,2,3-triazin-4-ilo, 1,2,3triazin-5-ilo, 1,2,4-, 1,3,2-, 1,3,6- and 1,2,6-oxazinilo,isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, 1,3-oxazol-2-yl, 1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3-thiazol-2-yl, 1,3-thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1,2,3,4-oxatriazol-5-yl, 1,2,3,4-thiatriazol-5-yl, 1,2,3,5-oxatriazol-4-yl, 1,2,3,5-thiatriazol-4-yl. The heteroaryl groups according to the present invention may further be substituted with one or more identical or different radicals. If two adjacent carbon atoms form part of another aromatic ring, these are fused heteroaromatic systems, such as fused or multiple-fused benzo heteroaromatics. Quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl); isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl,isoquinolin-4ilo, isoquinolin-5-ilo, isoquinolin-6-ilo, isoquinolin-7-ilo, isoquinolin-8-il);, quinoxalines; quinazolines; cinnolines; 1,5-naphthyridin; 1,6-naphthyridin; 1,7naphthyridin; 1,8-naphthyridin; 2,6-naphthyridin; 2,7-naphthyridin; phthalazine; pyridopyrazine; pyridopyrimidine; pyridopyridazine; pteridine;pyrimidopyrimidine. The heteroaryl examples also comprise fused benzo rings 5 ​​or 6 members selected from the group 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indol4-yl, 1H-indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran-5-yl, 1-benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophen-2-yl, 1-benzothiophen-3-yl, 1-benzothiophen-4-yl, 1benzothiophen-5-yl, 1-benzothiophen-6-yl, 1-benzothiophen-7-yl, 1H-indazol-1-yl, 1Hindazol-3-yl, 1H-indazol-4-yl, 1H-indazol-5-yl, 1H-indazol-6-yl, 1H-indazol-7yl, 2H-indazol-2-yl, 2H-indazol-3-yl, 2H-indazol-4-yl, 2H-indazol-5-yl, 2Hindazol-6-yl, 2H-indazol-7-yl, 2H-isoindol-2-yl, 2H-isoindol-1-yl, 2H-isoindol-3yl, 2H-isoindol-4-yl, 2H-isoindol-5-yl, 2H-isoindol-6-yl;2H-isoindol-7-yl, 1H-benzimidazol-1-yl, 1H-benzimidazol-2-yl, 1H-benzimidazol-4-yl, 1H-benzimidazol-5-yl, 1H-benzimidazol-6-yl, 1H-benzimidazol-7-yl, 1,3benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3-benzthiazol-5-yl, 1,3-benzthiazol-6yl, 1,3-benzthiazol-7-yl, 1,3-benzthiazol-2-yl, 1,3-benzthiazol-4-yl, 1,3-benzthiazol-5-yl, 1,3-benzthiazol-6-yl, 1,3-benzthiazol-7-yl, 1,2-benzisoxazol-3-yl, 1,2-benzisoxazol-4-yl, 1,2-benzisoxazol-5-yl, 1,2-benzisoxazol-6-yl, 1,2-benzisoxazol-7-yl, 1,2-benzisothiazol-3-yl, 1,2-benzisothiazol-4-yl, 1,2-benzisothiazol-5-yl, 1,2-benzisothiazol-6-yl, 1,2-benzisothiazol-7-yl.; The term halogen means, for example, fluorine, chlorine, bromine, or iodine. When the term is used for a radical, then halogen means, for example, an atom of fluorine, chlorine, bromine, or iodine. According to the invention, an “alkyl” refers to a saturated open-chain hydrocarbon radical, either linear or branched, which is optionally monosubstituted or polysubstituted, and in the latter case is called a “substituted alkyl.” Preferred substituents comprise halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino, or nitro groups, with methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine, or iodine being particularly preferred. The prefix “bis” also includes the combination of different alkyl radicals, for example, methyl(ethyl) or ethyl(methyl). A “haloalkyl”, “haloalkenyl” and “haloalkynyl” comprise identical or different halogen atoms, partially or completely substituted alkyl, alkenyl, alkynyl, e.g. monohaloalkyl (= monohaloalkyl) such as, e.g., CH2CH2CL CH2CH2Br, CHCOH3, CH2C CH2F; perhaloalkyl such as, e.g., CCl3, CClF2, CFCl2, CF2CClF2, CF2CClFCF3; polyhaloalkyl such as, e.g., CH2CHFCl, CF2CClFH, CF2CBrFH, CH2CF3; the term perhaloalkyl also includes the term perfluoroalkyl. A “haloalkoxy” comprises, for example, OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3 and OCH2CH2Cl; the same applies to a haloalkenyl and other halogen-substituted radicals. Here, the example of the term “(C1-C4)-alkyl” indicates an abbreviated notation for a linear or branched-chain alkyl group comprising one to four carbon atoms corresponding to the given range of carbon atoms; that is, it includes methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl, or tert-butyl radicals. General alkyl radicals having a greater specified range of carbon atoms, for example, “(C1-C6)-alkyl,” also include a linear or branched-chain alkyl radical with a greater number of carbon atoms; that is, for example, alkyl radicals with five and six carbon atoms. Unless otherwise specified, hydrocarbon radicals such as alkyl, alkenyl, and alkynyl radicals, also in compound radicals, constitute lower carbon skeletons, for example, of 1 to 6 carbon atoms or of unsaturated groups with 2 to 6 carbon atoms. Alkyl radicals, also in compound radicals such as alkoxy, haloalkyl, etc., mean, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyl, hexyl, such as n-hexyl, i-hexyl, and 1,3-dimethylbutyl, heptyl, such as heptyl, 1-methylhexyl, and 1,4-dimethylpentyl; alkenyl and alkynyl radicals refer to possible unsaturated radicals corresponding to alkyl radicals, comprising at least one double or triple bond. Radicals with a double or triple bond are preferred. The term “alkenyl” also includes in particular open-chain or linear-branched hydrocarbon radicals with more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, and also allenyl or cumulenyl radicals, which have one or more cumulative double bonds, for example, allenyl (1,2-propadienyl), 1,2-butadienyl and 1,2,3-pentatrienyl. An alkenyl comprises, for example, vinyl, which may be optionally substituted with alkyl radicals, for example (but not exhaustively) (C2-C6)-alkenyl such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenilo, 1-ethyl-1-propenilo, 1-ethyl-2-propenilo, 1-hexenilo, 2-hexenilo, 3-hexenilo, 4hexenilo, 5-hexenilo, 1-methyl-1-pentenilo, 2-methyl-1-pentenilo, 3-methyl-1pentenilo, 4-methyl-1-pentenilo, 1-methyl-2-pentenilo, 2-methyl-2-pentenilo, 3-methyl-2pentenilo, 4-methyl-2-pentenilo, 1-methyl-3-pentenilo, 2-methyl-3-pentenilo, 3-methyl-3pentenilo, 4-methyl-3-pentenilo, 1-methyl-4-pentenilo, 2-methyl-4-pentenilo, 3-methyl-4pentenilo, 4-methyl-4-butenylo, 1,1-dimethyl-2-butenylo, 1,1-dimethyl-3-butenylo, 1,2dimethyl-1-butenylo, 1,2-dimethyl-2-butenylo, 1,2-dimethyl-3-butenylo, 1,3-dimethyl-1butenylo, 1,3-dimethyl-2-butenylo, 1,3-dimethyl-3-butenylo, 2,2-dimethyl-3-butenylo, 2,3-dimethyl-1-butenylo, 2,3-dimethyl-2-butenylo, 2,3-dimethyl-3-butenylo, 3,3-dimethyl1-butenylo, 3,3-dimethyl-2-butenylo, 1-ethyl-1-butenylo, 1-ethyl-2-butenyl, 1-ethyl-3butenyl, 2-ethyl-1-butenilo, 2-ethyl-2-butenilo, 2-ethyl-3-butenilo, 1,1,2-trimethyl-2propenilo, 1-ethyl-1-methyl-2-propenilo,1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl. The term “alkynyl” also includes in particular open-chain or linear-branched hydrocarbon radicals with more than one double bond or also with one or more triple bonds and one or more double bonds, such as, for example, 1,3-butatrienyl or 3-penten-1-en-1-yl.A (C2-C6)-alkynyl group means, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-di-methyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl. The term “cycloalkyl” means a saturated carbocyclic ring system preferably comprising 3–8 ring carbon atoms, for example, cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl, which is further optionally substituted, preferably with hydrogen, alkyl, alkoxy, cyano, nitro, alkylthio, haloalkylthio, halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkoxycarbonyl, hydroxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, or cycloalkylaminocarbonyl. In the case of optionally substituted cycloalkyls, the cyclic systems include substituents where such substituents also include a double bond in the cycloalkyl radical, for example, an alkylidene group such as methylidene. In the case of optionally substituted cycloalkyls, they also include polycyclic aliphatic systems, such as, for example, bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[1.1.1]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]hept-2-yl, bicyclo[2.2.2]octan-2-yl, bicyclo[3.2.1]octan-2-yl, bicyclo[3.2.2]nonan-2-yl, adamantan-1-yl and adamantan-2-yl, but also systems such as, for example, 1,1'-bi(cyclopropyl)-1-yl, 1,1'-bi(cyclopropyl)-2-yl. The term “(C3-C7)-cycloalkyl” refers to an abbreviated notation of a cycloalkyl with three to seven carbon atoms corresponding to the range of carbon atoms. In the case of substituted cycloalkyls, they also include spirocyclic aliphatic systems, such as, for example, spiro[2.2]pent-1-yl, spiro[2.3]hex-1-yl, spiro[2.3]hex-4-yl, 3-spiro[2.3]hex-5-yl, spiro[3.3]hept1-yl, spiro[3.3]hept-2-yl. A “cycloalkenyl” refers to a partially unsaturated, non-aromatic, carbocyclic ring system, preferably of 4–8 carbon atoms, for example 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl, and also includes substituents with a double bond on the cycloalkenyl radical, for example an alkylidene group such as methylidene. In the case of optionally substituted cycloalkenyls, the description given for substituted cycloalkyls applies. The term “alkylidene,” for example also in the form (C1-C10)alkylidene, refers to a residue of an open-chain or branched-chain hydrocarbon radical linked by a double bond. Since the attachment site of the natural alkylidene is only the position in the parent group where two hydrogen atoms can be replaced by a bond, the radicals include, for example, =CH2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5, or =C(C2Hs)-C2Hs. A cycloalkylidene is a carbocyclic radical linked by a double bond. An “arylalkyl” refers to an aryl radical attached to an alkyl group, a “heteroarylalkyl” refers to a heteroaryl radical attached to an alkyl group, and a “heterocyclylalkyl” refers to a heterocyclyl radical attached to an alkyl group. According to the invention, a haloalkylthio - alone or as part of a chemical group - is a linear or branched chain S-haloalkyl, preferably of 1 to 8, or 1 to 6, carbon atoms, such as (C1-C8)-, (C1C6)- or (C1-C4)-haloalkylthio, for example (but not exhaustively) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio. A “halocycloalkyl” refers to a cycloalkyl partially or completely substituted with the same or different halogen atoms, such as, for example, F, Cl and Br, or haloalkyl, such as, for example, trifluoromethyl or difluoromethyl, for example 1-fluorocycloprop-1-yl, 2-fluorocycloprop-1-yl, 2,2-difluorocycloprop-1-yl, 1-fluorocyclobut-1-yl, 1-trifluoromethylcycloprop-1-yl, 2-trifluoromethylcycloprop-1-yl, 1-chlorocycloprop-1-yl, 2-chlorocycloprop-1-yl, 2,2-dichlorocycloprop-1-yl, 3,3-difluorocyclobutyl. De acuerdo con la invención, un trialquilsililo” - solo o como parte de un grupo químico - es Si-alquilo de cadena lineal o ramificada, preferiblemente de 1 a 8, o de 1 a 6, átomos de carbono, tal como tri-[(C1-C8)-, (C1-C6)- o (C1-C4)alquil]sililo, por ejemplo (pero en un sentido non taxativo) trimetilsilo, trietilsilo, tri-(n-propil)silo, tri-(iso-propil)silo, tri-(n-butil)silo, tri-(1-metilprop-1-il)silo, tri(2-metilprop-1 -il)silo, tri(1,1 -dimetilet-1 -il)silo, tri(2,2-dimetilet-1 -il)sililo. When compounds can form tautomers by a hydrogen exchange, which structurally would not be represented by General Formula (I), they are nevertheless considered to be included in the definition of compounds of General Formula (I) according to the present invention, unless a particular tautomer is the object of consideration. For example, many carbonyl compounds can exist in both the keto and enol forms, both of which are included in the definition of the compound of General Formula (I). Compounds in General Formula (I) can exist as stereoisomers depending on the nature and attachment of their substituents. All possible stereoisomers, defined by their specific spatial arrangement, such as enantiomers, diastereomers, and Z and E isomers, are included in General Formula (I). For example, if one or more alkenyl groups are present, diastereomers (Z and E isomers) may exist. Similarly, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers may exist. Stereoisomers can be obtained from the resulting preparation mixtures using conventional separation methods. Chromatographic separation can be performed on an analytical scale to determine enantiomeric or diastereomeric excess, or on a preparative scale for preparing test samples for biological assays.Similarly, stereoisomers can be selectively prepared using stereoselective reactions with optically active sources and / or adjuvants. Therefore, the invention also includes all stereoisomers comprising the general formula (I), without specifying their particular stereoform, and mixtures thereof. If the compounds are obtained as solids, purification can also be carried out by recrystallization or digestion. Unless the individual Compounds (I) can be satisfactorily obtained by the routes described below, they can be prepared by derivatization from other Compounds (I). Suitable methods for isolating, purifying, and separating stereoisomers of compounds of General Formula (I) are those well known to practitioners in analogous cases. These methods include physical methods such as crystallization, chromatographic methods (especially column chromatography and HPLC - high-performance liquid chromatography), distillation (optionally under reduced pressure), extraction, and other methods, where residual mixtures can be removed, for example, by chromatographic separation. For the separation of chiral solid phases, whether for preparative quantities or on an industrial scale, processes such as crystallization can be employed. For example, diastereomeric salts can be obtained from diastereomeric mixtures with optically active acids and, optionally, in the presence of acidic groups with optically active bases. The present invention also claims processes for the preparation of compounds of general formula (I) according to the invention. The compounds of the general formula (I) according to the present invention can be prepared, among other methods, by known methods. The synthetic routes used and investigated are based on commercially available or readily available building blocks. The groups X, A, R1, R2, R3, and m of the general formula (I) have the meanings defined above in the following schemes, unless other, non-restrictive, examples of definitions are specified. The compounds according to the invention where A is S(O)n can be prepared, for example, by the method described in Scheme 1. (EI) Scheme 1. Pyridines of the general formula (la) can be prepared by coupling pyridines (E-III), where LG is a leaving group, with a disulfide (E-IV) in the presence of zinc (O) and palladium catalysts (such as Pd(dppf)Cl2.CH2Cl2) or copper (O) and a base. The base can be an acetate salt of an alkali metal (such as sodium or potassium). In general, the reactions are carried out in an organic solvent, such as tetrahydrofuran, dimethyl sulfoxide, or dimethylformamide, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of the general formula (E-III) can be prepared by alkylation of pyridines (EI) in the presence of bases with a pyri(mi)dine (E-II), where LG is a leaving group, and copper(I) salts. The base can be a carbonate salt of an alkali metal (such as, for example, sodium, potassium, or cesium). The copper salts can be copper halides, such as, for example, copper(I) iodide. In general, the reactions are carried out in an organic solvent, such as acetonitrile or dimethylformamide, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of general formula (EI) are known from the literature and can be prepared, for example, according to the methods described in Organic Letters (2016), 18, 3106-9, WO2013 / 14170 and the like. The compounds according to the invention where n is 2 can be prepared, for example, by the method described in Scheme 2. Scheme 2 Sulfones and sulfoxides of general formula (Ib) can be prepared by oxidation of a pyridine (Ia). Such reactions are known to those skilled in the art and are described, for example, in Advanced Synthesis & Catalysis (2011), 353(2+3), 295-302. (EV) (E-II) (E-VI) (E-VII) (E-VIII) Scheme 3. (Ic) Pyridines of general formula (Ic) can be prepared by coupling pyridines (E-VII) with an alkyl halide (E-VIII), where Hal is a halogen, in the presence of palladium catalysts (such as, for example, Pd(PPh3)4) and a base. The base can be a carbonate salt of an alkali metal (such as, for example, sodium or potassium). In general, the reactions are carried out in an organic solvent such as, for example, tetrahydrofuran, toluene, or ethanol, with or without the addition of water, at temperatures between °C and the boiling point of the solvent. Pyridines of the general formula (E-VII) can be prepared by coupling pyridines (E-VI), where Hal is a halogen, with pinacolborane or bis(pinacolate)diborane in the presence of palladium catalysts (such as, for example, Pd(MeCN)2Cl2), ligands (such as, for example, XPhos), and a base. The base can be an amine (such as, for example, triethylamine). The reactions are generally carried out in an organic solvent, such as, for example, tetrahydrofuran or dioxane, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of the general formula (E-VI) can be prepared by alkylation of pyridines (EI) in the presence of bases with a pyri(mi)dine (EV), where LG is a leaving group, and copper(I) salts. The base can be a carbonate salt of an alkali metal (such as, for example, sodium, potassium, or cesium). The copper salts can be copper halides, such as, for example, copper(I) iodide. In general, the reactions are carried out in an organic solvent, such as acetonitrile or dimethylformamide, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of general formula (EI) are known from the literature and can be prepared, for example, according to the methods described in J. Am. Chem. Soc. (1952), 74, 1916-9 and similar methods. (E-IX) (EX) (E-XI) (E-XII) (E-II) (Id) Scheme 4. Pyridines of general formula (Id) can be prepared by alkylation of pyridines (E-XII) in the presence of bases with a pyri(mi)dine (E-II), where LG is a leaving group, and copper(I) salts. The base can be a carbonate salt of an alkali metal (such as, for example, sodium, potassium, or cesium). The copper salts can be copper halides, such as, for example, copper(I) iodide. In general, the reactions are carried out in an organic solvent, such as acetonitrile or dimethylformamide, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of the general formula (E-XII) can be prepared by demethylation of pyridines (E-XI) in the presence of hydrobromic acid and acetic acid or boron bromide. Reactions with boron bromide were generally carried out in an organic solvent, such as dichloromethane, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of the general formula (E-XI) can be prepared by coupling pyridines (E-IX) with boronic acid (EX) in the presence of copper(II) catalysts (such as, for example, Cu(OAc)₂) and a base. The base can be an amine (such as, for example, triethylamine). The reactions were generally carried out in an organic solvent, such as, for example, dichloromethane, at temperatures between 0 °C and the boiling point of the solvent. Pyridines of the general formula (E-IX) are known in the literature and can be prepared, for example, according to the methods described in EP1357111 and the like. Selected detailed synthesis examples of the compounds of General Formula (I) according to the invention will now be described. The 1H-NMR, 13C-NMR, and 19F-NMR spectroscopy data indicated for the chemical examples described in the following sections (400 MHz for 1H-NMR, 150 MHz for 13C-NMR, and 375 MHz for 19F-NMR, solvent CDCfe, CD3OD, or d6-DMSO, internal standard: tetramethylsilane δ = 0.00 ppm) were obtained using a Bruker instrument, and the indicated signals have the following meanings: br = width(s); s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = double doublet doublet, m = multiplet, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = double quartet, dt = double triplet. In the case of diastereomeric mixtures, the respective significant signals of both diastereomers or the characteristic signal of the main diastereomer are indicated.The abbreviations used for chemical groups have, by way of example, the following meanings: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, tBu = C(CH3)3, n-Bu = unbranched butyl, n-Pr = unbranched propyl, i-Pr = branched propyl, c-Pr = cyclopropyl, c-Hex = cyclohexyl. Examples of synthesis: Example Number of Table I-216: Synthesis step 1: 2-[(3-bromo-4-methyl-2-pyridyl)oxy]pyrimidine A mixture of 3-bromo-4-methylpyridin-2-ol (1.00 g, 5.32 mmol), 2-chloropyrimidine (609 mg, 5.32 mmol), copper(I) iodide (1.02 g, 5.36 mmol), cesium carbonate (3.50 g, 10.8 mmol), and DMF (15 mL) was heated in a microwave oven under nitrogen at 150°C for 1 h. The resulting reaction mixture was filtered and concentrated. The crude product was dissolved in ethyl acetate, washed with a saturated sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) of the resulting crude product yielded 2-[(3-bromo-4-methyl-2-pyridyl)oxy]pyrimidine (110 mg, 8% of the theoretical amount). Synthesis step 2: 2-[(4-methyl-3-phenylsulfanyl-2-pyridyl)oxy]pyrimidine (Number of Example from Table I-216): A mixture of 2-[(3-bromo-4-methyl-2-pyridyl)oxy]pyrimidine (280 mg, 1.05 mmol), biphenyl disulfide (138 mg, 0.63 mmol), copper (100 mg, 1.58 mmol), potassium acetate (206 mg, 2.10 mmol), and dimethyl sulfoxide (6 mL) was heated under nitrogen at 100°C for 40 h. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) yielded 2-[(4-methyl-3-phenylsulfanyl-2-pyridyl)oxy]pyrimidine (74 mg, 24% of the theoretical amount). Example Number of Table I-533: Synthesis step 1: 2-methoxy-6-methyl-3-phenoxypyridine: A mixture of 2-methoxy-6-methylpyridin-3-ol (960 mg, 6.89 mmol), phenylboronic acid (1.00 g, 8.27 mmol), copper(II) acetate (2.13 g, 11.7 mmol), triethylamine (1.92 mL, 13.7 mmol), 4A molecular sieves, and dichloromethane (38 mL) was prepared under argon at room temperature for 72 h. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) allowed the isolation of 2-methoxy-6-methyl-3-phenoxypyridine (925 mg, 62% of the theoretical amount). Synthesis step 2: 6-methyl-3-phenoxypyridin-2-ol: A mixture of 2-methoxy-6-methyl-3-phenoxypyridine (925 mg, 4.29 mmol), hydrobromic acid (45% solution in acetic acid, 5.2 mL, 42.9 mmol), and acetic acid (20 mL) was heated to 100°C for 1 h. The resulting reaction mixture was concentrated. The crude product was dissolved in water, adjusted to pH 5 with 2 M NaOH, and extracted with ethyl acetate. The combined organic phases were washed with a saturated sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated. This yielded 6-methyl-3-phenoxypyridin-2-ol (680 mg, 78% of the theoretical amount). Synthesis step 3: 2-[(6-methyl-3-phenoxy-2-pyridyl)oxy]-5-(trifluoromethyl)pyrimidine (Example No. from Table I-533): A mixture of 6-methyl-3-phenoxypyridin-2-ol (150 mg, 0.74 mmol), 2-chloro-5-trifluoromethylpyrimidine (280 mg, 1.52 mmol), copper(I) iodide (28 mg, 0.14 mmol), cesium carbonate (485 mg, 1.49 mmol), and acetonitrile (4 mL) was heated at 100°C for 3 h. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) yielded 2-[(6-methyl-3-phenoxy-2-pyridyl)oxy]-5-(trifluoromethyl)pyrimidine (153 mg, 59% of the theoretical amount). Example Number of Table I-478: Synthesis step 1: 2-[(3-bromo-4,6-dimethyl-2-pyridyl)oxy]-5-fluoropyrimidine A mixture of 3-bromo-4,6-dimethylpyridin-2-ol (3.35 g, 16.5 mmol), 2-chloro-5-fluoropyrimidine (3.29 g, 24.8 mmol), copper(I) iodide (630 mg, 3.31 mmol), cesium carbonate (10.8 g, 33.1 mmol), and dimethylformamide (15 mL) was heated at 130°C for 18 h. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) yielded 2-[(3-bromo-4,6-dimethyl-2-pyridyl)oxy]5-fluoropyrimidine (1.58 g, 32% of the theoretical yield). Synthesis step 2: 2-[[4,6-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)2-pyridyl]oxy]-5-fluoropyrimidine: A mixture of 2-[(3-bromo-4,6-dimethyl-2-pyridyl)oxy]-5-fluoropyrimidine (1.54 g, 5.15 mmol), pinacolborane (920 mg, 7.21 mmol), triethylamine (4.1 ml, 29.3 mmol), Pd(MeCN)2Cl2 (54 mg, 0.20 mmol), X-Phos (197 mg, 0.41 mmol) and dioxane (25 ml) was heated under argon at 110°C for 8 h. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) allowed the isolation of 2-[[4,6-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2pyridyl]oxy]-5-fluoropyrimidine (1.58 g, 89% of the theoretical). Synthesis step 3: 2-[(3-benzyl-4,6-dimethyl-2-pyridyl)oxy]-5-fluoropyrimidine (Example No. from Table I-478) A mixture of 2-[[4,6-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]oxy]-5-fluoropyrimidine (140 mg, 0.40 mmol), benzyl bromide (105 mg, 0.60 mmol), sodium carbonate (86 mg, 0.81 mmol), Pd(PPh3)4 (47 mg, 0.04 mmol), toluene (1.3 ml), ethanol (0.3 ml), and water (0.3 ml) was heated under argon at 80°C for 1.5 hours. The resulting reaction mixture was filtered and concentrated. Final purification by column chromatography (ethyl acetate / heptane gradient) allowed the isolation of 2-[(3-benzyl-4,6-dimethyl-2-pyridyl)oxy]-5-fluoropyrimidine (98 mg, 78% of the theoretical amount). Analogously to what has been described above and cited elsewhere, the following compounds of the General Formula (I) were obtained, which are mentioned and shown in Table 1. R3 Table 1 Example No. R2a R2b R3 X AR1 N° Ejemplo R2a R2b R3 X AR1 1-1 H H Cl CH 4-fluorofenoxi 1-2 H H Cl CH 3,4-difluorofenoxi 1-3 H H Cl CH 2,4-difluorofenoxi 1-4 H H Cl CH 3-(trifluorometil)fenoxi 1-5 H H Cl CH 3-clorofenoxi 1-6 H H Cl CH 3-metoxifenoxi 1-7 H H Cl CH 4-cianofenoxi 1-8 H H Cl CH 4-metilfenoxi 1-9 H H Cl CH fenoxi 1-10 H H F CH 4-fluorofenoxi 1-11 H H F CH 3,4-difluorofenoxi 1-12 H H F CH 2,4-difluorofenoxi 1-13 H H F CH 3-(trifluorometil)fenoxi 1-14 H H F CH 3-clorofenoxi 1-15 H H F CH 3-metoxifenoxi 1-16 H H F CH 4-cianofenoxi 1-17 H H F CH 4-metilfenoxi 1-18 H H F CH fenoxi 1-19 H H CF3 CH 4-fluorofenoxi 1-20 H H CF3 CH 3,4-difluorofenoxi 1-21 H H CF3 CH 2,4-difluorofenoxi 1-22 H H CF3 CH 3-(trifluorometil)fenoxi 1-23 H H CF3 CH 3-clorofenoxi 1-24 H H CF3 CH 3-metoxifenoxi No. Example R2a R2b R3 X AR1 1-25 HH CF3 CH 4-cyanophenoxy 1-26 HH CF3 CH 4-methylphenoxy 1-27 HH CF3 CH phenoxy 1-28 HHH CH 4-fluorophenoxy 1-29 HHH CH 4-fluorophenoxy 1-29 HHH CH-1-30 HHH CH 2,4-difluorophenoxy 1-31 HHH CH 3-(trifluoromethyl)phenoxy 1-32 HHH CH 3-chlorophenoxy 1-33 HHH CH 3-methoxyphenoxy 1-34 HHH CH 4-cyanophenoxy 1-35 H-H-H HHH CH phenoxy 1-37 HH Cl N 4-fluorophenoxy 1-38 HH Cl N 3,4-difluorophenoxy 1-39 HH Cl N 2,4-difluorophenoxy 1-40 HH Cl N 3-(trifluoromethyl)phenoxy 1-41 HH Cl N 3-H Cl N 3-methoxyphenoxy 1-43 HH Cl N 4-cyanophenoxy 1-44 HH Cl N 4-methylphenoxy 1-45 HH Cl N phenoxy 1-46 HHFN 4-fluorophenoxy 1-47 HHFN 3,4-difluorophenoxy 1-HH-difluorophenoxy 1-48 No. Example R2a R2b R3 X AR1 1-49 HHFN 3-(trifluoromethyl)phenoxy 1-50 HHFN 3-chlorophenoxy 1-51 HHFN 3-methoxyphenoxy 1-52 HHFN 4-cyanophenoxy 1-53 HHFN-HFN-methoxy 1-54 HHFN phenoxy 1-55 HH CF3 N 4-fluorophenoxy 1-56 HH CF3 N 3,4-difluorophenoxy 1-57 HH CF3 N 2,4-difluorophenoxy 1-58 HH CF3 N 3-(trifluoromethyl)phenoxy 1-59 HH CF3 N 1-60 HH CF3 N 3-methoxyphenoxy 1-61 HH CF3 N 4-cyanophenoxy 1-62 HH CF3 N 4-methylphenoxy 1-63 HH CF3 N phenoxy 1-64 HHHN 4-fluorophenoxy 1-65 HHHN 34-HH-HH-16H 2,4-difluorophenoxy 1-67 HHHN 3-(trifluoromethyl)phenoxy 1-68 HHHN 3-chlorophenoxy 1-69 HHHN 3-methoxyphenoxy 1-70 HHHN 4-cyanophenoxy 1-71 HHHN 4-Methylphenoxy HHHN 1-72 No. Example R2a R2b R3 X AR1 1-73 CH3 H Cl N 4-fluorophenoxy 1-74 CH3 H Cl N 3,4-difluorophenoxy 1-75 CH3 H Cl N 2,4-difluorophenoxy 1-77 N xymeth 31- H Cl CH3 H Cl N 3-chlorophenose 1-78 CH3 H Cl N 3-methoxyphenose 1-79 CH3 H Cl N 4-cyanophenose 1-80 CH3 H Cl N 4-methylphenose 1-81 CH3 H Cl N phenoxy CH3-1-HFN82 CH3 HFN 3,4-difluorophenose 1–84 CH3 HFN 2,4-difluorophenose 1–85 CH3 HFN 3-(trifluoromethyl)phenose 1–86 CH3 HFN 3-chlorophenose 1–87 CH3 -xime HFN 4-cyanophenose 1–89 CH3 HFN 4-methylphenose 1–90 CH3 HFN phenoxy 1–91 CH3 H CF3 N 4-fluorophenoxy 1–92 CH3 H CF3 N 3,4-difluorophenoxy 1–43 gold H1–43 diflu CH3 CH3 H CF3 N 3-(trifluoromethyl)phenose 1-95 CH3 H CF3 N 3-chlorophenose 1-96 CH3 H CF3 N 3-methoxyphenose N° Example R2a R2b R3 X AR1 1-97 CH3 H CF3 N 4-cyanophenoxy 1-98 CH3 H CF3 N 4-methylphenoxy 1-99 CH3 H CF3 N phenoxy 1-100 CH3 HHN 4-fluorophenoxy 1-CHN 101 HHN 3,4-difluorophenoxy 1-102 CH3 HHN 2,4-difluorophenoxy 1-103 CH3 HHN 3-(trifluoromethyl)phenoxy 1-104 CH3 HHN 3-chlorophenoxy 1-105 CH3 HHN 3-methoxy CH3-CHHN 1-106 4-cyanophenoxy 1-107 CH3 HHN 4-methylphenoxy 1-108 CH3 HHN phenoxy 1-109 HH Cl CH 4-fluorophenylthio 1-110 HH Cl CH 3,4-difluorophenylthio 1-111 HH Cl fluorophenyl CH HH Cl CH 3-(trifluoromethyl)phenylthio 1-113 HH Cl CH 3-chlorophenylthio 1-114 HH Cl CH 3-methoxyphenylthio 1-115 HH Cl CH 4-cyanophenylthio 1-116 HH Cl CH-4-methyl CH-17 phenylthio 1-118 HHF CH 4-fluorophenylthio 1-119 HHF CH 3,4-difluorophenylthio 1-120 HHF CH 2,4-difluorophenylthio N° Ejemplo R2a R2b R3 X AR1 1-121 HHF CH 3-(trifluoromethyl)phenylthio 1-122 HHF CH 3-chlorophenylthio 1-123 HHF CH 3-methoxyphenylthio 1-124 HHF CH 4-cyanophenylthio 1-125 HHF CH 4-methylphenylthio 1-127 HH CF3 CH 4-fluorophenylthio 1-128 HH CF3 CH 3,4-difluorophenylthio 1-129 HH CF3 CH 2,4-difluorophenylthio 1-130 HH CF3 CH 3-(trifluoromethyl)phenylthio 1-131 HH CF3 CH 3-chlorophenylthio 1-132 HH CF3 CH 3-methoxyphenylthio 1-133 HH CF3 CH 4-cyanophenylthio 1-134 HH CF3 CH 4-methylphenylthio 1-135 HH CF3 CH phenylthio 1-136 HHH CH 4-fluorophenylthio 1-137 HHH CH 3,4-difluorophenylthio 1-138 HHH CH 2,4-difluorophenylthio 1-139 HHH CH 3-(trifluoromethyl)phenylthio 1-140 HHH CH 3-chlorophenylthio 1-141 HHH CH 3-methoxyphenylthio 1-142 HHH CH 4-cyanophenylthio 1-143 HHH CH 4-methylphenylthio 1-144 HHH CH phenylthio N° Example R2a R2b R3 X AR1 1-145 HH Cl N 4-fluorophenylthio 1-146 HH Cl N 3,4-difluorophenylthio 1-147 HH Cl N 2,4-difluorophenylthio 1-148 HH Cl N 3-(trifluoromethyl)phenylthio 1-149 HH Cl N 3-chlorophenylthio 1-150 HH Cl N 3-methoxyphenylthio 1-151 HH Cl N 4-cyanophenylthio 1-152 HH Cl N 4-methylphenylthio 1-153 HH Cl N phenylthio 1-154 HHFN 4-fluorophenylthio 1-155 HHFN 3,4-difluorophenylthio 1-156 HHFN 2,4-difluorophenylthio 1-157 HHFN 3-(trifluoromethyl)phenylthio 1-158 HHFN 3-chlorophenylthio 1-159 HHFN 3-methoxyphenylthio 1-160 HHFN 4-cyanophenylthio 1-161 HHFN 4-methylphenylthio 1-162 HHFN phenylthio 1-163 HH CF3 N 4-fluorophenylthio 1-164 HH CF3 N 3,4-difluorophenylthio 1-165 HH CF3 N 2,4-difluorophenylthio 1-166 HH CF3 N 3-(trifluoromethyl)phenylthio 1-167 HH CF3 N 3-chlorophenylthio 1-168 HH CF3 N 3-methoxyphenylthio N° Ejemplo R2a R2b R3 X AR1 1-169 HH CF3 N 4-cyanophenylthio 1-170 HH CF3 N 4-methylphenylthio 1-171 HH CF3 N phenylthio 1-172 HHHN 4-fluorophenylthio 1-173 HHHN 3,4-difluorophenylthio 1-174 HHHN 2,4-difluorophenylthio 1-175 HHHN 3-(trifluoromethyl)phenylthio 1-176 HHHN 3-chlorophenylthio 1-177 HHHN 3-methoxyphenylthio 1-178 HHHN 4-cyanophenylthio 1-179 HHHN 4-methylphenylthio 1-180 HHHN phenylthio 1-181 CH3 H Cl N 4-fluorophenylthio 1-182 CH3 H Cl N 3,4-difluorophenylthio 1-183 CH3 H Cl N 2,4-difluorophenylthio 1-184 CH3 H Cl N 3-(trifluoromethyl)phenylthio 1-185 CH3 H Cl N 3-chlorophenylthio 1-186 CH3 H Cl N 3-methoxyphenylthio 1-187 CH3 H Cl N 4-cyanophenylthio 1-188 CH3 H Cl N 4-methylphenylthio 1-189 CH3 H Cl N phenylthio 1-190 CH3 HFN 4-fluorophenylthio 1-191 CH3 HFN 3,4-difluorophenylthio 1-192 CH3 HFN 2,4-difluorophenylthio N° Ejemplo R2a R2b R3 X AR1 1-193 CH3 HFN 3-(trifluoromethyl)fenilthio 1-194 CH3 HFN 3-chlorofenilthio 1-195 CH3 HFN 3-methoxyfenilthio 1-196 CH3 HFN 4-cyanofenilthio 1-197 CH3 HFN 4-methylfenilthio 1-198 1-199 CH3 H CF3 N 4-fluorofenilthio 1-200 CH3 H CF3 N 3,4-difluorofenilthio 1-201 CH3 H CF3 N 2,4-difluorofenilthio 1-202 CH3 H CF3 N 3-(trifluoromethyl)fenilthio 1-203 CH3 H CF3 N 3-chlorofenilthio 1-204 CH3 H CF3 N 3-methoxyphenylthio 1-205 CH3 H CF3 N 4-cyanofenilthio 1-206 CH3 H CF3 N 4-metilfenilthio 1-207 CH3 H CF3 N fenilthio 1-208 CH3 HHN 4-fluorofenilthio 1-209 CH3 HHN 3,4-difluorofenilthio 1-210 CH3 HHN 2,4-difluorofenilthio 1-211 CH3 HHN 3-(trifluoromethyl)fenilthio 1-212 CH3 HHN 3-chlorofenilthio 1-213 CH3 HHN 3-methoxyfenilthio 1-214 CH3 HHN 4-cyanofenilthio 1-215 CH3 HHN 4-metilfenilthio 1-216 CH3 HHN fenilthio N° Example R2a R2b R3 X AR1 1-217 HH Cl CH 4-fluorophenylmethyl 1-218 HH Cl CH 3,4-difluorophenylmethyl 1-219 HH Cl CH 2,4-difluorophenylmethyl 1-220 HH Cl CH 3-(trifluoromethyl)phenylmethyl 1-221 HH Cl CH 3-chlorophenylmethyl 1-222 HH Cl CH 3-methoxyphenylmethyl 1-223 HH Cl CH 4-cyanophenylmethyl 1-224 HH Cl CH 4-methylphenylmethyl 1-225 HH Cl CH benzyl 1-226 HHF CH 4-fluorophenylmethyl 1-227 HHF CH 3,4-difluorophenylmethyl 1-228 HHF CH 2,4-Difluorophenylmethyl 1-229 HHF CH 3-(Trifluoromethyl)phenylmethyl 1-230 HHF CH 3-Chlorophenylmethyl 1-231 HHF CH 3-Methoxyphenylmethyl 1-232 HHF CH 4-Cyanophenylmethyl 1-233 HHF CH 4-Methylphenylmethyl 1-234 HHF CH benzyl 1-235 HH CF3 CH 4-Fluorophenylmethyl 1-236 HH CF3 CH 3,4-Difluorophenylmethyl 1-237 HH CF3 CH 2,4-Difluorophenylmethyl 1-238 HH CF3 CH 3-(Trifluoromethyl)phenylmethyl 1-239 HH CF3 CH 3-Chlorophenylmethyl 1-240 HH CF3 CH 3-methoxyphenylmethyl No. Example R2a R2b R3 X AR1 1-241 HH CF3 CH 4-cyanophenylmethyl 1-242 HH CF3 CH 4-methylphenylmethyl 1-243 HH CF3 CH benzyl 1-244 HHH CH 4-fluorophenylmethyl 1-CH-CH 3,4-difluorophenylmethyl 1-246 HHH CH 2,4-difluorophenylmethyl 1-247 HHH CH 3-(trifluoromethyl)phenylmethyl 1-248 HHH CH 3-chlorophenylmethyl 1-249 HHH CH 3-methoxyphenylmethyl 1-250 HHH 4-cyanophenylmethyl 1-251 HHH CH 4-methylphenylmethyl 1-252 HHH CH benzyl 1-253 HH Cl N 4-fluorophenylmethyl 1-254 HH Cl N 3,4-difluorophenylmethyl 1-255 HH Cl N Cl N 3-(trifluoromethyl)phenylmethyl 1-257 HH Cl N 3-chlorophenylmethyl 1-258 HH Cl N 3-methoxyphenylmethyl 1-259 HH Cl N 4-cyanophenylmethyl 1-260 HH Cl N 4-methylphenyl methyl 1-6 HH Benzyl 1-262 HHFN 4-fluorophenylmethyl 1-263 HHFN 3,4-difluorophenylmethyl 1-264 HHFN 2,4-difluorophenylmethyl No. Example R2a R2b R3 X AR1 1-265 HHFN 3-(trifluoromethyl)phenylmethyl 1-266 HHFN 3-chlorophenylmethyl 1-267 HHFN 3-methoxyphenylmethyl 1-268 HHFN 4-cyanophenylmethyl-HFN269 4-methylphenylmethyl 1-270 HHFN benzyl 1-271 HH CF3 N 4-fluorophenylmethyl 1-272 HH CF3 N 3,4-difluorophenylmethyl 1-273 HH CF3 N 2,4-difluorophenylmethyl 1-274 HHFN trimethyl CF-H 1-275 HH CF3 N 3-chlorophenylmethyl 1-276 HH CF3 N 3-methoxyphenylmethyl 1-277 HH CF3 N 4-cyanophenylmethyl 1-278 HH CF3 N 4-methylphenylmethyl 1-279 HH CF3 N 3-chlorophenylmethyl 1-280 HH-HN 4-fluorophenylmethyl 1-281 HHHN 3,4-difluorophenylmethyl 1-282 HHHN 2,4-difluorophenylmethyl 1-283 HHHN 3-(trifluoromethyl)phenylmethyl 1-284 HHHN 3-chlorophenylmethyl 1-285 HHHN-Xylomethyl 1-286 HHHN 4-cyanophenylmethyl 1-287 HHHN 4-methylphenylmethyl 1-288 HHHN benzyl N° Example R2a R2b R3 X AR1 1-289 CH3 H Cl N 4-fluorophenylmethyl 1-290 CH3 H Cl N 3,4-difluorophenylmethyl 1-291 CH3 H Cl N 2,4-difluorophenylmethyl N CH3 H3-2 3-(trifluoromethyl)phenylmethyl 1-293 CH3 H Cl N 3-chlorophenylmethyl 1-294 CH3 H Cl N 3-methoxyphenylmethyl 1-295 CH3 H Cl N 4-cyanophenylmethyl 1-296 NCH7- CH3 H Clphen H2 N benzyl 1-298 CH3 HFN 4-fluorophenylmethyl 1-299 CH3 HFN 3,4-difluorophenylmethyl 1-300 CH3 HFN 2,4-difluorophenylmethyl 1-301 CH3 HFN CH-(3-3HFlumethyl 1) 3-chlorophenylmethyl 1-303 CH3 HFN 3-methoxyphenylmethyl 1-304 CH3 HFN 4-cyanophenylmethyl 1-305 CH3 HFN 4-methylphenylmethyl 1-306 CH3 HFN benzyl 30-methyl CF307 CH CH3 H CF3 N 3,4-difluorophenylmethyl 1-309 CH3 H CF3 N 2,4-difluorophenylmethyl 1-310 CH3 H CF3 N 3-(trifluoromethyl)phenylmethyl 1-311 CH3 H CF3 N methyl CF 3-chloro 3-methoxyphenylmethyl No. Example R2a R2b R3 X AR1 1-313 CH3 H CF3 N 4-cyanophenylmethyl 1-314 CH3 H CF3 N 4-methylphenylmethyl 1-315 CH3 H CF3 N benzyl 1-316 CH3 HHN 4-fluorophenylmethyl 1-33-CHHN 3,4-difluorophenylmethyl 1-318 CH3 HHN 2,4-difluorophenylmethyl 1-319 CH3 HHN 3-(trifluoromethyl)phenylmethyl 1-320 CH3 HHN 3-chlorophenylmethyl 1-321 CH3 HHN 3-chlorophenyl methyl 1-32 HHN 4-cyanophenylmethyl 1-323 CH3 HHN 4-methylphenylmethyl 1-324 CH3 HHN benzyl 1-325 HH Cl N 4-fluorophenylamine 1-326 HH Cl N 3,4-difluorophenylamine 1-327 HH Chlamyrophenylamine 1-3 HH Cl N 3-(trifluoromethyl)phenylamine 1-329 HH Cl N 3-chlorophenylamine 1-330 HH Cl N 3-methoxyphenylamine 1-331 HH Cl N 4-cyanophenylamine 1-332 HH Cl N 4-methyl phenylamine N3-33 Phenylamine 1-334 HHFN 4-fluorophenylamine 1-335 HHFN 3,4-difluorophenylamine 1-336 HHFN 2,4-difluorophenylamine No. Example R2a R2b R3 X AR1 1-337 HHFN 3-(trifluoromethyl)phenylamine 1-338 HHFN 3-chlorophenylamine 1-339 HHFN 3-methoxyphenylamine 1-340 HHFN 4-cyanophenylamine 1-HF33 HF3 4-methylphenylamino 1-342 HHFN phenylamine 1-343 HH CF3 N 4-fluorophenylamine 1-344 HH CF3 N 3,4-difluorophenylamine 1-345 HH CF3 N 2,4-difluorophenylamine 1-36 HHFN phenylamine 3-33 1-347 HH CF3 N 3-chlorophenylamine 1-348 HH CF3 N 3-methoxyphenylamine 1-349 HH CF3 N 4-cyanophenylamine 1-350 HH CF3 N 4-methylphenylamine 1-351 HH CF3 N phenylamine 1-352 HH-HH 4-fluorophenylamine 1-353 HHHN 3,4-difluorophenylamine 1-354 HHHN 2,4-difluorophenylamine 1-355 HHHN 3-(trifluoromethyl)phenylamine 1-356 HHHN 3-chlorophenylamine 1-35 HHHN-phenylamine 1-358 HHHN 4-cyanophenylamine 1-359 HHHN 4-methylphenylamine 1-360 HHHN phenylamine N° Example R2a R2b R3 X AR1 1-361 CH3 H Cl N 4-fluorophenylamino 1-362 CH3 H Cl N 3,4-difluorophenylamino 1-363 CH3 H Cl N 2,4-difluorophenylamino N CH 1-366 3-(trifluoromethyl)phenylamino 1-365 CH3 H Cl N 3-chlorophenylamino 1-366 CH3 H Cl N 3-methoxyphenylamino 1-367 CH3 H Cl N 4-cyanophenylamino 1-368 N CH3- CH3 H Cl3 Hl N 4 phenylamino 1-370 CH3 HFN 4-fluorophenylamino 1-371 CH3 HFN 3,4-difluorophenylamino 1-372 CH3 HFN 2,4-difluorophenylamino 1-373 CH3 HFN CH1 3-()3HFyloromethyl 3-chlorophenylamino 1-375 CH3 HFN 3-methoxyphenylamino 1-376 CH3 HFN 4-cyanophenylamino 1-377 CH3 HFN 4-methylphenylamino 1-378 CH3 HFN phenylamino CH34-amino CFflu 1-380 CH3 H CF3 N 3,4-difluorophenylamino 1-381 CH3 H CF3 N 2,4-difluorophenylamino 1-382 CH3 H CF3 N 3-(trifluoromethyl)phenylamino 1-383 N H84 amino CH3- H 1 CF3 CF3 N 3-methoxyphenylamino N° Example R2a R2b R3 X AR1 1-385 CH3 H CF3 N 4-cyanophenylamino 1-386 CH3 H CF3 N 4-methylphenylamino 1-387 CH3 H CF3 N phenylamino 1-388 CH3 HHN HH3ylHN9 4-flu 3,4-difluorophenylamino 1-390 CH3 HHN 2,4-difluorophenylamino 1-391 CH3 HHN 3-(trifluoromethyl)phenylamino 1-392 CH3 HHN 3-chlorophenylamino 1-CH3-393yl amino CH3-H3 HHN 4-cyanophenylamino 1-395 CH3 HHN 4-methylphenylamino 1-396 CH3 HHN phenylamino 1-397 H CH3 Cl N benzyl 1-398 H CH3 Cl N 4-fluorophenylmethyl 1-39nylmethylf H 3 1-400 H CH3 Cl N 2,4-difluorophenylmethyl 1-401 H CH3 Cl N 4-chlorophenylmethyl 1-402 H CH3 Cl N (3-fluoro,4methylphenyl)methyl 1-403 H CH3 Cl N C04 N CHmethyl H1-methoxyphenyl (3-fluoro,4chlorophenyl)methyl 1-405 H CH3 Cl N 4-methylphenylmethyl 1-406 H CH3 Cl N (4-fluoro,3- N° Example R2a R2b R3 X AR1 methoxyphenyl)methyl 1-407 H CH3 Cl N (2,4-difluoro,3- methoxyphenyl)methyl 1-408 H CH3 Cl CH benzyl 1-409 H CH3 Cl Cl CH 4-metholy CH3 H 1-fluorophenyl 3,4-difluorophenylmethyl 1–411 H CH3 Cl CH 2,4-difluorophenylmethyl 1–412 H CH3 Cl CH 4-chlorophenylmethyl 1–413 H CH3 Cl CH (3-fluoro,4methylphenyl)methyl CH CH 1methyl 1–4 1-415 H CH3 Cl CH (3-fluoro,4chlorophenyl)methyl 1-416 H CH3 Cl CH 4-methylphenylmethyl 1-417 H CH3 Cl CH (4-fluoro,3methoxyphenyl)methyl 1-418 H CH3,3,3methoxyphenyl)methyl 1-418 H CH3,3,3-difluoroCH 1-419 H CH3 Cl CF benzyl 1-420 H CH3 Cl CF 4-fluorophenylmethyl 1-421 H CH3 Cl CF 3,4-difluorophenylmethyl 1-422 H CH3 Cl CF 2,4-difluoromethyl CH-32clophenylmethyl CF 1 1–424 H CH3 Cl CF (3-fluoro,4- N° Example R2a R2b R3 X AR1 methylphenyl)methyl 1–425 H CH3 Cl CF 3-methoxyphenylmethyl 1–426 H CH3 Cl CF (3-fluoro,4chlorophenyl)methyl 1–427 H CH3 Cl CHl CF methyl 8 CF1-methyl (4-fluoro,3methoxyphenyl)methyl 1–429 H CH3 Cl CF (2,4-difluoro,3- methoxyphenyl)methyl 1–430 H CH3 FN benzyl 1–431 H CH3 FN 4-fluorophenylmethyl 1–43Fdimethyl CHlu,lu H CH3 FN 2,4-difluorophenylmethyl 1-434 H CH3 FN 4-chlorophenylmethyl 1-435 H CH3 FN (3-fluoro,4methylphenyl)methyl 1-436 H CH3 FN 3-methoxyphenylmethyl CH -phenylmethyl F3 ( H 1–438 H CH3 FN 4-methylphenylmethyl 1–439 H CH3 FN (4-fluoro,3methoxyphenyl)methyl 1–440 H CH3 FN (2,4-difluoro,3-methoxyphenyl)methyl N° Example R2a R2b R3 X AR1 1-441 H CH3 HN benzyl 1-442 H CH3 HN 4-fluorophenylmethyl 1-443 H CH3 HN 3,4-difluorophenylmethyl 1-444 H CH3 HN CHlu 2,4 H4-dif 4-chlorophenylmethyl 1-446 H CH3 HN (3-fluoro,4methylphenyl)methyl 1-447 H CH3 HN 3-methoxyphenylmethyl 1-448 H CH3 HN (3-fluoro,4chlorophenyl)methyl 1-449 metyl H54 H-methyl CH3 HN (4-fluoro,3methoxyphenyl)methyl 1–451 H CH3 HN (2,4-difluoro,3- methoxyphenyl)methyl 1–452 H CH3 H CH benzyl 1–453 H CH3 H CH 4-fluorophenylmethyl 1–454 di H 3 CH 1-455 H CH3 H CH 2,4-difluorophenylmethyl 1-456 H CH3 H CH 4-chlorophenylmethyl 1-457 H CH3 H CH (3-fluoro,4methylphenyl)methyl 1-458 H CH3 H CH H5methyl CH 1-methoxyphenyl (3-fluoro,4- N° Example R2a R2b R3 X AR1 chlorophenyl)methyl 1-460 H CH3 H CH 4-methylphenylmethyl 1-461 H CH3 H CH (4-fluoro,3methoxyphenyl)methyl 1-462 H CH3 H CH 1-xyphenyl)6-methol H 1 CH3 CF3 N benzyl 1-464 H CH3 CF3 N 2,4-difluorophenylmethyl 1-465 H CH3 CF3 N (4-fluoro,3methoxyphenyl)methyl 1-466 H CH3 CF3 N 4-methylphenylmethyl CH-l C1 4 CH6637 CH3 Cl N 4-fluorophenylmethyl 1-469 CH3 CH3 Cl N 3,4-difluorophenylmethyl 1-470 CH3 CH3 Cl N 2,4-difluorophenylmethyl 1-471 CH3 CH3 Cl N 4-CH13-CH377methyl (3-fluoro,4methylphenyl)methyl 1-473 CH3 CH3 Cl N 3-methoxyphenylmethyl 1-474 CH3 CH3 Cl N (3-fluoro,4chlorophenyl)methyl 1-475 CH3 CH3 Cl N 4-methylphenylmethyl CH3 1- (4-fluoro,3methoxyphenyl)methyl No. Example R2a R2b R3 X AR1 1-477 CH3 CH3 Cl N (2,4-difluoro,3- methoxyphenyl)methyl 1-478 CH3 CH3 FN benzyl 1-479 CH3 CH3 FN 4-fluorophenylmethyl CH30 F CH3 1-47 3,4-difluorophenylmethyl 1-481 CH3 CH3 FN 2,4-difluorophenylmethyl 1-482 CH3 CH3 FN 4-chlorophenylmethyl 1-483 CH3 CH3 FN (3-fluoro,4methylphenyl)methyl Phenyl CH3-484 1-485 CH3 CH3 FN (3-fluoro,4chlorophenyl)methyl 1-486 CH3 CH3 FN 4-methylphenylmethyl 1-487 CH3 CH3 FN (4-fluoro,3methoxyphenyl)methyl 1-488 CH3xy,4methoxyphenyl)methyl 1-488 CH3,43-dimethyl FNfluoro 1-489 CH3 CH3 HN benzyl 1-490 CH3 CH3 HN 4-fluorophenylmethyl 1-491 CH3 CH3 HN 3,4-difluorophenylmethyl 1-492 CH3 CH3 HN 2,4-difluoromethyl CH3-493 HNylmethyl 1 1-494 CH3 CH3 HN(3-fluoro,4methylphenyl)methyl N° Example R2a R2b R3 X AR1 1-495 CH3 CH3 HN 3-methoxyphenylmethyl 1-496 CH3 CH3 HN (3-fluoro,4chlorophenyl)methyl 1-497 CH3 CH3 HN 4-methylphenylmethyl H N 1-493 (4-fluoro,3methoxyphenyl)methyl 1-499 CH3 CH3 HN (2,4-difluoro,3-methoxyphenyl)methyl 1-500 H CH3 Cl N phenoxide 1-501 H CH3 Cl N 4-fluorophenoxy CH3-4-diCl0f H flu 1-503 H CH3 Cl N 2,4-difluorophenose 1-504 H CH3 Cl N 4-chlorophenose 1-505 H CH3 Cl N 3-fluoro,4-methylphenoxy 1-506 H CH3 Cl N 3-CH03 Cl07 H 1 3-fluoro,4-chlorophenose 1-508 H CH3 Cl N 4-methylphenose 1-509 H CH3 Cl N 4-fluoro,3-methoxyphenose 1-510 H CH3 Cl N 2,4-difluoro,3-methoxyphenose H3-15 Nphenose H 1- CH3 FN 4-fluorophenose 1-513 H CH3 FN 3,4-difluorophenose 1-514 H CH3 FN 2,4-difluorophenose 1-515 H CH3 FN 4-chlorophenose No. Example R2a R2b R3 X AR1 1-516 H CH3 FN 3-fluoro,4-methylphenose 1-517 H CH3 FN 3-methoxyphenose 1-518 H CH3 FN 3-fluoro,4-chlorophenose H 4 CH-1-methylF19 CH3 FN 4-fluoro,3-methoxyphenose 1–521 H CH3 FN 2,4-difluoro,3-methoxyphenoxy 1–522 H CH3 HN phenoxy 1–523 H CH3 HN 4-fluorophenoxy 1–5no H15 HN 3–CH4-CH3 CH3 HN 2,4-difluorophenose 1-526 H CH3 HN 4-chlorophenose 1-527 H CH3 HN 3-fluoro,4-methylphenose 1-528 H CH3 HN 3-methoxyphenose 1-529 H-chlorophenose 1-529 H-chlof3 HN CH3 HN 4-methylphenose 1-531 H CH3 HN 4-fluoro,3-methoxyphenose 1-532 H CH3 HN 2,4-difluoro,3-methoxyphenose 1-533 H CH3 CF3 N phenoxy 1-534 chloro N CH3 CH3 CF3 N 4-fluoro,3-methoxyphenose 1–536 CH3 CH3 Cl N phenoxy 1–537 CH3 CH3 Cl N 4-fluorophenoxy 1–538 CH3 CH3 Cl N 3,4-difluorophenoxy C-xil N 2,539 N° Example R2a R2b R3 X AR1 1-540 CH3 CH3 Cl N 4-chlorophenoxy 1-541 CH3 CH3 Cl N 3-fluoro,4-methylphenoxy 1-542 CH3 CH3 Cl N 3-methoxyphenoxy CH43 Cl 1-5 3-fluoro,4-chlorophenose 1-544 CH3 CH3 Cl N 4-methylphenose 1-545 CH3 CH3 Cl N 4-fluoro,3-methoxyphenose 1-546 CH3 CH3 Cl3 N 2,4-difluoro CH43 C5xy CH1-metho phenoxy 1–548 CH3 CH3 Cl CF 4-fluorophenoxy 1–549 CH3 CH3 Cl CF 3,4-difluorophenoxy 1–550 CH3 CH3 Cl CF 2,4-difluorophenoxy 1–551 chloro CH55 CF2xi CH4- CH3 Cl CF 3-fluoro,4-methylphenose 1-553 CH3 CH3 Cl CF 3-methoxyphenose 1-554 CH3 CH3 Cl CF 3-fluoro,4-chlorophenose 1-555 CH3 CH3 Cl CH56 CFxi C4-methyl 4-fluoro,3-methoxyphenose 1-557 CH3 CH3 Cl CF 2,4-difluoride,3-methoxyphenose 1-558 CH3 CH3 Cl CH phenoxy 1-559 CH3 CH3 Cl CH 4-fluorophenoxy CH60 CHl 1-5 3,4-difluorophenose 1-561 CH3 CH3 Cl CH 2,4-difluorophenose 1-562 CH3 CH3 Cl CH 4-chlorophenose 1-563 CH3 CH3 Cl CH 3-fluoro,4-methylphenose No. Example R2a R2b R3 X AR1 1-564 CH3 CH3 Cl CH 3-methoxyphenoxy 1-565 CH3 CH3 Cl CH 3-fluoro,4-chlorophenoxy 1-566 CH3 CH3 Cl CH 4-CH 567 C 4-fluoro,3-methoxyphenose 1-568 CH3 CH3 Cl CH 2,4-difluoro,3-methoxyphenose 1-569 CH3 CH3 FN phenoxy 1-570 CH3 CH3 FN 4-fluorophenoxy N CH3 CH3-5431-Fluophenose 1-572 CH3 CH3 FN 2,4-difluorophenose 1-573 CH3 CH3 FN 4-chlorophenose 1-574 CH3 CH3 FN 3-fluoro,4-methylphenose 1-575 CH3 CH3 FN CH76 FN3 CH3-methoxyphenose 3-fluoro,4-chlorophenose 1-577 CH3 CH3 FN 4-methylphenose 1-578 CH3 CH3 FN 4-fluorine,3-methoxyphenose 1-579 CH3 CH3 FN 2,4-difluoro,3-CHN CH 13-methoxyphenose 1-581 CH3 CH3 HN 4-fluorophenose 1-582 CH3 CH3 HN 3,4-difluorophenose 1-583 CH3 CH3 HN 2,4-difluorophenose 1-584 CH3 CH3 HN HN 4-CHlorophenose 3-fluoro,4-methylphenose 1-586 CH3 CH3 HN 3-methoxyphenose 1-587 CH3 CH3 HN 3-fluoro,4-chlorophenose No. Example R2a R2b R3 X AR1 1-588 CH3 CH3 HN 4-methylphenose 1-589 CH3 CH3 HN 4-fluoro,3-methoxyphenose 1-590 CH3 CH3 HN 2,4-difluoro CH3-593 F1-metho 5-chloro-3-fluoro-2-pyridyloxy 1-592 CH3 CH3 FN 5-chloro-2-pyridyloxy 1-593 CH3 CH3 FN 5-fluoro-2-pyridyloxy 1-594 CH3 CH3 FN 3,5-CH1-difluoride FN 3,5-CH1-CH5935 5-fluoro-2-pyrimidyloxy 1-596 CH3 CH3 FN 5-chloro-2-pyrimidloxy 1-597 CH3 CH3 Cl N 5-chloro-3-fluoro-2-pyridyloxy 1-598 CH3 CH3 Cl N CH 5-dichloro C1-dichloro-2 5-fluoro-2-pyridyloxy 1-600 CH3 CH3 Cl N 3,5-difluoro-2-pyridyloxy 1-601 CH3 CH3 Cl N 5-fluoro-2-pyrimidyloxy 1-602 CH3 CH3 Cl N 5-chloro60N Hpyrimidyloxy H2-2- 5-chloro-3-fluoro-2-pyridylose 1-604 H CH3 FN 5-chloro-2-pyridylose 1-605 H CH3 FN 5-fluoro-2-pyridylose 1-606 H CH3 FN 3,5-difluoro-2-pyridyloxy 1-607 H CH3 FN 5-fluoro-2-pyrimidyloxy 1-608 H CH3 FN 5-chloro-2-pyrimidyloxy 1-609 H CH3 Cl N 5-chloro-3-fluoro-2-pyridyloxy 1-610 H CH3 Cl N 5-chloro-2-pyridyloxy 1-611 H CH3 Cl N 5-fluoro-2-pyridyloxy, No. Example R2a R2b R3 X AR1 1-612 H CH3 Cl N 3,5-difluoro-2-pyridyloxy 1-613 H CH3 Cl N 5-fluoro-2-pyrimidyloxy 1-614 H CH3 Cl N 5-chloro-2-pyrimidyloxy 1-615 CH3 CH3 F CH 5-chloro-3-fluoro-2-pyridyloxy 1-616 CH3 CH3 F CH 5-chloro-2-pyridyloxy 1-617 CH3 CH3 F CH 5-fluoro-2-pyridyloxy 1-618 CH3 CH3 F CH 3,5-difluoro-2-pyridyloxy 1-619 CH3 CH3 F CH 5-fluoro-2-pyrimidyloxy 1-620 CH3 CH3 F CH 5-chloro-2-pyrimidyloxy 1-621 CH3 CH3 Cl CH 5-chloro-3-fluoro-2-pyridyloxy 1-622 CH3 CH3 Cl CH 5-chloro-2-pyridyloxy 1-623 CH3 CH3 Cl CH 5-fluoro-2-pyridyloxy 1-624 CH3 CH3 Cl CH 3,5-difluoro-2-pyridyloxy 1-625 CH3 CH3 Cl CH 5-fluoro-2-pyrimidyloxyl 1-626 CH3 CH3 Cl CH 5-chloro-2-pyrimidyloxyl 1-627 H CH3 F CH 5-chloro-3-fluoro-2-pyridyloxyyl 1-628 H CH3 F CH 5-chloro-2-pyridyloxyyl 1-629 H CH3 F CH 5-fluoro-2-pyridyloxyyl 1-630 H CH3 F CH 3,5-difluoro-2-pyridyloxy 1-631 H CH3 F CH 5-fluoro-2-pyrimidyloxy 1-632 H CH3 F CH 5-chloro-2-pyrimidyloxy 1-633 H CH3 Cl CH 5-chloro-3-fluoro-2-pyridyloxy 1-634 H CH3 Cl CH 5-chloro-2-pyridyloxy 1-635 H CH3 Cl CH 5-fluoro-2-pyridyloxy, No. Example R2a R2b R3 X AR1 1-636 H CH3 Cl CH 3,5-difluoro-2-pyridyloxy 1-637 H CH3 Cl CH 5-fluoro-2-pyrimidyloxy 1-638 H CH3 Cl CH 5-CFymidyloxy F 5-chloro-3-fluoro-2-pyridyloxy 1-640 CH3 CH3 F CF 5-chloro-2-pyridyloxy 1-641 CH3 CH3 F CF 5-fluoro-2-pyridyloxy 1-642 CH3 CH3 F CF CHxi F 3,2-CH3-difluoro CF 5-fluoro-2-pyrimidlose 1-644 CH3 CH3 F CF 5-chloro-2-pyrimidlose 1-645 CH3 CH3 Cl CF 5-chloro-3-fluoro-2-pyridilose 1-646 CH3 CH3 dichloxi Cl7 CH-2 -5-5 Cl CF 5-fluoro-2-pyridyloxy 1-648 CH3 CH3 Cl CF 3,5-difluoro-2-pyridyloxy 1-649 CH3 CH3 Cl CF 5-fluoro-2-pyrimidylox 1-650 CH3 CH5-pyrimidyl Cl61 CF2 F CF 5-chloro-3-fluoro-2-pyridyloxy 1-652 H CH3 F CF 5-chloro-2-pyridyloxy 1-653 H CH3 F CF 5-fluoro-2-pyridyloxy 1-654 H CH3 F CF 3,5-difluoro-2-pyridyloxy 1-655 H CH3 F CF 5-fluoro-2-pyrimidyloxy 1-656 H CH3 F CF 5-chloro-2-pyrimidyloxy 1-657 H CH3 Cl CF 5-chloro-3-fluoro-2-pyridyloxy 1-658 H CH3 Cl CF 5-chloro-2-pyridyloxy 1-659 H CH3 Cl CF 5-fluoro-2-pyridyloxy, No. Example R2a R2b R3 NMR data from selected examples (final and intermediate products) Procedure used for NMR peaks The 1H-NMR data for selected examples are presented as 1H-NMR peak lists. For each signal peak, the δ value in ppm is given first, followed by the signal intensity in parentheses. Different δ-signal intensity pairs are listed, separated by semicolons. Therefore, the list of signal peaks for an Example takes the following form: δ1(Intensity?; δ2(Intensity2);........; δι (Intensity?;......; δn(Intensityn) The intensity of the sharp signals correlates with the signal height in a printed example of an NMR spectrum in cm and shows the actual relationships between the signal intensities. In the case of broad signals, several peaks are observed and considered, or the center of the signals (central signal) and its relative intensity compared to the strongest signal in the spectrum are considered. Tetramethylsilane and / or solvent shift are used to calibrate the chemical shift of 1H-NMR spectra, especially in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may appear in the list of NMR peaks, but this is not always the case. 1H-MRI peak listings are similar to classical 1H-MRI printouts and therefore generally contain all the peaks listed according to a classical MRI interpretation. Furthermore, as in classic 1H-NMR prints, solvent signals, signals from stereoisomers of the compounds of interest, which are also an object of the invention, and / or impurity peaks can be observed. When composite signals in the delta range of solvents and / or water are indicated, the 1H-NMR peak listings herein show the usual solvent peaks, e.g. DMSO peaks in DMSO-D6 and the water peak, which generally have a high average intensity. The peaks of stereoisomers of compounds of interest and / or the peaks of impurities generally have, on average, a lower intensity than the peaks of said compounds of interest (e.g., with a purity of >90%). These stereoisomers and / or impurities may be a result of a particular preparation process. Their peaks can thus help identify the replicability of the manufacturing process in question through "byproduct fingerprinting." The specialist calculating the peaks of the compounds of interest will use known methods (MestreC, ACD simulation, but also empirically evaluated expected values) and can isolate the peaks of these compounds, as needed, optionally using additional intensity filters. This isolation would be similar to peak selection according to the classical interpretation of 1H-NMR. Further details on 1H-NMR peak listings can be found in the Research Disclosure Database No. 564025. Example No. I-397:1H-NRM(400.6 MHz, CDCl3): δ= 8.4126 (16.0); 7.4745 (1.9); 7.4555 (2.1); 7.2599 (44.6); 7.2276 (0.6); 7.2234 (0.9); 7.2119 (0.7); 7.2073 (2.6); 7.2030 (1.6); 7.1923 (1.1); 7.1887 (2.8); 7.1865 (2.0); 7.1831 (0.6); 7.1660 (1.1); 7.1624 (1.1); 7.1487 (1.7); 7.1447 (2.9); 7.1404 (3.1); 7.1341 (0.7); 7.1297 (0.9); 7.1283 (1.0); 7.1243 (1.8); 7.1207 (1.2); 7.0382 (1.9); 7.0193 (1.8); 3.9295 (5.8); 2.4678 (12.8); 0.8821 (0.9); 0.0080 (0.7); 0.0002 (26.5); -0.0085 (0.8) Example No. I-400: 1H-NMR(400.0 MHz, CDCl3): δ= 8.4920 (0.7); 8.4616 (16.0); 7.5009 (1.1); 7.4831 (1.2); 7.2607 (14.0); 7.1218 (0.5); 7.1171 (0.8); 7.1010 (0.8); 7.0423 (1.8); 7.0226 (1.6); 6.7585 (0.7); 6.7424 (0.6); 6.7356 (2.2); 6.7143 (2.2); 6.7075 (0.7); 6.6955 (0.5); 3.9163 (3.9); 2.6147 (0.7); 2.4569 (11.0); 1.5563 (6.0); 0.0080 (0.7); -0.0002 (18.4); -0.0085 (0.7) Example No. I-405: 1H-NMR(400.0 MHz, CDCl3): δ= 8.4073 (9.2); 7.4640 (1.2); 7.4450 (1.3); 7.2592 (4.8); 7.0275 (1.4); 7.0099 (16.0); 3.8797 (3.9); 2.4635 (7.8); 2.2781 (8.8); 1.5678 (1.0); 1.2644 (1.0); 0.8818 (1.6); 0.8641 (0.6); -0.0002 (6.2) Example No. I-406:1H-NRM(400.0 MHz, CDCI3): δ= 8.4666 (2.2); 8.4474 (13.6); 8.4354 (2.2); 7.4577 (1.5); 7.4387 (1.6); 7.2621 (5.0); 7.0416 (1.8); 7.0234 (1.9); 6.9381 (1.1); 6.9175 (1.4); 6.9100 (1.2); 6.8894 (1.3); 6.7666 (0.8); 6.7614 (0.9); 6.7462 (0.8); 6.7410 (0.9); 6.6779 (0.6); 6.6726 (0.5); 6.6672 (0.6); 6.6619 (0.6); 6.6573 (0.5); 5.2978 (5.0); 3.9432 (0.6); 3.8883 (4.0); 3.8769 (0.5); 3.8064 (16.0); 2.4663 (10.3); 1.5924 (1.5); -0.0002 (6.4) Example No. I-408: 1H-NMR(400.0 MHz, CDCI3): δ= 8.1461 (2.7); 8.1394 (2.8); 7.6547 (2.4); 7.6480 (2.3); 7.6330 (2.5); 7.6263 (2.4); 7.5189 (0.5); 7.4023 (2.4); 7.3834 (2.6); 7.2765 (1.3); 7.2731 (1.9); 7.2601 (96.5); 7.2412 (1.7); 7.2376 (3.3); 7.2030 (1.4); 7.1998 (1.3); 7.1818 (3.9); 7.1780 (3.9); 7.1613 (2.6); 6.9961 (0.5); 6.9479 (2.7); 6.9333 (3.6); 6.9320 (3.8); 6.9294 (2.6); 6.9116 (3.1); 3.9289 (7.8); 2.4189 (16.0); 1.5469 (6.8); 1.3331 (0.8); 1.2843 (1.3); 1.2556 (2.6); 0.8803 (0.5); 0.0693 (0.9); 0.0080 (2.1); 0.0002 (56.5); -0.0084 (2.0) Example No. I-419: 1H-NMR(400.0 MHz, CDCI3): δ= 8.0098 (4.6); 8.0042 (4.7); 7.5250 (2.6); 7.5194 (2.5); 7.5030 (2.6); 7.4975 (2.5); 7.3706 (2.4); 7.3518 (2.6); 7.2938 (0.9); 7.2909 (1.4); 7.2870 (0.7); 7.2752 (2.4); 7.2726 (3.3); 7.2700 (2.5); 7.2590 (46.7); 7.2549 (4.4); 7.2206 (4.6); 7.2142 (2.3); 7.2033 (2.2); 7.1999 (2.0); 7.1939 (1.8); 7.1762 (0.6); 6.9001 (2.6); 6.8813 (2.4); 4.0053 (7.5); 2.3544 (16.0); 1.5571 (0.7); 0.0080 (0.9); -0.0002 (27.1); -0.0085 (0.8) Example No. I-422: 1H-NMR(400.0 MHz, CDCI3): δ= 8.0272 (4.3); 8.0217 (4.4); 7.5377 (2.4); 7.5322 (2.3); 7.5158 (2.4); 7.5103 (2.3); 7.4161 (1.8); 7.3974 (1.9); 7.2594 (8.4); 7.2012 (0.5); 7.1799 (1.0); 7.1635 (1.0); 7.1423 (0.5); 6.9107 (2.6); 6.8918 (2.4); 6.8008 (0.7); 6.7957 (1.8); 6.7799 (1.0); 6.7747 (4.4); 6.7539 (2.0); 6.7485 (0.7); 3.9888 (5.7); 2.3449 (16.0); 1.5493 ​​(2.5); -0.0002 (11.1) Example No. I-428: 1H-NMR(400.0 MHz, CDCI3): δ= 8.0312 (2.8); 8.0256 (2.8); 7.5443 (1.6); 7.5388 (1.6); 7.5224 (1.6); 7.5168 (1.8); 7.3747 (1.5); 7.3558 (1.6); 7.2598 (6.4); 7.0774 (0.5); 6.9912 (1.2); 6.9706 (1.4); 6.9630 (1.2); 6.9425 (1.4); 6.9081 (1.6); 6.8893 (1.4); 6.8642 (0.8); 6.8589 (0.9); 6.8437 (0.8); 6.8385 (0.9); 6.7491 (0.6); 6.7438 (0.5); 6.7384 (0.6); 6.7331 (0.5); 5.2978 (1.2); 4.0080 (0.6); 3.9614 (4.1); 3.9013 (0.6); 3.8296 (16.0); 2.3531 (10.9); 2.1042 (0.8); 1.5523 (1.8); -0.0002 (9.0) Example No. I-430: 1H-NMR(400.0 MHz, CDCI3): δ= 8.3534 (16.0); 7.4614 (2.1); 7.4424 (2.3); 7.2596 (14.7); 7.2329 (0.7); 7.2298 (1.0); 7.2253 (0.7); 7.2185 (0.8); 7.2143 (1.4); 7.2112 (2.3); 7.2086 (2.0); 7.2060 (1.5); 7.1941 (3.4); 7.1628 (2.6); 7.1575 (3.9); 7.1461 (1.9); 7.1389 (2.1); 7.1290 (0.7); 7.0181 (2.2); 6.9993 (2.0); 3.9447 (6.6); 2.4534 (13.9); 2.4350 (0.7); 1.5586 (3.8); 1.2635 (0.5); 0.8819 (0.9); 0.0080 (0.7); -0.0002 (19.6); -0.0085 (0.8) Example No. I-433: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3968 (16.0); 7.4932 (1.6); 7.4743 (1.7); 7.2612 (12.4); 7.1528 (0.6); 7.1364 (0.7); 7.1317 (1.0); 7.1156 (1.0); 7.0242 (2.4); 7.0051 (2.2); 6.7670 (0.7); 6.7606 (0.9); 6.7447 (0.8); 6.7381 (3.1); 6.7311 (0.5); 6.7170 (2.9); 6.7130 (1.0); 6.6985 (0.6); 6.6961 (0.6); 3.9314 (5.3); 2.6154 (0.6); 2.4432 (14.9); 1.5644 (6.7); 0.0079 (0.5); -0.0002 (15.7) Example No. I-438: 1H-NMR(400.0 MHz, CDCI3): δ= 8.6597 (1.1); 8.6476 (1.1); 8.3605 (16.0); 7.4435 (2.2); 7.4245 (2.4); 7.2891 (0.9); 7.2770 (0.5); 7.2599 (9.2); 7.0509 (0.7); 7.0285 (13.9); 7.0049 (2.8); 6.9856 (2.1); 3.8948 (6.8); 2.4478 (14.1); 2.3200 (0.6); 2.2784 (14.7); 1.5765 (4.9); 0.0080 (0.5); -0.0002 (11.6); -0.0085 (0.5) Example No. I-439: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3861 (11.0); 7.4483 (1.5); 7.4294 (1.6); 7.2610 (16.4); 7.0240 (1.6); 7.0050 (1.5); 6.9428 (1.1); 6.9222 (1.3); 6.9147 (1.1); 6.8942 (1.3); 6.7867 (0.8); 6.7815 (0.9); 6.7663 (0.8); 6.7612 (0.9); 6.6915 (0.6); 6.6862 (0.5); 6.6809 (0.6); 6.6755 (0.5); 5.2998 (0.7); 3.9053 (4.3); 3.8096 (16.0); 2.6155 (0.8); 2.4527 (10.1); 1.5528 (9.5); 0.0080 (0.6); -0.0002 (22.2); -0.0085 (0.6) Example No. I-441: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5217 (10.9); 8.5097 (11.2); 7.4457 (2.4); 7.4267 (2.6); 7.2609 (8.3); 7.2326 (0.8); 7.2296 (1.3); 7.2256 (0.6); 7.2143 (2.1); 7.2115 (3.1); 7.2085 (2.3); 7.1995 (1.2); 7.1940 (4.0); 7.1920 (2.8); 7.1896 (1.0); 7.1717 (1.8); 7.1667 (4.7); 7.1605 (2.4); 7.1538 (1.3); 7.1500 (2.0); 7.1475 (1.7); 7.1463 (1.8); 7.1403 (1.7); 7.1229 (0.6); 7.0205 (5.7); 7.0085 (6.7); 7.0028 (2.5); 6.9966 (3.4); 3.9298 (7.3); 2.4743 (16.0); 2.2314 (0.6); 1.6132 (1.1); -0.0002 (10.9) Example No. I-444: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5368 (9.8); 8.5249 (10.0); 7.5029 (1.6); 7.4840 (1.7); 7.2617 (14.4); 7.1513 (0.6); 7.1351 (0.7); 7.1300 (1.2); 7.1139 (1.2); 7.1092 (0.7); 7.0931 (0.6); 7.0505 (2.9); 7.0386 (7.9); 7.0265 (2.9); 7.0206 (2.4); 6.7494 (0.7); 6.7431 (0.9); 6.7270 (0.8); 6.7201 (1.2); 6.7189 (1.2); 6.7115 (0.9); 6.7094 (0.7); 6.7027 (0.9); 6.6964 (1.0); 6.6909 (1.5); 6.6890 (1.2); 6.6841 (0.8); 6.6823 (0.8); 6.6703 (0.6); 6.6677 (0.6); 5.2994 (0.7); 3.9190 (5.4); 3.7973 (0.7); 2.6160 (0.6); 2.4707 (16.0); 2.2526 (1.7); 1.5844 (3.3); 0.0079 (0.5); -0.0002 (19.3); -0.0085 (0.5) Example No. I-449: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5315 (6.5); 8.5196 (6.7); 7.4264 (2.5); 7.4074 (2.7); 7.2602 (14.5); 7.0621 (1.6); 7.0415 (7.8); 7.0307 (8.1); 7.0167 (4.7); 7.0080 (4.4); 6.9887 (2.6); 3.8803 (8.4); 2.6148 (0.7); 2.4689 (16.0); 2.3180 (0.5); 2.2755 (15.4); 2.0451 (0.7); 1.5621 (8.8); -0.0002 (18.2) Example No. I-450: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5201 (5.7); 8.5081 (5.9); 7.4597 (1.4); 7.4407 (1.6); 7.2614 (15.7); 7.0393 (3.3); 7.0273 (3.6); 7.0210 (1.4); 7.0153 (1.8); 6.9226 (1.1); 6.9020 (1.4); 6.8945 (1.1); 6.8739 (1.3); 6.7733 (0.8); 6.7682 (0.8); 6.7530 (0.8); 6.7478 (0.8); 6.6884 (0.5); 6.6777 (0.6); 6.6723 (0.5); 3.8927 (3.9); 3.7941 (16.0); 2.6156 (0.7); 2.4805 (9.5); 1.5632 (7.5); 0.0080 (0.6); -0.0002 (20.8); -0.0085 (0.6) Example No. I-455: 1H-NMR(400.0 MHz, CDCI3): δ= 8.2100 (1.2); 8.2083 (1.3); 8.2051 (1.3); 8.2033 (1.3); 8.1976 (1.3); 8.1958 (1.3); 8.1926 (1.3); 8.1909 (1.2); 7.7177 (1.2); 7.7126 (1.2); 7.6995 (1.4); 7.6970 (1.4); 7.6945 (1.4); 7.6920 (1.3); 7.6790 (1.3); 7.6739 (1.2); 7.4298 (1.7); 7.4108 (1.8); 7.2603 (15.5); 7.1692 (0.6); 7.1486 (1.2); 7.1326 (1.2); 7.1259 (0.7); 7.1099 (0.5); 7.0439 (1.3); 7.0416 (1.4); 7.0314 (1.3); 7.0292 (1.4); 7.0258 (1.3); 7.0236 (1.3); 7.0134 (1.2); 7.0111 (1.3); 6.9772 (1.6); 6.9753 (2.6); 6.9545 (2.8); 6.9519 (3.2); 6.9319 (2.4); 6.7765 (0.6); 6.7703 (1.1); 6.7617 (0.9); 6.7548 (0.9); 6.7457 (1.6); 6.7416 (1.8); 6.7349 (0.8); 6.7287 (0.7); 6.7224 (1.6); 3.9234 (5.7); 2.4218 (16.0); 1.5573 (2.7); 1.3334 (0.7); 1.2843 (0.9); 1.2555 (1.1); 1.1374 (0.6); 1.1216 (0.6); 0.9169 (0.6); 0.0079 (0.6); -0.0002 (21.3); -0.0084 (0.7) Example No. I-461: 1H-NMR(400.0 MHz, CDCI3): δ= 8.2153 (0.8); 8.2136 (0.9); 8.2104 (0.9); 8.2086 (0.9); 8.2029 (0.9); 8.2011 (0.9); 8.1979 (0.9); 8.1961 (0.8); 7.7182 (0.8); 7.7132 (0.8); 7.7001 (1.0); 7.6976 (1.0); 7.6951 (1.0); 7.6926 (0.9); 7.6795 (0.9); 7.6745 (0.9); 7.3943 (1.6); 7.3754 (1.7); 7.2618 (8.4); 7.0473 (0.9); 7.0449 (1.0); 7.0348 (1.0); 7.0325 (1.0); 7.0292 (1.0); 7.0269 (1.0); 7.0167 (0.9); 7.0144 (0.9); 6.9747 (1.1); 6.9726 (2.1); 6.9708 (2.2); 6.9541 (2.8); 6.9522 (3.0); 6.9503 (2.5); 6.9426 (1.3); 6.9352 (1.6); 6.9221 (1.3); 6.8121 (0.9); 6.8070 (1.0); 6.7917 (0.9); 6.7866 (0.9); 6.7176 (0.6); 6.7123 (0.5); 6.7068 (0.6); 6.7016 (0.6); 6.6970 (0.5); 3.9040 (2.2); 3.8909 (4.5); 3.7903 (16.0); 2.4325 (10.4); 1.5784 (0.9); 1.3335 (1.0); 1.2844 (1.4); 1.2544 (1.4); 0.0701 (0.6); -0.0002 (11.7) Example No. I-463: 1H-NMR(400.0 MHz, CDCI3): δ= 8.6554 (7.9); 8.6537 (7.4); 7.5432 (2.4); 7.5241 (2.6); 7.2596 (12.0); 7.1822 (0.7); 7.1779 (1.0); 7.1739 (0.6); 7.1622 (2.2); 7.1537 (1.1); 7.1474 (1.6); 7.1433 (3.4); 7.1378 (1.2); 7.1249 (1.5); 7.1212 (1.7); 7.1065 (4.6); 7.1003 (4.7); 7.0861 (2.5); 7.0804 (3.0); 3.9282 (7.6); 2.4964 (16.0); 1.5535 (5.1); 1.2642 (0.6); 0.8820 (0.9); 0.0080 (0.6); -0.0002 (15.7); -0.0084 (0.7) Example No. I-464: 1H-NMR(400.0 MHz, CDCI3): δ= 8.7268 (7.6); 8.7250 (7.7); 7.5564 (1.7); 7.5376 (1.8); 7.2622 (3.8); 7.1092 (0.7); 7.0989 (2.7); 7.0936 (1.0); 7.0880 (1.5); 7.0798 (2.6); 7.0720 (1.4); 7.0671 (0.8); 7.0507 (0.6); 6.7407 (0.8); 6.7343 (0.9); 6.7185 (0.9); 6.7158 (0.8); 6.7120 (1.2); 6.7097 (1.2); 6.6987 (0.9); 6.6963 (0.9); 6.6931 (1.0); 6.6875 (1.2); 6.6781 (1.4); 6.6697 (0.9); 6.6576 (0.6); 6.6550 (0.6); 5.2973 (2.4); 3.9126 (5.9); 2.4857 (16.0); 1.5978 (1.6); -0.0002 (4.9) Example No. I-465: 1H-NMR(400.0 MHz, CDCI3): δ= 8.7729 (0.7); 8.7710 (0.7); 8.7201 (1.0); 8.7182 (1.1); 8.7145 (2.2); 8.7128 (5.0); 8.7108 (5.0); 7.5117 (1.5); 7.4927 (1.6); 7.2618 (5.5); 7.1002 (1.7); 7.0810 (1.4); 6.9077 (1.1); 6.8871 (1.4); 6.8797 (1.2); 6.8591 (1.3); 6.7348 (0.8); 6.7296 (0.9); 6.7145 (0.8); 6.7094 (0.9); 6.6496 (0.6); 6.6442 (0.6); 6.6389 (0.6); 6.6336 (0.6); 6.6290 (0.5); 6.6183 (0.5); 5.2983 (2.6); 3.9502 (0.5); 3.8841 (4.1); 3.7972 (16.0); 2.4965 (10.2); 1.5761 (2.2); -0.0002 (7.4) Example No. I-466: 1H-NMR(400.6 MHz, CDCI3): δ= 8.6395 (7.7); 8.6376 (7.6); 7.5432 (2.4); 7.5242 (2.6); 7.2598 (11.0); 7.0935 (2.5); 7.0745 (2.3); 6.9820 (0.9); 6.9679 (0.7); 6.9606 (9.1); 6.9557 (8.2); 6.9485 (0.7); 6.9346 (0.8); 5.2979 (0.5); 3.8809 (7.1); 2.4944 (16.0); 2.2372 (15.0); 1.5642 (4.2); -0.0002 (14.8) Example No. I-478: 1H-NMR(400.0 MHz, CDCI3): δ= 8.3304 (9.7); 7.2604 (36.0); 7.1866 (0.8); 7.1714 (1.4); 7.1685 (2.0); 7.1655 (1.6); 7.1567 (0.9); 7.1511 (2.6); 7.1275 (3.2); 7.1196 (1.5); 7.1110 (1.6); 7.0990 (1.2); 6.9298 (2.6); 4.0222 (5.1); 2.4285 (11.2); 2.2802 (10.8); 1.5519 (16.0); 0.0080 (1.0); -0.0002 (25.2); -0.0085 (1.2) Example No. I-479: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3622 (15.6); 7.2608 (10.7); 7.1105 (1.6); 7.1050 (0.7); 7.0971 (1.9); 7.0885 (2.0); 7.0807 (0.8); 7.0751 (2.0); 6.9261 (3.4); 6.8864 (2.6); 6.8810 (0.8); 6.8699 (0.8); 6.8647 (4.7); 6.8593 (0.8); 6.8482 (0.7); 6.8428 (2.0); 3.9866 (5.6); 2.4224 (16.0); 2.2686 (15.0); 1.5651 (1.6); -0.0002 (14.7) Example No. I-481: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4357 (2.3); 8.3706 (16.0); 7.2620 (35.2); 7.0106 (0.5); 6.9903 (1.0); 6.9724 (1.0); 6.9685 (0.7); 6.9513 (0.6); 6.9367 (3.4); 6.7478 (0.7); 6.7414 (0.9); 6.7243 (1.4); 6.7168 (1.1); 6.7004 (0.7); 6.6940 (0.9); 6.6767 (0.5); 6.6595 (0.7); 6.6553 (0.6); 6.6492 (0.6); 6.6382 (0.7); 3.9744 (5.0); 2.4566 (2.2); 2.4217 (15.0); 2.3602 (2.2); 2.2722 (14.3); 1.5808 (5.0); 0.0700 (0.6); 0.0079 (0.6); 0.0022 (0.8); -0.0002 (20.7); -0.0085 (0.6) Example No. I-482: 1H-NMR(400.6 MHz, CDCl3): δ= 8.4352 (1.3); 8.3637 (15.9); 7.2614 (35.5); 7.1576 (3.8); 7.1526 (1.4); 7.1415 (1.6); 7.1363 (6.3); 7.1303 (1.0); 7.0824 (0.7); 7.0765 (4.6); 7.0713 (1.4); 7.0600 (1.0); 7.0550 (2.7); 6.9256 (3.7); 5.1087 (0.5); 4.8590 (0.6); 3.9874 (7.1); 2.4564 (1.4); 2.4217 (16.0); 2.3599 (1.4); 2.2581 (15.5); 1.5745 (9.7); 0.0079 (0.6); 0.0002 (21.8); -0.0085 (0.7) Example No. I-483: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4352 (0.8); 8.3570 (15.4); 7.2610 (25.8); 7.2560 (0.5); 6.9913 (0.8); 6.9719 (1.8); 6.9515 (1.1); 6.9267 (3.6); 6.8122 (1.2); 6.8084 (1.5); 6.7891 (1.3); 6.7785 (1.3); 6.7516 (1.2); 3.9725 (6.3); 2.4564 (0.9); 2.4270 (16.0); 2.3596 (0.9); 2.2644 (16.0); 2.2407 (0.5); 2.2359 (0.6); 2.1720 (6.9); 2.1682 (7.1); 1.5715 (2.6); 0.0079 (0.5); -0.0002 (18.5); -0.0085 (0.5) Example No. I-484: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4351 (0.6); 8.3328 (8.5); 7.2611 (29.3); 7.1072 (0.8); 7.0877 (1.6); 7.0681 (1.0); 6.9238 (2.2); 6.7166 (0.9); 6.6976 (0.9); 6.6781 (0.7); 6.6730 (1.3); 6.6696 (1.1); 6.6602 (1.0); 6.6553 (0.5); 6.6403 (0.7); 6.6349 (0.5); 3.9943 (4.2); 3.8752 (0.8); 3.8210 (1.4); 3.7870 (0.9); 3.7830 (0.9); 3.7201 (16.0); 2.4565 (0.6); 2.4259 (8.9); 2.3598 (0.7); 2.2827 (9.7); 1.5771 (6.2); -0.0002 (18.7); -0.0085 (0.6) Example No. I-485: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4354 (2.2); 8.3826 (15.4); 7.2619 (26.2); 7.2194 (1.7); 7.1994 (2.7); 7.1798 (1.8); 6.9444 (1.2); 6.9392 (1.7); 6.9337 (3.6); 6.9192 (1.1); 6.9144 (1.4); 6.8956 (1.4); 6.8938 (1.4); 6.8906 (1.1); 6.8888 (1.0); 6.8752 (1.1); 6.8732 (1.2); 6.8702 (1.0); 6.8683 (0.9); 3.9986 (7.2); 2.4565 (2.0); 2.4245 (14.8); 2.3599 (2.3); 2.2570 (16.0); 1.5769 (2.7); -0.0002 (18.0); -0.0085 (0.5) Example No. I-486: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4346 (0.6); 8.3357 (15.1); 7.2597 (22.1); 7.0216 (1.7); 7.0063 (1.2); 7.0009 (5.4); 6.9824 (5.2); 6.9621 (1.7); 6.9183 (3.6); 3.9719 (6.5); 2.4563 (0.6); 2.4238 (15.2); 2.3591 (0.6); 2.2717 (16.0); 2.2509 (13.1); 1.5805 (3.6); -0.0002 (14.0) Example No. I-487: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3689 (11.0); 7.2611 (16.2); 6.9227 (2.3); 6.9010 (1.2); 6.8803 (1.4); 6.8729 (1.2); 6.8523 (1.4); 6.8021 (0.8); 6.7969 (0.8); 6.7817 (0.8); 6.7765 (0.8); 6.6478 (0.5); 6.6371 (0.6); 6.6318 (0.5); 5.2996 (1.3); 3.9786 (3.7); 3.9631 (0.8); 3.9052 (1.2); 3.7972 (16.0); 2.4208 (10.6); 2.2773 (10.2); 1.5600 (2.4); 1.2693 (1.2); 1.2417 (10.4); 0.0080 (0.6); -0.0002 (21.8); -0.0085 (0.6) Example No. I-488: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3778 (11.6); 7.2604 (50.3); 6.9349 (2.2); 6.6756 (0.7); 6.6716 (1.2); 6.6500 (0.8); 6.6462 (1.0); 6.6426 (0.6); 6.6273 (0.7); 6.6235 (0.6); 6.6089 (0.5); 3.9711 (3.0); 3.9592 (5.3); 3.9568 (8.6); 3.9543 (5.4); 2.4213 (10.2); 2.2693 (9.2); 1.5396 (16.0); 0.0079 (1.9); 0.0064 (0.6); 0.0047 (0.6); 0.0038 (0.8); -0.0002 (67.5); -0.0027 (3.6); -0.0051 (1.4); -0.0068 (0.8); -0.0084 (2.2) Example No. I-500: 1H-NMR(400.6 MHz, CDCI3): δ= 9.3392 (0.7); 8.4924 (1.0); 8.4380 (16.0); 7.2995 (1.7); 7.2975 (0.7); 7.2939 (0.9); 7.2912 (2.7); 7.2831 (1.0); 7.2809 (2.8); 7.2779 (2.3); 7.2711 (3.3); 7.2642 (1.2); 7.2609 (15.5); 7.1007 (0.6); 7.0980 (1.3); 7.0953 (0.7); 7.0812 (3.1); 7.0798 (3.9); 7.0760 (0.7); 7.0611 (2.8); 7.0600 (2.1); 6.9371 (2.6); 6.9342 (3.3); 6.9325 (1.5); 6.9289 (0.8); 6.9202 (0.8); 6.9179 (1.4); 6.9152 (2.6); 6.9127 (2.4); 2.5272 (14.5); 1.5552 (2.8); 0.0080 (0.6); -0.0002 (20.3); -0.0085 (0.5) Example No. I-504: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4479 (9.3); 7.3151 (3.8); 7.2949 (4.5); 7.2618 (26.8); 7.2540 (0.8); 7.2456 (7.1); 7.2400 (2.2); 7.2288 (2.2); 7.2231 (7.9); 7.2147 (0.8); 7.1095 (0.9); 7.0892 (0.8); 6.8825 (0.7); 6.8741 (7.8); 6.8685 (2.3); 6.8572 (2.1); 6.8516 (6.8); 6.8432 (0.6); 5.2996 (2.7); 2.5303 (16.0); 1.2709 (0.7); -0.0002 (16.8); -0.0085 (0.6) Example No. I-509: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4775 (0.7); 8.4589 (12.9); 8.4312 (0.7); 8.2355 (1.1); 7.2762 (2.0); 7.2614 (33.7); 7.2561 (3.0); 7.0847 (1.8); 7.0836 (1.7); 7.0645 (1.5); 7.0633 (1.4); 6.9882 (1.3); 6.9661 (1.4); 6.9611 (1.3); 6.9391 (1.4); 6.6034 (1.0); 6.5963 (1.1); 6.5857 (1.0); 6.5786 (1.1); 6.4525 (0.8); 6.4451 (0.9); 6.4439 (0.9); 6.4367 (0.7); 6.4304 (0.7); 6.4230 (0.8); 6.4219 (0.8); 6.4146 (0.6); 5.3002 (0.9); 3.8103 (16.0); 2.5221 (11.6); 1.5594 (1.5); 1.2423 (0.6); 0.0080 (0.7); -0.0002 (25.2); 0.0085 (0.8) Example No. I-511: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3677 (7.5); 7.3039 (3.7); 7.2978 (2.4); 7.2925 (1.0); 7.2837 (4.3); 7.2791 (3.8); 7.2763 (3.3); 7.2703 (0.6); 7.2609 (64.6); 7.2580 (6.1); 7.2517 (1.1); 7.0980 (0.8); 7.0954 (1.6); 7.0927 (1.0); 7.0770 (3.2); 7.0610 (1.5); 7.0585 (2.0); 7.0559 (1.1); 6.9387 (0.5); 6.9350 (3.3); 6.9321 (4.3); 6.9268 (1.1); 6.9180 (1.0); 6.9158 (1.8); 6.9130 (3.5); 6.9106 (3.1); 2.5267 (16.0); 0.0079 (1.0); -0.0002 (38.5); -0.0085 (1.3) Example No. I-515: 1H-NMR(400.6 MHz, CDCI3): δ= 8.3703 (10.4); 7.3132 (3.1); 7.2931 (3.7); 7.2614 (57.4); 7.2483 (0.6); 7.2398 (5.8); 7.2343 (1.9); 7.2230 (1.8); 7.2173 (6.6); 7.2090 (0.6); 7.0925 (1.6); 7.0724 (1.4); 6.8803 (0.6); 6.8719 (6.4); 6.8662 (1.9); 6.8550 (1.7); 6.8494 (5.7); 6.8410 (0.5); 2.5225 (16.0); 1.6803 (1.4); 0.0080 (0.8); -0.0002 (32.2); -0.0085 (1.1) Example No. I-520: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4016 (0.7); 8.3853 (11.2); 7.2786 (2.0); 7.2617 (27.4); 7.2586 (3.3); 7.0742 (1.7); 7.0731 (1.7); 7.0540 (1.4); 7.0529 (1.4); 6.9835 (1.3); 6.9614 (1.4); 6.9565 (1.3); 6.9344 (1.4); 6.6065 (1.0); 6.5994 (1.1); 6.5887 (1.0); 6.5817 (1.1); 6.4500 (0.8); 6.4427 (0.8); 6.4415 (1.0); 6.4342 (0.7); 6.4279 (0.7); 6.4207 (0.8); 6.4194 (0.8); 6.4121 (0.7); 3.8090 (16.0); 3.3772 (0.7); 2.5155 (11.1); 1.5591 (2.4); 1.2422 (3.5); 0.0079 (0.5); -0.0002 (19.7); -0.0085 (0.6) Example No. I-522: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5411 (6.9); 8.5290 (7.1); 7.3072 (2.9); 7.2868 (5.3); 7.2812 (0.9); 7.2701 (1.1); 7.2680 (3.1); 7.2648 (2.9); 7.2611 (17.7); 7.2514 (1.1); 7.2464 (2.8); 7.0873 (3.0); 7.0864 (2.7); 7.0848 (2.4); 7.0819 (1.0); 7.0661 (4.0); 7.0504 (0.6); 7.0477 (1.0); 7.0448 (0.7); 7.0426 (2.3); 7.0306 (4.4); 7.0185 (2.2); 6.9412 (0.5); 6.9377 (3.0); 6.9349 (3.7); 6.9332 (1.8); 6.9295 (1.0); 6.9208 (0.9); 6.9185 (1.6); 6.9158 (3.0); 6.9133 (2.7); 2.5417 (16.0); 0.0080 (0.6); -0.0002 (19.5); -0.0085 (0.6) Example No. I-526: 1H-NMR(400.0 MHz, CDCI3): δ= 8.5167 (3.0); 8.5048 (3.0); 7.3095 (3.1); 7.2894 (3.8); 7.2607 (62.8); 7.2269 (0.5); 7.2185 (5.4); 7.2129 (1.7); 7,2017 (1.8); 7.1960 (6.3); 7.1876 (0.6); 7.0937 (1.2); 7.0736 (1.0); 7.0277 (1.7); 7.0157 (3.3); 7.0037 (1.6); 6.8780 (0.6); 6.8696 (6.2); 6.8640 (1.7); 6.8527 (1.6); 6.8471 (5.4); 2.5373 (16.0); 2.0449 (0.5); 1.5503 (12.3); 1.2420 (7.6); 0.0080 (1.4); -0.0002 (43.6); -0.0085 (1.2) Example No. I-531: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5339 (5.6); 8.5220 (5.7); 7.2798 (2.0); 7.2612 (46.5); 7.0778 (1.7); 7.0575 (1.4); 7.0405 (1.7); 7.0285 (3.3); 7.0166 (1.6); 6.9665 (1.3); 6.9444 (1.4); 6.9394 (1.3); 6.9173 (1.4); 6.6006 (1.0); 6.5936 (1.1); 6.5828 (1.0); 6.5757 (1.1); 6.4582 (0.8); 6.4496 (0.9); 6.4424 (0.7); 6.4361 (0.7); 6.4288 (0.8); 6.4276 (0.8); 6.4204 (0.6); 3.7962 (16.0); 2.5323 (11.2); 1.5523 (5.9); 0.0079 (0.9); -0.0002 (34.7); 0.0085 (1.1) Example No. I-533: 1H-NMR(400.6 MHz, CDCI3): δ= 8.7378 (6.5); 8.7358 (6.5); 7.3171 (2.9); 7.3004 (2.0); 7.2968 (3.8); 7.2842 (1.0); 7.2819 (3.1); 7.2788 (2.6); 7.2653 (1.2); 7.2605 (30.6); 7.2544 (0.6); 7.1207 (2.4); 7.1196 (2.4); 7.1054 (0.8); 7.1025 (1.9); 7.1001 (2.6); 7.0877 (0.8); 7.0859 (0.9); 7.0842 (2.2); 7.0805 (0.7); 7.0684 (0.6); 7.0657 (1.1); 7.0629 (0.6); 6.9347 (3.0); 6.9319 (3.9); 6.9300 (1.8); 6.9265 (1.0); 6.9178 (0.9); 6.9155 (1.6); 6.9128 (3.0); 6.9103 (2.8); 2.5434 (16.0); 1.5436 (3.6); 0.0080 (1.0); -0.0002 (36.5); -0.0085 (1.1) Example No. I-534: 1H-NMR(400.6 MHz, CDCI3): δ= 8.7454 (6.3); 8.7435 (6.3); 7.3294 (2.9); 7.3091 (3.5); 7.2616 (27.5); 7.2563 (0.9); 7.2476 (5.5); 7.2420 (1.8); 7.2308 (1.7); 7.2251 (6.2); 7.2167 (0.6); 7.1404 (2.3); 7.1398 (2.3); 7.1202 (1.9); 7.1195 (1.9); 6.8825 (0.6); 6.8741 (6.1); 6.8684 (1.8); 6.8572 (1.6); 6.8516 (5.4); 2.5444 (16.0); 1.5589 (2.9); 1.4106 (0.9); 1.3392 (0.9); -0.0002 (16.5); -0.0085 (0.6) Example No. I-535: 1H-NMR(400.6 MHz, CDCI3): δ= 8.7633 (4.3); 8.7615 (4.4); 7.2971 (2.0); 7.2768 (2.6); 7.2616 (33.3); 7.1232 (1.7); 7.1027 (1.3); 6.9932 (1.3); 6.9711 (1.4); 6.9662 (1.4); 6.9442 (1.4); 6.5980 (1.0); 6.5909 (1.1); 6.5803 (1.0); 6.5732 (1.1); 6.4540 (0.8); 6.4455 (1.0); 6.4382 (0.7); 6.4319 (0.7); 6.4235 (0.9); 6.4162 (0.6); 3.8083 (16.0); 2.5435 (1.0); 2.5384 (11.3); 1.5561 (3.3); 1.4108 (6.4); 0.0080 (0.5); -0.0002 (19.9); -0.0085 Ϊ07] Example No. I-537: 1H-NMR(400.6 MHz, CDCI3): δ= 8.4912 (0.7); 8.4119 (16.0); 7.2628 (9.4); 7.0353 (3.1); 6.9062 (2.2); 6.9001 (0.7); 6.8891 (0.9); 6.8861 (2.4); 6.8831 (3.0); 6.8801 (0.8); 6.8691 (0.8); 6.8629 (2.8); 6.7252 (2.9); 6.7190 (0.8); 6.7144 (3.0); 6.7082 (1.5); 6.7021 (2.1); 6.6973 (0.8); 6.6914 (2.1); 5.2987 (2.3); 2.4986 (14.8); 2.2058 (13.0); 2.2047 (12.0); 0.0002 (7.3) Example No. I-548: 1H-NMR(400.6 MHz, CDCI3): δ= 7.9331 (3.9); 7.9276 (4.1); 7.4496 (2.2); 7.4440 (2.2); 7.4277 (2.2); 7.4222 (2.2); 7.2604 (14.1); 6.9365 (5.0); 6.9310 (1.3); 6.9196 (1.0); 6.9165 (2.5); 6.9136 (3.4); 6.9106 (1.0); 6.8995 (0.9); 6.8934 (3.2); 6.7787 (3.2); 6.7726 (0.9); 6.7679 (3.2); 6.7617 (1.5); 6.7557 (2.3); 6.7509 (0.8); 6.7450 (2.2); 2.4100 (16.0); 2.2027 (13.7); 2.2019 (13.6); -0.0002 (10.8) Example No. I-570: 1H-NMR(400.6 MHz, CDCI3): δ= 8.5206 (0.6); 8.3379 (15.0); 7.2623 (12.7); 7.0224 (3.4); 6.9050 (2.3); 6.8989 (0.8); 6.8878 (1.0); 6.8848 (2.6); 6.8818 (3.3); 6.8788 (0.9); 6.8678 (0.9); 6.8617 (3.0); 6.7314 (3.1); 6.7253 (0.9); 6.7207 (3.2); 6.7144 (1.6); 6.7083 (2.2); 6.7036 (0.9); 6.6976 (2.2); 2.4905 (16.0); 2.2055 (14.2); 2.2044 (13.2); -0.0002 (9.9) NMR data of the final products (manual evaluation) Example No. I-154: 1H-NMR (400.0 MHz, d6-DMSO): δ= 8,80 (s, 2H), 8,19-8,17 (m, 1H), 7,54-7,50 (m, 3H), 7,32-7,27 (m, 3H) N° de Ejemplo I-156: 1H-RMN (300,0 MHz, d6-DMSO): δ= 8,81 (s, 2H), 8,20-8,17 (m, 1H), 7,67-7,43 (m, 3H), 7,32-7,17 (m, 2H) N° de Ejemplo I-157: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,75 (s, 2H), 8,33-8,31 (m, 1H), 7,92-7,90 (m, 1H), 7,69-7,60 (m, 4H), 7,417,38 (m, 1H) N° de Ejemplo I-158: 1H-RMN (400,0 MHz, de-DMSO): δ= 8,78 (s, 2H), 8,30-8,29 (m, 1H), 7,86-7,84 (m, 1H), 7,41-7,29 (m, 5H) N° de Ejemplo I-162: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,79 (s, 2H), 8,21-8,19 (m, 1H), 7,59-7,57 (m, 1H), 7,43-7,40 (m, 5H), 7,337,29 (m, 1H) N° de Ejemplo I-172: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,69 (d, 2H), 8,21-8,19 (m, 1H), 7,54-7,49 (m, 3H), 7,37-7,26 (m, 4H) N° de Ejemplo I-174: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,69 (d, 2H), 8,21-8,20 (m, 1H), 7,61-7,45 (m, 3H), 7,37-7,29 (m, 2H), 7,187,17 (m, 1H) N° de Ejemplo I-175: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,64 (d, 2H), 8,35 (dd, 1H), 7,91 (dd, 1H), 7,67-7,59 (m, 4H), 7,40 (dd, 1H), 7,32 (t, 1H) N° de Ejemplo I-176: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,67 (d, 2H), 8,32 (dd, 1H), 7,85 (dd, 1H), 7,40-7,29 (m, 6H) N° de Ejemplo I-180: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,69 (d, 2H), 8,22 (dd, 1H), 7,57 (dd, 1H), 7,42-7,30 (m, 7H) N° de Ejemplo I-210: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,58 (d, 2H), 8,26 (d, 1H), 7,39 (d, 1H), 7,29-7,23 (m, 2H), 7,17-7,11 (m, 1H), 6,99-6,94 (m, 1H), 2,50 (s, 3H) N° de Ejemplo I-212: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,61 (d, 2H), 8,33 (d, 1H), 7,44 (d, 1H), 7,30-7,20 (m, 3H), 7,10-7,02 (m, 2H), 2,43 (s, 3H) N° de Ejemplo I-216: 1H-RMN (400,0 MHz, d6-DMSO): δ= 8,62 (d, 2H), 8,30 (d, 1H), 7,41 (d, 1H), 7,29-7,24 (m, 3H), 7,16 (t, 1H), 7,0992 7,07 (m, 2H), 2,40 (s, 3H) N° de Ejemplo I-591: 1H-RMN (400,0 MHz, CDCI3): δ= 8,38 (s, 2H), 7,79 (d, 1H), 7,43 (dd, 1H), 7,04 (s, 1H), 2,49 (s, 3H), 2,25 (s, 3H) N° de Ejemplo I-595: 1H-RMN (400,0 MHz, CDCI3): δ= 8,37 (s, 2H), 8,35 (s, 2H), 7,05 (s, 1H), 2,49 (s, 3H), 2,25 (s, 3H) N° de Ejemplo I-649: 1H-RMN (400,0 MHz, CDCI3): δ= 8,38 (s, 2H), 7,96 (d, 1H), 7,45 (dd, 1H), 6,95 (s, 1H), 2,40 (s, 3H), 2,25 (s, 3H) The object of the present invention further relates to the use of one or more compounds of the general Formula (I) and / or their salts, defined above, preferably in a preferred embodiment or a particularly preferred embodiment, in particular of one or more compounds of Formulas (I.001) to (I.662) and / or their salts, defined above, as herbicides and / or plant growth regulators, preferably in crops of useful and / or ornamental plants. Another object of the present invention relates to a method for controlling weeds and / or regulating plant growth, characterized in that it comprises applying an effective amount of - one or more compounds of the general Formula (I) and / or their salts, as defined above, preferably in a preferred or particularly preferred embodiment, in particular one or more compounds of Formulas (I.001) to (I.662) and / or their salts, each as defined above, or - an agent according to the present invention, which will be defined later, to plants (weeds), to plant seeds (weeds), to the soil in which the plants (weeds) grow, or to the cultivated area. The object of the present invention also comprises a method for controlling unwanted plants, preferably in crops of useful plants, characterized in that it comprises applying an effective amount of - one or more compounds of the general Formula (I) and / or their salts, as defined above, preferably in a preferred or particularly preferred embodiment, in particular one or more compounds of Formulas (I.001) to (I.662) and / or their salts, each as defined above, or - an agent according to the present invention, which will be defined later, to undesirable plants (e.g., weeds such as monocotyledonous or dicotyledonous weeds or undesirable crops), seeds of the undesirable plants (i.e., plant seeds, e.g., grains, seeds or vegetative propagules such as tubers or shoots with buds), the soil in which the undesirable plants grow (e.g., cultivated or uncultivated land) or the cultivation area (i.e., the area on which the undesirable plants will grow). The object of the present invention also comprises a method for controlling the regulation of growth, preferably of useful plants, characterized in that it comprises applying an effective amount of - one or more compounds of the general Formula (I) and / or their salts, as defined above, preferably in a preferred or particularly preferred embodiment, in particular one or more compounds of Formulas (I.001) to (I.662) and / or their salts, each as defined above, or - an agent according to the present invention, which will be defined later, to the plant, to the seeds of the plant (i.e., seeds such as grains, seeds or vegetative reproductive organs such as tubers or shoots with buds), to the soil in or on which the plants grow, (i.e., the area of ​​cultivated or uncultivated land) or to the surface (i.e., the area where the plants grow). In this case, the compounds or agents according to the invention should be applied pre-emergence and / or post-emergence, for example, before sowing (possibly also by incorporation into the soil). In particular, by way of example, some representative members of the monocotyledonous and dicotyledonous weed flora that can be controlled by the compounds according to the invention can be mentioned, without limitation to specific species. Preferably, in a method according to the invention for controlling weeds or regulating plant growth, one or more compounds of General Formula (I) and / or their salts are employed to control weeds or regulate growth in crops of useful plants or ornamental plants, wherein in a preferred embodiment the crops of useful plants or ornamental plants comprise transgenic plants. The compounds of the General Formula (I) and / or their salts according to the present invention are suitable for controlling the following genera of monocotyledonous and dicotyledonous weeds: Monocotyledonous weeds belong to the following genera: Aegilops, Agropiron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristilis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum. Dicotyledonous weeds belong to the following genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sfenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds of the General Formula (I) according to the invention are applied to the surface of the soil (weeds and / or wild plants) before germination (pre-emergence method), the emergence of weed seedlings is completely prevented, or they grow to the cotyledon stage but then stop growing and finally die after three to four weeks. When the active compounds of the General Formula (I) are applied to the green parts of the plants after sprouting, growth stops after treatment and the weeds remain at the existing growth stage at the time of application or die after a certain time, and in this way the competition that weeds represent for crops is eliminated very early and sustainably. Although the compounds of General Formula (I) have excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, they have a negligible adverse effect on economically important crop plants, for example, dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, triticale, Triticum, Zea, depending on the particular structure of the compound of the invention and the application rate. The compounds present are very suitable for these reasons for selective control of unwanted plant growth in plant crops such as useful agricultural plants or ornamental plants. Furthermore, the compounds of General Formula (I) of the present invention (depending on their respective structures and application rates) have excellent growth-regulating properties in cultivated plants. They regulate plant metabolism and can therefore be used to specifically affect plant components and facilitate harvesting, such as by inducing desiccation and stunted growth. In addition, they are also suitable for general control and inhibition of unwanted vegetative growth without killing the plants. Inhibition of vegetative growth plays an important role in many monocotyledonous and dicotyledonous crops, as it can, for example, reduce or completely prevent accumulation. Due to their herbicidal and plant growth-regulating properties, the active compounds in General Formula (I) can also be used to control weeds in genetically modified or conventional crops. Transgenic plants are generally characterized by particular advantageous traits, such as resistance to certain pesticides, especially herbicides, or resistance to plant diseases or pathogens, including insects or microorganisms like fungi, bacteria, or viruses. Other special characteristics relate to the crop in terms of quantity, quality, shelf life, composition, and specific ingredients. For example, transgenic plants with higher starch content, altered starch quality, or different fatty acid compositions are known. Preferably, with respect to transgenic crops, the application of the compounds of the General Formula (I) of the invention and / or their salts in economically important transgenic crops of useful and ornamental plants, for example cereals such as wheat, barley, rye, oats, millet, rice and corn, or also in crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas and other vegetables. Preferably, the compounds of General Formula (I) according to the invention can be used as herbicides in crops that are resistant to the phytotoxic effects of herbicides or have become genetically resistant. Due to their herbicidal and plant growth-regulating properties, the compounds of General Formula (I) according to the invention can also be used to control weeds in known or yet-to-be-developed genetically modified plant crops. Transgenic plants are generally characterized by possessing particular advantageous traits, such as resistance to certain pesticides, especially certain herbicides, or resistance to plant diseases or pathogens, such as certain insects or microorganisms, including fungi, bacteria, or viruses. Other special characteristics relate, for example, to the crop in terms of quantity, quality, shelf life, composition, and special ingredients. Thus, transgenic plants with a higher starch content or altered starch quality, or those with different fatty acid compositions, are known.Other particular properties may include tolerance or resistance to the presence of abiotic stressors, for example heat, cold, drought, salinity, and ultraviolet radiation. The use of the compounds of General Formula (I) or their salts according to the present invention is preferred in economically important transgenic crops of useful and ornamental plants, for example, cereals such as wheat, barley, rye, oats, triticale, millet, rice, cassava and corn or also crops of sugar beet, cotton, soybean, rapeseed, potato, tomato, pea and other vegetables. Preferably, the compounds of General Formula (I) can be used as herbicides in crops that are resistant to the phytotoxic effects of herbicides or that have become genetically resistant. Conventional methods for producing new plants with modified properties compared to existing plants include, for example, classical breeding methods and the production of mutants. Alternatively, new plants with altered properties can be generated using genetic engineering techniques. The specialist in this field is familiar with numerous molecular biology techniques that can be used to create new transgenic plants with altered properties. To employ genetic engineering, nucleic acid molecules can be introduced into plasmids, allowing mutagenesis, or sequence alteration, through recombination of DNA sequences. Base exchanges, partial sequence deletions, or the addition of natural or synthetic sequences can be performed using, for example, standard methods. Adapters or connectors can be attached to the DNA fragments to join them together. The production of plant cells having reduced activity of a gene product can be achieved, for example, by expressing at least one corresponding antisense RNA, a sense RNA to obtain a cosuppression effect, or by expressing at least one appropriately manipulated ribozyme that specifically cleaves transcripts of the aforementioned gene product. For this purpose, DNA molecules comprising the complete coding sequence of a gene product, including any flanking sequences that may be present, as well as molecules of 100 DNA comprising only portions of the coding sequence, which must be extensive enough to be present in cells to produce an antisense effect. If an antisense effect is desired, it is also possible to use DNA sequences that exhibit a high degree of homology to the coding sequences of a gene product, but are not completely identical. The synthesized protein can be localized to any compartment of the plant cell for the expression of nucleic acid molecules in plants. However, to achieve localization to a particular compartment, for example, the coding region is linked to DNA sequences that ensure localization to that specific compartment. Such sequences are known to specialists in the field (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227). The expression of nucleic acid molecules can also take place in the organelles of plant cells. Transgenic plant cells can be regenerated into whole plants using established techniques. In principle, transgenic plants can be of any plant species, that is, both monocots and dicots. Therefore, transgenic plants can be made available with properties altered by overexpression, suppression or inhibition of homologous (= natural) genes or gene sequences or expression of heterologous (= foreign) gene sequences. Preferably, the compounds of General Formula (I) according to the invention can be used in transgenic crops that are resistant to growth factors, such as, for example, dicamba, or against herbicides 101 that contain essential plant enzymes, for example acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), or are resistant to herbicides of the sulfonylurea group, glyphosate, glufosinate or benzoylisoxazole and analogues. The application of the compounds of the General Formula (I) according to the invention in transgenic crops often produces, in addition to the effects observed in other crops against weeds, effects that are specific to an application in the respective transgenic crop, for example, a modified or especially extended spectrum of weeds that can be controlled; the application doses that can be used for the application preferably allow a good ability to combine with the herbicides to which the transgenic crop is resistant, and influence the growth and yield of the transgenic crops. Therefore, the invention also relates to the use of the compounds of General Formula (I) and / or their salts according to the present invention as herbicides for controlling weeds in crops of useful or ornamental plants, optionally for transgenic crop plants. The use of the compounds in General Formula (I) is preferred in cereals, preferably maize, wheat, barley, rye, oats, millet or rice, in pre or post-emergence. The use of compounds from General Formula (I) is also preferred in soybeans in pre- or post-emergence. The use according to the invention for controlling weeds or regulating plant growth also includes the case in which the compound of General Formula (I) or its salts is obtained from a precursor substance 102 (prodrug) and is only formed after application to the plant, in the plant or in the soil. The invention also provides the use of one or more compounds of General Formula (I) or their salts or an agent according to the present invention (which will be defined later) (in a method) for controlling weeds or for regulating plant growth, characterized in that an effective amount of one or more compounds of General Formula (I) or their salts is applied to the plants (weeds, probably together with crops), seeds, the soil in or on which the plants grow or the surface. The invention also provides a herbicidal agent and / or plant growth regulator, characterized in that the agent comprises (a) one or more compounds of the general formula (I) and / or their salts, defined above, preferably in a preferred or particularly preferred embodiment, in particular one or more compounds of formulas (I.001) to (I.662) and / or their salts, each defined above, and (b) one or more additional substances selected from groups (i) and / or (ii): (i) one or more additional active agrochemicals, preferably selected from the group consisting of insecticides, acaricides, nematicides, additional herbicides (i.e., those not corresponding to the General Formula (I) defined above), fungicides, protectants, fertilizers and / or other growth regulators, (ii) one or more formulation aids commonly used in the 103 crop protection. The other active agrochemical substances of component (i) of an agent according to the invention are preferably selected from the group of substances described in The Pesticide Manual, 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012. A herbicide or plant growth regulator according to the invention preferably comprises one, two, three or more plant protectant formulation aids (ii) selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, powders, at 25 °C and 1013 mbar, solid vehicles, preferably adsorbents, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer solutions, antifoams, water, organic solvents, preferably at 25 °C and 1013 mbar with water at any ratio of miscible organic solvents. The compounds of General Formula (I) according to the present invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions, powders, or granules in conventional formulations. Therefore, the invention also relates to herbicides and plant growth regulators containing the compounds of General Formula (I) and / or salts thereof. The compounds of the General Formula (I) of the invention and / or their salts can be formulated in different ways, depending on predetermined biological and / or physicochemical parameters. Possible formulation options include, for example, wettable powders (WP) and soluble powders. 104 in water (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), water- or oil-based dispersions, oil-miscible solutions, suspensions in capsules (CS), dispersible powders (DP), disinfectants, granules for dispersion and application in soil, granules (GR) in the form of microgranules, sprayable granules, spray and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes. These types of formulations and individual auxiliary formulations, such as inert materials, surfactants, solvents, and other additives, are known in the art and are described, for example, in: Watkins, Handbook of Insecticide Dust Diluents and Carriers, 2nd edition, Darland Books, Caldwell NJ; H.v. Olfen, Introduction to Clay Colloid Chemistry, 2nd edition, J. Wiley & Sons, NY; C. Marsden, Solvents Guide, 2nd edition, Interscience, NY 1963; McCutcheon's Detergents and Emulsifiers Annual, MC Publ. Corp., Ridgewood NJ; Sisley and Wood, Encyclopedia of Surface Active Agents, Chem. Publ. Co. Inc., NY 1964; Schonfeldt, Grenzflachenaktive Athilenoxidaddukte, Wiss. Verlagsgesellschaft, Stuttgart 1976. WinnackerKüchler, Chemische Technologie, Band 7, C. Hanser Verlag München, 4th edition, 1986. Wettable powders are uniformly dispersible in water and, in addition to the active ingredient, comprise a diluent or inert substance, ionic and / or non-ionic surfactants (wetting agents, dispersing agents), for example polyoxyethylated alkylphenols, fatty alcohols 105 polyoxyethylates, polyoxyethylated fatty amines, polyglycol ether of fatty alcohols, alkane sulfonates, alkylbenzenesulfonates, sodium ligninsulfonate, 2,2'-dinaphthylmethan-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate or sodium oleoylmethyltaurinate. . To prepare wettable powders, the herbicidal active ingredients are finely ground, for example with conventional equipment such as hammer mills, blow mills and air jet mills, and are mixed simultaneously or subsequently with the adjuvant formulation agents. Emulsifiable concentrates are prepared by dissolving the active compound in an organic solvent, such as butanol, cyclohexanone, dimethylformamide, xylene, or aromatic compounds, hydrocarbons, or mixtures of high-boiling organic solvents, with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Emulsifiers that can be used include, for example, calcium alkylaryl sulfonates, such as calcium dodecylbenzenesulfonate, or non-ionic emulsifiers such as polyglycol fatty acid esters, polyglycol alkylyl ethers, polyglycol fatty alcohol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as fatty acid esters and sorbitan, or polyoxyethylene sorbitan esters, such as polyoxyethylene. Fine powders are obtained by grinding the active substance with finely divided solid substances, such as talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth. Concentrated suspensions can be water-based or oil-based. They can be obtained, for example, by wet milling using mills of 106 commercially available balls and, if appropriate, with the addition of surfactants, such as, for example, those already listed above for other types of formulations. Emulsions, for example oil-in-water (EW) emulsions, can be made, for example, with agitators, colloid mills and / or static mixers using aqueous organic solvents and surfactants, optionally, for example, those already mentioned above for other types of formulations. Granules can be prepared by adsorption onto a granulated inert material, by applying the active ingredients using adhesives, or by injecting the active ingredient—for example, polyvinyl alcohol, sodium polyacrylate, or mineral oils—onto the surface of substrates such as sand, kaolinite, or a granulated inert material. It is also possible to granulate the appropriate active ingredients in the usual way to produce fertilizer granules, if it is desired to mix them with fertilizers. Water-dispersible granules are generally prepared by the usual procedures, such as spray drying, fluidized bed granulation, tray granulation, mixing using high-speed mixers, and extrusion without any solid inert material. For the preparation of granules by plate, fluidized bed, extrusion and spray drying, see, for example, Spray-Drying Handbook 3rd edition 1979, G. Goodwin Ltd., London; JE Browning, Agglomeration, Chemical and Engineering 1967, page 147 et seq.; Perry's Chemical Engineer's Handbook, 5th edition, McGraw-Hill, New York 1973, pp. 8-57. 107 For further details on the formulation of crop protection agents, see, for example, GC Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pages 81-96 and JD Freyer, SA Evans, Weed Control Handbook, 5th edition, Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical preparations, preferably herbicide or plant growth regulator compositions of the present invention, preferably contain a total amount of between 0.1 and 99% by weight, preferably between 0.5 and 95% by weight, more preferably between 1 and 90% by weight, with special preference between 2 and 80% by weight, of active ingredients of General Formula (I) and their salts. In the case of wettable powders, the drug concentration is, for example, approximately 10 to 90% by weight, with the usual formulation constituents making up the remaining 100% by weight. In emulsifiable concentrates, the concentration of the active ingredient can be approximately 1 to 90%, preferably 5 to 80% by weight. Powder formulations contain 1 to 30% by weight of active ingredient, preferably at least 5 to 20% by weight. Sprayable solutions contain approximately 0.05 to 80% by weight, preferably 2 to 50% by weight of active ingredient. In the case of water-dispersible granules, the active ingredient content depends, in part, on whether the active compound is liquid or solid and on the granulation additives, fillers, etc., used.In water-dispersible granules, the active ingredient content comprises, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight. 108 In addition, the formulations of the aforementioned active ingredients optionally include the usual adhesives, wetting agents, dispersants, emulsifiers, penetrants, preservatives, antifreeze and solvents, fillers, carriers and colorants, antifoams, evaporation inhibitors, and pH and viscosity regulators. Examples of formulation aids are described, among others, in Chemistry and Technology of Agrochemical Formulations, edited by D.A. Knowles, Kluwer Academic Publishers (1998). The compounds of General Formula (I) of the invention or their salts may be used as such or in the form of their preparations (formulations) with other active pesticide substances, for example, insecticides, acaricides, nematicides, herbicides, fungicides, protectants, fertilizers, and / or growth regulators, for example, as a finished formulation or as tank mixes. Combined formulations may be prepared based on the aforementioned formulations, taking into account the physical properties and stability of the active ingredients being combined. The combination members for the compounds of General Formula (I) in mixture formulations or in a tank mix comprise, for example, known active ingredients that can be used for inhibition, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, phydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase are described, for example, in Weed Research 26 (1986) 441-445 or The Pesticide Manual, 16th edition, The British Crop 109 Protection Council and the Royal Soc. of Chemistry, 2012 and the literature cited therein. Of particular interest is the selective control of weeds in commercial and ornamental plant crops. Although the compounds of General Formula (I) according to the invention already exhibit very good or sufficient selectivity in many crops, phytotoxicity may occur in some crops, especially in the case of mixtures with other, less selective herbicides. In this respect, combinations of compounds (I) according to the invention containing the compounds of General Formula (I) or their combinations with other herbicides, pesticides, or protectants are of particular interest.Protectants, which are used in an effective quantity as an antidote, reduce the phytotoxic side effects of herbicides / pesticides used, for example in economically important crops such as cereals (wheat, barley, rye, maize, rice, millet), sugar beet, sugar cane, oilseed rape, cotton and soybeans, preferably cereals. The weight ratio between the herbicide (mixture) and the protectant generally depends on the application rate of the herbicide and the efficacy of the particular protectant and can vary within wide limits, for example in the range of between 200:1 and 1:200, preferably between 100:1 and 1:100, especially between 20:1 and 1:20. Protectants can be formulated analogously to the compounds in General Formula (I) or mixtures thereof with other herbicides / pesticides and are supplied and used as a finished formulation or as a tank mix with the herbicides. For use, herbicide formulations or herbicide protectants The 110 commercially available preparations can be diluted with water in the conventional manner, for example, as wettable powders, emulsifiable concentrates, dispersions, and water-dispersible granules. In general, it is not necessary to dilute powder, ground granule, or dispersed preparations and sprayable solutions with other inert substances before use. External conditions such as temperature, humidity, etc., influence the application rate of the compounds in General Formula (I) and / or their salts to some extent. The application rate can vary within wide limits. When used as a herbicide for weed control, the total amount of the compounds in General Formula (I) and their salts is preferably in the range of 0.001 to 10.0 kg / ha, preferably in the range of 0.005 to 5 kg / ha, more preferably in the range of 0.01 to 1.5 kg / ha, and more preferably in the range of 0.05 to 1 kg / ha. These values ​​are valid for both pre-emergence and post-emergence applications. In applications of the compounds of General Formula (I) of the invention and / or their salts as plant growth regulators, for example as stem reducers in crops, as mentioned above, preferably in cereal crops such as wheat, barley, rye, triticale, millet, rice, or maize, the total application rate is preferably in the range of 0.001 to 2 kg / ha, preferably in the range of 0.005 to 1 kg / ha, particularly in the range of 10 to 500 g / ha, and more preferably in the range of 20 to 250 g / ha. These values ​​are valid for both pre-emergence and post-emergence applications. 111 The application as a size reducer can be carried out at various stages of plant growth. For example, application after thinning at the beginning of longitudinal growth is preferred. Alternatively, when used as a plant growth regulator, seed treatment can be considered, including various coating and seed-staining techniques. The application rate depends on the specific technique and can be determined through preliminary testing. The combination members for the compounds of the General Formula (I) in the agents according to the invention (e.g., mixture or tank mix formulations) comprise, for example, known active ingredients that can be used for inhibition, such as, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, phydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase, as described, for example, in Weed Research 26 (1986) 441-445 or The Pesticide Manual, 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 and the literature cited therein.The following are known herbicides or plant growth regulators that can be combined with the compounds of the invention, and these agents are referred to by their common name in the English version according to the International Organization for Standardization (ISO), or by their chemical name or code number. This includes all application forms, such as acids, salts, esters, and all isomeric forms, such as stereoisomers and optical isomers. 112 are always considered to be included, even if they are not explicitly mentioned. Examples of such mixture members include: acetochlor, acifluorophene, acifluorophene-sodium, acloniphene, alachlor, alidochlor, aloxidim, aloxidim-sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridin-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, aminopyralide, amitrole, ammonium sulfamate, anilofos, asulam, atrazine, azaphenidine, azimsulfuron, beflubutamide, benazoline, benazoline-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobiciclone, benzofenap, bicyclopyrone, bifenox, bilanafos, bilanafos-sodium, bispiribac, bispiribac-sodium, bromacil, bromobutide, bromophenoxim, bromoxynyl, bromoxynyl-butyrate, -potassium, -heptanoate and octanoate, busoxinone, butachlor, butafenacyl, butamiphos, butenachlor, butralin, butroxydim, butylate, cafenstrol, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron,chlorofenac, chlorofenac-sodium, chlorofenprop, chloroflurenol, chloroflurenol-methyl, chloridazone, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorosulfuron, cinidone, cinidone-ethyl, cinmethylline, cinnosulfuron, clacifos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralide, chloransulam, chloransulam-methyl, cumiluron, cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cypriazine, 2,4-D, 2,4-D-butyl, -butyl, dimethylammonium, -diolamine, -ethyl 2-ethylhexyl, -isobutyl, -isooctyl, isopropylammonium, -potassium, -triisopropanolammonium and -trolamine, 2,4-DB, 2,4-DBbutyl, -dimethylammonium, isooctyl, -potassium and -sodium, daimuron (dymron), dalapon, 113 dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, dichlorobenzyl, 2-(2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2-(2,5dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimetachlor, dimetamethrin, dimethenamide, dimethenamide-P, dimetrasulfuron, dinitramine, dinoterb, dipenamide, diquat, diquat-dibromide, dithiopyr, diuron, DNOC, endothal, EPTC, esprocarb, etalfluralin, etametsulfuron, etametsulfuron-methyl, etiozine, etofumesate, etoxyfenp, etoxyphene-ethyl, etoxysulfuron, etobenzanide, F-9600, F5231, i.e., N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]-ethansulfonamide, F-7967, i.e., 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidin- 2,4(1H,3H)-diona, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-Petilo, fenoxasulfona, fenquinotriona, fentrazamida, flamprop, flamprop-Misopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butylo, fluazifop-P-butylo, flucarbazona, flucarbazona-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazine, fluometuron, flurenol, flurenolbbutyl, -dimethylamonium and -methyl, fluoroglycophen, fluoroglicofeno-ethyl, flupropanate, flupirsulfurón, flupirsulfurón-metil-sodio, fluridona, flurocloridona, fluroxypir, fluroxypir-meptil, flurtamona, flutiacet, flutiacet-metilo, fomesafeno, fomesafeno-sodio, foramsulfurón, fosamine, glufosinate, glufosinato-amonio, glufosinato-P-sodio, glufosinato-P-amonio, glufosinato-P-sodio, glyphosate, glyphosate-amonio, -isopropilamonio, -diamonio, -dimetilamonio, -potasio, -sodio y -trimesio, H-9201, es decir, O-(2,4-dimethyl-6-nitrophenyl)-O-ethyl114 isopropylphosphoramidothioate, halauxifen, halauxifen-methyl, halosaphene, halosulfuron, halosulfuron-methyl, haloxifop, haloxifop-P, haloxifop-ethoxyethyl, haloxifop-P-ethoxyethyl, haloxifop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e. 1-(dimethoxyphosphoryl)-ethyl-(2,4-dichlorophenoxy)acetate, 4-hydroxy-1-methoxy-5methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 4-hydroxy-1-methyl-3-[4(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, imazametabenz, imazametabenzmethyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquine, imazaquine-ammonium, imazetapyr, imazetapyr-ammonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxinyl, ioxinyl-octanoate, -potassium and sodium, ipfencarbazone, isoproturon, isouron, isoxabene, isoxaflutol, karbutylate, KUH043, i.e., 3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, cetospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butoyl, -dimethylammonium, -2-ethylhexyl, isopropylammonium, -potassium and -sodium, MCPB, MCPB-methyl, -ethyl and -sodium, mecoprop, mecoprop-sodium and -butoyl, mecoprop-P, mecoprop-P-butoyl, dimethylammonium, -2-ethylhexyl and -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, metabenzthiazureon, metam, metamifop, metamitron, metazachlor, metazo-sulfuron, metabenzthiazureon, methiopyrsulfuron, methiazoline, methyl isothiocyanate, metho-bromuron, metolachlor, S-metolachlor, metosulam methoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinat, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e., N-[3-chloro-4-(1-methylethyl)phenyl]-2-methylpentanamide, NGGC-011, napropamide, NC-310, i.e., 4-(2,4-dichlorobenzoyl)-1-methyl-5-benzyloxypyrazole, neburon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazone, oleic acid (fatty acids), 115 orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazone, oxasulfuron, oxaziclomefone, oxotrione (lancotrione), oxyfluorofen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, petoxamide, petroleum oils, fenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxidim, prometon, promethrin, propachlor, propanil, propaquizafop, propazine, profam, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufeno-ethyl, pyrasulfotol, pyrazolinate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyphene, piribambenz, piribambenz-isopropyl, piribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyrifthalide, piriminobac, piriminobac-methyl, pirimisulfan, piritiobac, piritiobac-sodium, pyroxasulfone, piroxsulam, quinclorac, quinmerac, quinoclaminequizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, symmetrine, SL-261, sulcotrione, sulfentrazone, sulfometuron, sulfometuronmethyl, sulfosulfuron, SYN-523, SYP-249, i.e., 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl-5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, i.e. 1[7-fluoro-3-oxo-4-(prop-2-en-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dione, 2,3,6-TBA, TCA (trifluoroacetic acid), TCA-sodium, tebutyuron, tefuryltrione, tembotrione, tepral-oxidim, terbacil, terbucarb, terbumetone, terbuthylazine, terbutrine, tenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, tifensulfuron, tifensulfuron-methyl, thiobencarb, thiafenacil, tolpyralate, topramezone, tralcoxidim, triafamone, trialate, triasulfuron, triaziflam, tribenuron tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron, 116 sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, ZJ-0862, i.e., 3,4-dichloro-N-{2[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, as well as the following compounds: Examples of plant growth regulators as potential combination members: acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, acimidol, 6-benzylaminopurine, brassinolide, catechol, chlormequat chloride, chloroprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac sodium, endothal, endothal-dipotassium, disodium and mono(N,N-dimethylalkylammonium), ethephon, flumethralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid (IAA), 4-indole-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, methyl jasmonate, maleic acid hydrazide, chloride of mepiquat, 1-methylcyclopropene, 2(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate mixture, 4-oxo-4[(2-phenylethyl)amino]butyric acid, paclobutrazol, N-phenylphthalamic acid, prohexadione, calcium prohexadione, prohydrojasmone 117 salicylic acid, strigolactone, technacene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P. They are also suitable as combining members for compounds of General Formula (I) according to the invention, for example, the following protectants: S1) Compounds of the group of heterocyclic derivatives of carboxylic acid: S1a) Compounds of the dichlorophenylpyrazolin-3-carboxylic acid type (S1a), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carboxylic acid, ethyl ester of 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carboxylic acid (S1-1) (mefenpyr-diethyl”), and related compounds, such as those described in WO-A-91 / 07874; S1b) Derivatives of dichlorophenylpyrazolecarboxylic acid (S1b), preferably compounds such as ethyl ester of 1-(2,4-dichlorophenyl)-5-methylpyrazole-3-carboxylic acid (S1-2), ethyl ester of 1-(2,4-dichlorophenyl)-5-isopropylpyrazole-3-carboxylic acid (S1-3), ethyl ester of 1-(2,4-dichlorophenyl)-5-(1,1-dimethylethyl)pyrazole-3-carboxylic acid (S1-4) and related compounds, as described in EP-A-333131 and EP-A-269806; S1c) Derivatives of 1,5-diphenylpyrazol-3-carboxylic acid (S1c), preferably compounds such as ethyl ester of 1-(2,4-dichlorophenyl)-5-phenylpyrazol-3-carboxylic acid (S1-5), methyl ester of 1-(2-chlorophenyl)-5-phenylpyrazol-3-carboxylic acid (S1-6) and related compounds such as those described, for example, in EP-A-268554; S1d) Compounds of the triazolecarboxylic acid type (S1d), 118 preferably compounds such as fenchlorazol(-ethyl ester), i.e., ethyl ester of 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazol-3-carboxylic acid (S1-7), and related compounds such as those described in EP-A-174562 and EP-A-346620; S1e) Compounds of the type of 5-benzyl- or 5-phenyl-2-isoxazolin-3-carboxylic acids, or of 5,5-diphenyl-2-isoxazolin-3-carboxylic acids (S1e), preferably compounds such as ethyl ester of 5-(2,4-dichlorobenzyl)2-isoxazolin-3-carboxylic acid (S1-8) or ethyl ester of 5-phenyl-2-isoxazolin-3-carboxylic acid (S1-9) and related compounds, as described in WO-A-91 / 08202; or 5,5-diphenyl-2-isoxazolin-3-carboxylic acid (S1-10) or ethyl ester of 5,5-diphenyl-2-isoxazolin-3-carboxylic acid (S1-11) (isoxadiphen-ethyl”) or n-propyl ester of 5,5-diphenyl-2-isoxazolin-3-carboxylic acid (S1-12) or ethyl ester of 5-(4-fluorophenyl)-5-phenyl-2-isoxazolin-3-carboxylic acid (S1-13), as described in Patent Application WO-A-95 / 07897. S2) Compounds of the 8-quinolinoxy derivative group (S2): S2a) Compounds of the type of 8-quinolinoxyacetic acids (S2a), preferably (1-methylhexyl)-ester of (5-chloro-8-quinolinoxy)acetic acid (cloquintocet-mexyl”) (S2-1), (1,3-dimethyl-but-1-yl)-ester of (5-chloro-8-quinolinoxy)acetic acid (S2-2), 4-allyl-oxy-butyl-ester of (5-chloro-8-quinolinoxy)acetic acid (S2-3), 1-allyloxyprop-2-yl-ester of (5-chloro-8-quinolinoxy)acetic acid (S2-4), ethyl-ester of (5-chloro-8-quinolinoxy)acetic acid (S25), methyl-ester of (5-chloro-8-quinolinoxy)acetic acid (S2-6), allyl-ester of acid 5-chloro-8-quinolinoxy)acetic (S2-7), 2-(2-propylidene-iminoxy)-1-ethyl ester of (5-chloro-8-quinolinoxy)acetic acid (S2-8), 2-oxoprop-1-yl ester of (5-chloro-8-quinolinoxy)acetic acid (S2-9) and related compounds, such as those that 119 describe in EP-A-86750, EP-A-94349 and EP-A-191736 or in EP-A-0 492 366, as well as (5-chloro-8-quinolinoxy)acetic acid (S2-10), its hydrates and salts, for example the lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts, as described in WO-A2002 / 34048; S2b) Compounds of the (5-chloro-8-quinolinoxy)malonic acid type (S2b), preferably compounds such as (5-chloro-8-quinolinoxy)malonic acid diethyl ester, (5-chloro-8-quinolinoxy)malonic acid diallyl ester, (5-chloro-8-quinolinoxy)malonic acid methyl ethyl ester and related compounds, as described in EP-A-0 582 198. S3) Active ingredients of the dichloroacetamide (S3) type, which are often used as pre-emergence protectants (active protectants in the soil), e.g., B. Dichlormide (N,N-diallyl-2,2-dichloroacetamide) (S3-1), R-29148 (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) of Stauffer (S32), R-28725 (Stauffer's 3-dichloroacetyl-2,2,-dimethyl-1,3-oxazolidine) (S3-3), Benoxacor (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S34), PPG-1292 (N-allyl-N-[(1,3-dioxolan-2-yl)-methyl]-dichloroacetamide) from PPG Industries (S3-5), DKA-24 (N-allyl-N-[(allylaminocarbonyl)methyl]-dichloroacetamide) from SagroChem (S3-6), AD-67 or MON 4660 (3-dichloroacetyl-1-oxa-3-aza-spiro[4,5]decane) from Nitrochemistry or Monsanto (S3-7), 120 TI-35 (1-dichloroacetyl-azepane) from TRI-Chemical RT (S3-8), Diclonon (Dicyclone) or BAS145138 or LAB145138 (S3-9) ((RS)-1 -dichloroacetyl-3,3,8a-trimethylperhydropyrrole[1,2 a]pyrimidin-6-one) from BASF, Furilazole or MON 13900 ((RS)-3-dichloroacetyl-5-(2-furyl)-2,2 dimethyloxazolidine) (S3-10), as well as the (R) isomer (S3-11). S4) Compounds of the acylsulfonamide class (S4): S4a) N-acylsulfonamides of Formula (S4a) and their salts as described in WO-A-97 / 45016,Ra1 OO11II SN—L III OH (RA)mA (S4a) where RA1(C1-C6)alkyl, (C3-C6)cycloalkyl, wherein the last radicals are substituted with vA substituents of the group consisting of halogen, (C1-C4)alkoxy, (Ci-Ce)haloalkoxy and (C1-C4)alkylthio and in the case of cyclic radicals they may also be substituted by (C1-C4)alkyl and (C1C4)haloalkyl; Ra2halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3; mA or 2; goes S4b) is 0, 1, 2 or 3; Compounds of the 4-(benzoylsulfamoyl)benzamide type of Formula (S4b) and their salts, as described in WO-A-99 / 16744, Rb1 N Rb2Z (RB3)mB(S4b) S--N 121 where Rb1, Rb2 independently comprise hydrogen, (C3-C6)alkyl, (C3-C8)cycloalkyl, (C3-C6)alkenyl, (C3-Cs)alkynyl, Rb3 halogen, (C1-C4)alkyl, (C1-C4)haloalkyl or (C1-C4)alkoxy and mBes i or 2, where, for example, Rb1= cyclopropyl, Rb2= hydrogen and (Rb3) = 2-OMe (cyprosulfamide, S4-1), Rb1= cyclopropyl, Rb2= hydrogen and (Rb3) = 5-Cl-2-OMe (S4-2), Rb1= ethyl, Rb2= hydrogen and (Rb3) = 2-OMe (S4-3), Rb1= isopropyl, Rb2= hydrogen and (Rb3) = 5-Cl-2-OMe (S4-4) and Rb1= isopropyl, Rb2= hydrogen and (Rb3) = 2-OMe (S4-5); S4c) Compounds of the benzoylsulfamoylphenylurea class of the Formula (S4c), as described in EP-A-365484, (S4c) where Rc1, Rc2 independently of each other, comprise hydrogen, (C1-C8)alkyl, (C3-C8)cycloalkyl, (C3-C6)alkenyl, (C3-C6)alkynyl, Rc3 halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3 and mCes i or 2; For example 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea; 122 S4d) Compounds of the type of N-phenylsulfonylterephthalamides of Formula (S4d) and their salts, disclosed in CN 101838227, where RD4 halogen, (C1-C4) alkyl, (C1-C4) alkoxy, CF3;mD 1 or 2; RD5 is hydrogen, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C5-C6)cycloalkenyl. S5) Active ingredients of the class of hydroxyaromatic and aromatic-aliphatic carboxylic acid derivatives (S5), such as ethyl ester of 3,4,5-triacetoxybenzoic acid, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicylic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active ingredients of the 1,2-dihydroquinoxalinine-2-one class (S6), such as -methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2dihydro-quinoxalin-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydro-quinoxalin2-one, as described in WO-A-2005 / 112630. S7) Compounds of the class of diphenylmethoxyacetic acid derivatives (S7), such as, for example, methyl ester of the acid 123 diphenylmethoxyacetic acid (CAS Reg. No. 41858-19-9) (S7-1), ethyl ester of diphenylmethoxyacetic acid or diphenylmethoxyacetic acid as described in WOA-98 / 38856. S8) Compounds of Formula (S8), as described in WO-A- 98 / 27049, (Rd1) Rd3(S8) where the symbols and indices have the following meaning: Rd1 is halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1C4)haloalkoxy, Rd2 is hydrogen or (C1-C4)alkyl, Rd3 is hydrogen, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl or aryl, wherein each of the aforementioned C-containing radicals is either unsubstituted or substituted with one or more, preferably up to three, identical or different radicals from the group consisting of a substituted halogen and alkoxy; or their salts, nDes is an integer from 0 to 2. S9) Active ingredients of the 3-(5-tetrazolylcarbonyl)-2-quinolone (S9) class, for example 1,2-dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No.: 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolyl-carbonyl)-2-quinolone (CAS Reg. No.: 95855-00-8), as described in WO-A1999 / 000020. S10) Compounds of Formulas (S10a) or (S10b), as described 124 in WO-A-2007 / 023719 and WO-A-2007 / 023764, where RE1 halogen, (C1-C4) alkyl, methoxy, nitro, cyano, CF3, OCF3 YE, ZE independently of each other, comprise O or S, nE is an integer from 0 to 4, RE2(C1-C16)alkyl, (C2-C6)alkenyl, (C3-C6)cycloalkyl, aryl; benzyl, halobenzyl, RE3 is hydrogen or (C1-C6)alkyl. S11) Active ingredients of the oxyimino (S11) type, known as seed treatment compounds, such as Oxabetrinyl ((Z)-1,3-dioxolan-2-ylmethoxy-imino-(phenyl)acetonitrile) (S11 1), known as a millet seed protectant against damage caused by metolachlor, Fluxofenim (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethan-O-(1,3-dioxolan-2-ylmethyl)-oxime) (S11-2), which is used as a protectant in the treatment of millet seeds against damage caused by metolachlor, and Cyanomethrin or CGA-43089 ((Z)-cyanomethoxy-imin(phenyl)acetonitrile) (S11-3), known as a protectant for the treatment of millet seeds against damage caused by metolachlor. S12) Active ingredients of the isothiochromanone class (S12), 125 such as [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]methyl acetate (CAS Reg. No.: 205121-04-6) (S12-1) and related compounds described in WO-A-1998 / 13361. S13) One or more compounds from group (S13): Naphthalene anhydride (1,8-naphthalenedicarboxylic acid) anhydride (S13-1), known as a protectant in the treatment of millet seeds against damage caused by the herbicide thiocarbamate, Fenchlorim (4,6-dichloro-2-phenylpyrimidine) (S13-2), as a protectant against pretylachlor in sown rice, Flurazol (benzyl-2-chloro-4-trifluoromethyl-1,3-thiazol-5-carboxylate) (S13-3), which is used as a protectant for millet crops against damage caused by alachlor and metolachlor, CL 304415 (CAS Reg. No.: 31541-57-8) (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic) acid (S13-4) from American Cyanamid, known as a protectant in corn against damage caused by imidazolinones, MG 191 (CAS Reg. No.: 96420-72-3) (2-dichloromethyl-2-methyl-1,3-dioxolan) (S13-5) from Nitrokemia, known as a protectant in corn, MG 838 (CAS Reg. No.: 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) from Nitrokemia Disulfoton (O,O-diethyl and S-2-ethylthioethyl phosphorodithioate) (S13-7), Dietolate (O,O-diethyl-O-phenylphosphorothioate) (S13-8), Mephenate (4-chlorophenyl-methylcarbamate) (S13-9). S14) Active ingredients that, in addition to herbicidal activity 126 against harmful plants, exhibit protective activity in cultivated plants such as rice, such as, for example, Dimepiperate or MY-93 (S-1-methyl-1-phenylethyl-piperidin-1-carbothioate), known as a rice protectant against damage caused by the herbicide molinate, Daimuron or SK 23 (1-(1-methyl-1-phenylethyl)-3-p-tolyl-urea), known as a rice protectant against damage caused by the herbicide imazosulfuron, Cumiluron = JC-940 (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, see JP-A-60087270), known as a rice protectant against damage caused by various herbicides, Methoxyphenone or NK 049 (3,3'-dimethyl-4-methoxybenzophenone), known as a rice protectant against damage caused by various herbicides, Kumiai CSB (1-bromo-4-(chloromethylsulfonyl)benzol), (CAS Reg. No.: 54091-06-4), known as a rice protectant against damage caused by various herbicides. S15) Compounds of Formula (S15) or tautomers thereof, as described in WO-A-2008 / 131861 and WO-A-2008 / 131860, wherein Orh'' <Ϊ 1 rhnoHH Rh1 is a (C1-C6)haloalkyl radical and RH2 is hydrogen or halogen and (S15) 127 Rh3, Rh4 independently comprise hydrogen, (Ci-Ci6)alkyl, (C2-C-16)alkenyl or (C2-C1s)alkynyl, wherein each of the last 3 radicals is unsubstituted or substituted with one or more radicals from the halogen group, hydroxy, cyano, (C1C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3Cs)cycloalkyl, each of which may be substituted or unsubstituted, phenyl, substituted or unsubstituted, and heterocyclyl, substituted or unsubstituted, or (C3-Ce)cycloalkyl, (C4-Ce)cycloalkenyl, (C3-Ce)cycloalkyl, fused on one side of the ring to a saturated or unsaturated 4- to 6-membered carbocyclic ring, or (C4-C3)cycloalkenyl, fused on one side of the ring to a saturated or unsaturated 4- to 6-membered carbocyclic ring, wherein each of the last 3 radicals is unsubstituted or substituted with one or more halogen group radicals,hydroxy, cyano, (C1C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1C4)haloalkoxy]carbonyl, (C3-C3)cycloalkyl, each of which may be substituted or unsubstituted, phenyl, substituted or unsubstituted, and heterocyclyl, substituted or unsubstituted, or, Rh3(C1-C4)-alkoxy, (C2-C4)alkenyloxy, (C2-Ce)alkynyloxy or (C2C4)haloalkoxy and Rh4hydrogen or (C1-C4)-alkyl or RH3 and RH4 together with the N atom to which they are attached, comprise a heterocyclic ring of four to eight members, which may contain, in addition to the N atom and other ring heteroatoms, preferably up to 128 two additional ring N and O heteroatoms and S, which are either unsubstituted or substituted with one or more radicals of the halogen, cyano, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy and (C1C4)alkylthio group. S16) Active ingredients that are primarily used as herbicides, but also have a protective effect on crop plants, such as (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (Mecoprop), 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-o-tolyloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (Dicamba), 1-(ethoxycarbonyl)ethyl-3,6-dichloro-2-methoxybenzoate (Lactidichlor-ethyl). The preferred protectants for combining with the compounds of General Formula (I) according to the invention and / or their salts, in particular with the compounds of Formulas (I.1) to (I.662) and / or their salts are: cloquintocet-mexyl, cyprosulfamide, fenchlorazole ethyl ester, isoxadiphen-ethyl, mefenpyrimethyl, fenchlorim, cumiluron, S4-1 and S4-5, and the particularly preferred protectants are: cloquintocet-mexyl, cyprosulfamide, isoxadiphen-ethyl and mefenpyr-diethyl. Biological examples: A. Herbicidal activity in early post-emergence 129 Monocotyledonous or dicotyledonous weed seeds were placed in 96-well microtiter plates in quartz sand and grown in a climate chamber under controlled growth conditions. The test plants were treated at the cotyledon stage, 5 to 7 days after sowing. The compounds according to the invention, formulated as emulsifiable concentrates (ECs), were applied at a rate of 2200 liters per hectare. After 9 to 12 days, the activity of the preparations on the test plants in the climate chamber under optimal growth conditions was compared with that of untreated controls by visual examination. For example, 100% activity = plants are dead, 0% activity = test plants are the same as control plants. The effects of the selected compounds from the General Formula (I) in Table 1 on various weeds and a corresponding application rate of 1900 g / ha, obtained according to the procedure mentioned above, are shown in Tables A1 to A2 below. Table A1: Effect on Agrostis tenuis (AGSTE) in early post-emergence Example No. Dosage [g / ha] AGSTE I-591 1900 100 I-595 1900 100 I-649 1900 100 Table A2: Effect on Poa annua (POAAN) in early post-emergence Example No. Dosage [g / ha] POAAN 130 Example No. Dosage [g / ha] POAAN I-591 1900 100 I-595 1900 100 I-649 1900 100 The test results demonstrate that the compounds of General Formula (I) according to the invention exhibit good herbicidal activity against certain weeds such as Agrostis tenuis (AGSTE) and Poa annua (POAAN) at a respective application rate of 1900 g of active ingredient per hectare in early post-emergence treatment. B. Herbicidal activity and crop compatibility in post-emergence Monocotyledonous or dicotyledonous weed seeds were placed in plastic pots filled with sand (two seeds of one monocotyledonous or dicotyledonous weed species per pot), covered with soil, and grown in a greenhouse under controlled growing conditions. The test plants were treated at the single-leaf stage, 2 to 3 weeks after sowing. The compounds according to the invention, formulated as wettable powders (WP) or emulsifiable concentrates (EC), were then applied to the green parts of the plant as an aqueous suspension or emulsion with the addition of 0.5% additives at a rate of 600 liters per hectare. After approximately 3 weeks, the activity of the preparations on the test plants in the greenhouse under optimal growing conditions was compared with that of untreated controls by visual examination. For example, 100% activity = the plants are 131 dead, 0% activity = test plants are the same as control plants. Tables B1 to B8 below show the effects of the selected compounds from General Formula (I) according to Table 1 on various weeds at an application rate corresponding to 1,280 g / ha, which were obtained according to the test procedure mentioned above. Table B1: Post-emergence effect on Echinochloa crus-galli (ECHCG) Example No. Dosage [g / ha] ECHCG I-158 1280 100 I-210 1280 90 I-212 1280 100 I-216 1280 100 I-478 1280 90 I-479 1280 100 I-481 1280 100 I-484 1280 100 I-487 1280 100 I-500 1280 90 I-504 1280 90 I-515 1280 100 Table B2: Post-emergence effect on Poa annua (POAAN) 132 No. Example Dosage [g / ha] POAAN I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-406 1280 90 I-430 1280 90 I-433 1280 100 I-444 1280 100 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 90 I-484 1280 100 I-485 1280 90 I-486 1280 100 I-487 1280 100 I-488 1280 90 I-500 1280 100 I-504 1280 100 I-511 1280 100 I-515 1280 100 I-522 1280 90 133 Example No. Dosage [g / ha] POAAN I-526 1280 100 I-533 1280 100 Table B3: Post-emergence effect on Abutilon theophrasti (ABUTH) Example No. Dosage [g / ha] ABUTH I-156 1280 100 I-210 1280 90 I-216 1280 100 I-397 1280 90 I-433 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 90 I-483 1280 90 I-484 1280 100 I-485 1280 90 I-486 1280 90 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-511 1280 90 I-520 1280 90 134 Table B4: Post-emergence effect on Amaranthus retroflexus (AMARE) Example No. Dosage [g / ha] AMARE I-154 1280 100 I-156 1280 100 I-158 1280 100 I-216 1280 100 I-406 1280 90 I-430 1280 90 I-433 1280 90 I-438 1280 90 I-441 1280 100 I-450 1280 90 I-465 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 90 I-484 1280 100 I-485 1280 100 I-486 1280 90 I-487 1280 100 I-488 1280 100 I-504 1280 100 135 Example No. Dosage [g / ha] AMARE I-509 1280 100 I-511 1280 100 I-515 1280 100 I-520 1280 100 I-522 1280 100 Table B5: Post-emergence effect on Stellaria media (STEME) Example No. Dosage [g / ha] STEME I-156 1280 100 I-158 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-406 1280 90 I-430 1280 100 I-433 1280 100 I-438 1280 90 I-439 1280 90 I-441 1280 100 I-444 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 136 N° Sample Dosage [g / ha] STEME I-482 1280 100 I-483 1280 100 I-484 1280 100 I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 100 I-511 1280 100 I-515 1280 100 I-522 1280 100 Table B6: Post-emergence effect on Lolium rigidum (LOLRI) N° Sample Dosage [g / ha] STEME I-478 1280 100 I-479 1280 100 I-481 1280 100 I-484 1280 100 I-511 1280 90 I-515 1280 100 Table B7: Post-emergence effect on Setaria viridis (SETVI) 137 N° Sample Dosage [g / ha] STEME I-433 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 90 I-484 1280 100 I-486 1280 100 I-487 1280 90 I-488 1280 100 I-504 1280 100 I-511 1280 90 I-515 1280 90 Table B8: Postemergence effect on Matricaria inodora (MATIN) N° Sample Dosage [g / ha] STEME I-444 1280 90 I-478 1280 90 I-479 1280 100 I-481 1280 90 I-484 1280 100 I-487 1280 100 The test results demonstrate that the compounds in the General formula (I) according to the invention exhibits good activity 138 herbicide against certain weeds such as, for example, Echinochloa crus-galli (ECHCG), Poa annua (POAAN), _Abutilon theophrasti (ABUTH), Amaranthus retroflexus (AMARE), Stellaria media (STEME), Lolium rigidum (LOLRI), Setaria viridis (SETVI) and Matricaria oodora (MATIN) at an application rate of 1280 g of ingredient active per hectare in post-emergence treatment. C. Herbicidal activity and crop compatibility in pre-emergence Monocotyledonous and dicotyledonous weed seeds were placed in plastic pots filled with sand (two seeds of one monocotyledonous or dicotyledonous weed species per pot) and covered with soil. The compounds according to the invention, formulated as wettable powders (WP) or emulsifiable concentrates (EC), were then applied to the surface of the soil as an aqueous suspension or emulsion with the addition of 0.5% additives at a rate of 600 liters per hectare. After treatment, the pots were placed in a greenhouse and maintained under good growing conditions for the test plants. After approximately 3 weeks, the activity of the preparations was visually assessed compared to untreated controls, expressed as a percentage. For example, 100% activity = plants are dead, 0% activity = test plants are the same as control plants. Tables C1 to C8 below show the effects of the selected compounds of General Formula (I) according to Table 1 on various weeds at an application rate corresponding to 1280 g / ha, 139 that were obtained in accordance with the aforementioned testing procedure. Table C1: Pre-emergence effect on Echinochloa crus-galli (ECHCG) Example No. Dosage [g / ha] ECHCG I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-430 1280 100 I-433 1280 100 I-439 1280 100 I-441 1280 100 I-450 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 90 I-484 1280 100 I-485 1280 90 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 140 Example No. Dosage [g / ha] ECHCG I-511 1280 100 I-515 1280 100 I-522 1280 100 I-526 1280 100 I-531 1280 90 I-533 1280 90 Table C2: Pre-emergence effect on Lolium rigidum (LOLRI) Example No. Dosage [g / ha] LOLRI I-210 1280 100 I-212 1280 100 I-216 1280 90 I-397 1280 100 I-406 1280 90 I-430 1280 90 I-433 1280 90 I-441 1280 90 I-444 1280 90 I-450 1280 90 I-465 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 141 Example No. Dosage [g / ha] LOLRI I-482 1280 100 I-483 1280 90 I-484 1280 100 I-485 1280 90 I-486 1280 90 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 90 I-509 1280 90 I-511 1280 90 I-515 1280 90 I-520 1280 100 I-522 1280 90 I-534 1280 100 Table C3: Pre-emergence effect on Poa annua (POAAN) Example No. Dosage [g / ha] POAAN I-154 1280 100 I-156 1280 100 I-158 1280 90 I-210 1280 100 I-212 1280 100 142 No. Example Dosage [g / ha] POAAN I-216 1280 100 I-397 1280 100 I-400 1280 100 I-406 1280 100 I-430 1280 100 I-433 1280 100 I-439 1280 100 I-441 1280 100 I-444 1280 100 I-449 1280 90 I-450 1280 100 I-465 1280 100 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 100 I-484 1280 100 I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 143 Example No. Dosage [g / ha] POAAN I-504 1280 90 I-509 1280 100 I-511 1280 100 I-515 1280 100 I-520 1280 100 I-522 1280 100 I-526 1280 100 I-531 1280 100 I-533 1280 90 Table C4: Pre-emergence effect on Setaria viridis (SETVI) Example No. Dosage [g / ha] SETVI I-154 1280 100 I-156 1280 90 I-158 1280 90 I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-400 1280 100 I-405 1280 100 I-406 1280 100 I-430 1280 100 144 No. Example Dosage [g / ha] SETVI I-433 1280 100 I-439 1280 100 I-441 1280 100 I-444 1280 100 I-450 1280 100 I-465 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 100 I-484 1280 100 I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 100 I-509 1280 90 I-511 1280 100 I-515 1280 100 I-520 1280 90 I-522 1280 100 145 Example No. Dosage [g / ha] SETVI I-526 1280 100 I-531 1280 100 I-533 1280 90 I-534 1280 90 Table C5: Pre-emergence effect on Abutilon theophrasti (ABUTH) Example No. Dosage [g / ha] ABUTH I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-430 1280 100 I-433 1280 100 I-438 1280 90 I-439 1280 100 I-441 1280 100 I-450 1280 100 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 100 I-484 1280 100 146 Example No. Dosage [g / ha] ABUTH I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 90 I-509 1280 100 I-511 1280 100 I-515 1280 100 I-520 1280 90 I-522 1280 100 I-526 1280 100 I-531 1280 100 Table C6: Pre-emergence effect on Amaranthus retroflexus (AMARE) Example No. Dosage [g / ha] AMARE I-154 1280 100 I-156 1280 100 I-158 1280 100 I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 90 147 Example No. Dosage [g / ha] AMARE I-400 1280 90 I-405 1280 100 I-406 1280 90 I-430 1280 100 I-433 1280 100 I-439 1280 90 I-441 1280 100 I-444 1280 100 I-450 1280 90 I-465 1280 100 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 100 I-484 1280 100 I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 100 I-509 1280 100 148 Example No. Dosage [g / ha] AMARE I-511 1280 100 I-515 1280 100 I-520 1280 100 I-522 1280 90 I-526 1280 100 I-531 1280 100 I-534 1280 90 Table C7: Pre-emergence effect on Matricaria inodora (M ATIN) Example No. Dosage [g / ha] MATIN I-154 1280 100 I-156 1280 90 I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-400 1280 90 I-406 1280 100 I-430 1280 100 I-433 1280 100 I-438 1280 100 I-441 1280 100 I-444 1280 100 149 No. Example Dosage [g / ha] MATIN I-450 1280 100 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 I-483 1280 100 I-484 1280 100 I-485 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 90 I-504 1280 90 I-509 1280 100 I-511 1280 100 I-515 1280 100 I-520 1280 100 I-522 1280 90 I-526 1280 100 I-531 1280 100 I-534 1280 90 Table C8: Pre-emergence effect on Stellaria media (STEME) 150 N° Ejemplo Dosificación [g / ha] STEME I-154 1280 100 I-156 1280 100 I-158 1280 100 I-210 1280 100 I-212 1280 100 I-216 1280 100 I-397 1280 100 I-400 1280 100 I-405 1280 100 I-406 1280 100 I-430 1280 100 I-433 1280 100 I-438 1280 100 I-439 1280 100 I-441 1280 100 I-444 1280 100 I-449 1280 100 I-450 1280 100 I-465 1280 90 I-478 1280 100 I-479 1280 100 I-481 1280 100 I-482 1280 100 151 N° Ejemplo Dosificación [g / ha] STEME I-483 1280 100 I-484 1280 100 I-485 1280 100 I-486 1280 100 I-487 1280 100 I-488 1280 100 I-500 1280 100 I-504 1280 100 I-509 1280 100 I-511 1280 100 I-515 1280 100 I-520 1280 100 I-522 1280 100 I-526 1280 100 I-531 1280 100 I-533 1280 100 I-534 1280 100 The test results demonstrate that the compounds of the General Formula (I) according to the invention exhibit good herbicidal activity against certain weeds such as Echinochloa crus-galli (ECHCG), Lolium rigidum (LOLRI), Setaria viridis (SETVI), Poa annua (POAAN), Abutilon theophrasti (ABUTH), Amaranthus retroflexus (AMARE), Stellaria media (STEME) and Matricaria inodora (MATIN) at a dose of 152 application of 1280 g of active ingredient per hectare in the pre-emergence treatment. 153

Claims

1. Substituted 2-heteroaryloxypyridine compounds, characterized in that they are of General Formula (I) or its salts (FORMULA 1) wherein X is nitrogen, -CF- or -CH-, A is oxygen, -S(O)n-, -C(R 4 )(R 5 )-, -C(=O)- or -NR 6 - wherein n is 0, 1 or 2, R 1 is an optionally substituted aryl, heteroaryl, heterocyclyl, (C3-10)-cycloalkyl or (C3-10)-cycloalkenyl, wherein each ring or ring system is optionally substituted with a maximum of 5 substituents selected independently from each other from group R 7 ; R 2 is, independently of each other, halogen, cyano, nitro, formyl, formamide, (C1-8)-alkyl, (C1-8)-haloalkyl, (C2-8)-alkenyl, (C2-8)-alkynyl, (C2-8)-haloalkenyl, (C2-8)-haloalkynyl, (C1-4)-alkoxy-(C1-4)-alkyl, (C1-4)-haloalkoxy-(C1-4)-alkyl, (C1-4)-alkylthio-(C1-4)-alkyl, (C1-4)-alkylsulfinyl-(C1-4)-alkyl, (C1-4)-alkylsulfonyl-(C1-4)-alkyl, (C1-8)-alkylcarbonyl, (C1-8)-haloalkylcarbonyl, (C3-8)-cycloalkylcarbonyl, carboxyl,(C1-8)-alkoxycarbonyl, (C1-8)-haloalkoxycarbonyl, (C3-8)-cycloalkoxycarbonyl, carbamoyl, (C2-8)-alkylaminocarbonyl, (C2-10)-dialkylaminocarbonyl, (C3-10)-cycloalkylaminocarbonyl, (C1-4)-alkoxycarbonyl-(C1-4)-alkyl, (C1-4)-haloalkoxycarbonyl-(C1-4)-alkyl, carboxy-(C1-4)-alkyl, hydroxy, amino, (C1-8)-alkoxy, (C1-8)-haloalkoxy, (C1-8)-alkylthio, (C1-8)-haloalkylthio, (C3-8)-cycloalkylthio, (C1-8)-alkylsulfinyl, (C1-8)-haloalkylsulfinyl, (C3-8)-cycloalkylsulfinyl, (C1-8)-alkylsulfonyl, (C1-8)-haloalkylsulfonyl, (C3-8)-cycloalkylsulfonyl, (C1-8)-alkylaminosulfonyl, (C2-8)-dialkylaminosulfonyl or (C3-8)-trialkylsilyl, m is 0, 1, 2 or 3, R3 is hydrogen, halogen, cyano, nitro, formyl, (C1-8)-alkyl, (C1-8)-haloalkyl, (C2-8)-alkenyl, (C2-8)-alkynyl, (C2-8)-haloalkenyl, (C2-8)-haloalkynyl, (C1-4)-alkoxy-(C1-4)-alkyl, (C1-4)-haloalkoxy-(C1-4)-alkyl, (C1-4)-alkylthio-(C1-4)-alkyl, (C1-4)-alkylsulfinyl-(C1-4)-alkyl,(C1-4)-alkylsulfonyl-(C1-4)-alkyl, (C1-8)-alkylcarbonyl, (C1-8)-haloalkylcarbonyl, (C3-8)-cycloalkylcarbonyl, carboxyl, (C1-8)-alkoxycarbonyl, (C1-8)-haloalkoxycarbonyl, (C3-8)-cycloalkoxycarbonyl, (C1-8)-alkylaminocarbonyl, (C2-8)-dialkylaminocarbonyl, (C3-8)-cycloalkylaminocarbonyl, hydroxy, (C1-8)-alkoxy, (C1-8)-haloalkoxy, (C1-8)-alkylthio, (C1-8)-haloalkylthio, (C3-8)-cycloalkylthio, (C1-8)-alkylsulfinyl, (C1-8)-haloalkylsulfinyl, (C3-8)-cycloalkylsulfinyl, (C1-8)-alkylsulfonyl, (C1-8)-haloalkylsulfonyl, (C3-8)-cycloalkylsulfonyl, (C1-8)-alkylaminosulfonyl, (C2-8)-dialkylaminosulfonyl or (C3-8)-trialkylsilyl, R 4 and R 5 are, independently of each other, hydrogen, hydroxy, halogen, (C1-8)-alkyl, (C1-8)-haloalkyl, (C2-8)-alkenyl, (C2-8)-alkynyl, (C1-4)-alkoxy-(C1-4)-alkyl, (C1-4)-haloalkoxy-(C1-4)-alkyl, (C1-4)-alkylthio-(C1-4)-alkyl, (C1-4)-alkylsulfinyl-(C1-4)-alkyl, (C1-4)-alkylsulfonyl-(C1-4)-alkyl,(C1-8)-alkylcarbonyl, (C1-8)-haloalkylcarbonyl, (C3-8)-cycloalkylcarbonyl, (C1-8)-alkoxycarbonyl, (C1-8)-haloalkoxycarbonyl, (C3-8)-cycloalkoxycarbonyl, (C1-8)-alkylaminocarbonyl, (C2-8)-dialkylaminocarbonyl, (C3-8)-cycloalkylaminocarbonyl, (C1-8)-alkoxy, (C1-8)-alkylthio, (C1-8)-haloalkylthio, (C3-8)-cycloalkylthio, or R4 and R5 together form a 3- to 6-membered carbocyclic ring or a 3- to 6-membered saturated heterocyclic ring having up to 2 oxygen atoms, or R4 and R5 together form a (C1-3)-alkylidene radical or a radical (C1-3)-haloalkylidene, R 6 is hydrogen, (C1-8)-alkyl, (C1-8)-haloalkyl, aryl-(C1-6)-alkyl, heteroaryl-(C1-6)-alkyl, (C3-6)-cycloalkyl, (C3-6)-cycloalkyl-(C1-6)-alkyl, (C3-6)-halocycloalkyl, (C3-6)-halocycloalkyl-(C1-4)-alkyl, (C2-8)-alkenyl, (C2-8)-alkynyl, (C1-4)-alkoxy-(C1-4)-alkyl, (C1-4)-haloalkoxy-(C1-4)-alkyl, (C1-4)-alkylthio-(C1-4)-alkyl, (C1-4)-alkylsulfinyl-(C1-4)-alkyl,(C1-4)-alkylsulfonyl-(C1-4)-alkyl, (C1-8)-alkylcarbonyl, (C1-8)-haloalkylcarbonyl, (C3-8)-cycloalkylcarbonyl, formyl, (C1-8)-alkoxycarbonyl, (C1-8)-haloalkoxycarbonyl, (C3-8)-cycloalkoxycarbonyl, (C1-8)-alkylaminocarbonyl, (C2-8)-dialkylaminocarbonyl, (C3-8)-cycloalkylaminocarbonyl, and R 7 is hydrogen, halogen, cyano, nitro, formyl, (C1-8)-alkyl, (C1-8)-haloalkyl, (C2-8)-alkenyl, (C2-8)-alkynyl, (C2-8)-haloalkenyl, (C2-8)-haloalkynyl, (C1-4)-alkoxy-(C1-4)-alkyl, (C1-4)-haloalkoxy-(C1-4)-alkyl, (C1-4)-alkylthio-(C1-4)-alkyl, (C1-4)-alkylsulfinyl-(C1-4)-alkyl, (C1-4)-alkylsulfonyl-(C1-4)-alkyl, (C1-8)-alkylcarbonyl, (C1-8)-haloalkylcarbonyl, (C3-8)-cycloalkylcarbonyl, carboxyl, (C1-8)-alkoxycarbonyl, (C1-8)-haloalkoxycarbonyl, (C3-8)-cycloalkoxycarbonyl, (C1-8)-alkylaminocarbonyl, (C2-8)-dialkylaminocarbonyl, (C3-8)-cycloalkylaminocarbonyl, hydroxy, (C1-8)-alkoxy, (C1-8)-haloalkoxy, (C1-8)-alkylthio, (C1-8)-haloalkylthio,(C3-8)-cycloalkylthio, (C1-8)-alkylsulfinyl, (C1-8)-haloalkylsulfinyl, (C3-8)-cycloalkylsulfinyl, (C1-8)-alkylsulfonyl, (C1-8)-haloalkylsulfonyl, (C3-8)-cycloalkylsulfonyl, (C1-8)-alkylaminosulfonyl, (C2-8)-dialkylaminosulfonyl or (C3-8)-trialkylsilyl. Twelve claims follow.